EurekaMag Full Text Articles Chapter 53,514

Hossain, N.; Schatz, F.; Paidas, M.J. 2009: Heparin and maternal fetal interface: why should it work to prevent pregnancy complications?. Thrombosis Research 124(6): 653-655

Triolo, G.; Mariano, F. 2008: Heparin and more. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 25(1): 105

Yi Qian; Jing Pan; Xiaodong Zhou; Weiser, P.; Hong Lu; Shih, F.F.; Porche-Sorbet, R.; Eby, C.; Lijuan Zhang 2010: Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 16(3): 251-260

Gonçalves, F.S.; Barretto, L.S.S.; Arruda, R.P.; Perri, S.H.V.; Mingoti, G.Z. 2014: Heparin and penicillamine-hypotaurine-epinephrine (PHE) solution during bovine in vitro fertilization procedures impair the quality of spermatozoa but improve normal oocyte fecundation and early embryonic development. In Vitro Cellular and Developmental Biology. Animal 50(1): 39-47

Jagroop, I.Anita.; Mikhailidis, D.P. 2012: Heparin and platelet activation. Thrombosis Research 130(4): 685; Author Reply 686

Xu, C.; Xu, G.; Tu, W.; Wu, X.; Fang, X.; Huang, T. 2011: Heparin and prednisone-associated priapism: two case reports. Andrologia 43(1): 68-70

Vaheri, A.; Vaheri, A. 2007: Heparin and related polyionic substances as virus inhibitors. 1964. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 115(5): 565-570; Discussion: 571-572

Li, J.; Wu, H.Mei.; Zhang, L.; Zhu, B.; Dong, B.Rong. 2010: Heparin and related substances for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2010(9): Cd005631

Longo-Sorbello, G.S.A.; Gao, H.; Mishra, P.J.; Kamen, B.; Soto, A.; Jimeno, J.; Aracil, M.; Paz de Paz, M.F.; Bertino, J.R.; Banerjee, D. 2009: Heparin and suramin alter plitidepsin uptake via inhibition of GPCR coupled signaling. Journal of ChemoTherapy 21(5): 550-557

Van Doormaal, F.F.; Büller, H.R. 2010: Heparin and survival in cancer patients. Hematology/Oncology Clinics of North America 24(4): 777-784 IX-X

Margetts, P. 2009: Heparin and the peritoneal membrane. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 29(1): 16-19

Naina, H.V.K.; Harris, S. 2008: Heparin and thrombocytopenia: guilty till proven innocent?. Archives of Internal Medicine 168(19): 2169-2170; Author Reply 2171

Asero, R.; Tedeschi, A.; Cugno, M. 2010: Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study. International Archives of Allergy and Immunology 152(4): 384-389

Stoker, S.B.; Pollard, J. 1946: Heparin and trauma effects in blood. Journal of Physiology 105: 15

Heit, J.A.; Lahr, B.D.; Petterson, T.M.; Bailey, K.R.; Ashrani, A.A.; Melton, L.J. 2011: Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood 118(18): 4992-4999

Udit, A.K.; Everett, C.; Gale, A.J.; Reiber Kyle, J.; Ozkan, M.; Finn, M.G. 2009: Heparin antagonism by polyvalent display of cationic motifs on virus-like particles. Chembiochem: a European Journal of Chemical Biology 10(3): 503-510

Conti, C.Richard. 2007: Heparin anticoagulation. Clinical Cardiology 30(4): 154-155

Tanaka, K.A.; Thourani, V.H.; Williams, W.H.; Duke, P.G.; Levy, J.H.; Guyton, R.A.; Puskas, J.D. 2007: Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. Journal of Anesthesia 21(3): 297-303

Alsayegh, F.; Al-Rasheed, M.; Al-Muhaini, A.; Al-Humoud, E.; Al-Ostaz, M.; Mousa, S.A. 2009: Heparin anticoagulation responsiveness in a coronary care unit: a prospective observational study. Cardiovascular Therapeutics 27(2): 77-82

Bulpitt, C.J. 1967: Heparin as an Analgesic in Myocardial Infarction: A Double-blind Trial. British Medical Journal 3(5560): 279-281

Zacharski, L.R.; Lee, A.Y. 2008: Heparin as an anticancer therapeutic. Expert Opinion on Investigational Drugs 17(7): 1029-1037

Borsig, L. 2010: Heparin as an inhibitor of cancer progression. Progress in Molecular Biology and Translational Science 93: 335-349

Matsuoka, T.; Inoue, K.; Mizuno, K.; Kita, Y.; Nakanishi, S.; Asai, S.; Taoka, R.; Soda, T.; Terai, A. 2012: Heparin as bridging anticoagulant and antiplatelet therapy during the perioperative period. Hinyokika Kiyo. Acta Urologica Japonica 58(5): 223-226

Rodríguez-Torres, M.del.Pilar.; Díaz-Torres, L.Armando.; Romero-Servin, S. 2014: Heparin assisted photochemical synthesis of gold nanoparticles and their performance as SERS substrates. International Journal of Molecular Sciences 15(10): 19239-19252

Rostelato-Ferreira, S.; Leite, G.B.; Cintra, A.él.C.O.; da Cruz-Höfling, M.A.; Rodrigues-Simioni, L.éa.; Oshima-Franco, Y. 2010: Heparin at low concentration acts as antivenom against Bothrops jararacussu venom and bothropstoxin-i neurotoxic and myotoxic actions. Journal of Venom Research 1: 54-60

Senak, M. 2008: Heparin at the center of the storm. American Health and Drug Benefits 1(6): 23-24

Liu, Y.; He, Y.; Wu, X.; Zhang, S.; Chong, Z.; Jiang, Y.; Zhou, C.; Jin, X. 2014: Heparin attenuates HMGB1 expression in arterial tissue subjected to limb ischemia/reperfusion. International Journal of Cardiology 176(2): 543-546

Mu, E.; Ding, R.; An, X.; Li, X.; Chen, S.; Ma, X. 2014: Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and transforming growth factor -β/Smad signaling pathway. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26(11): 810-814

Nurunnabi, M.; Khatun, Z.; Moon, W-Choon.; Lee, G.; Lee, Y-Kyu. 2012: Heparin based nanoparticles for cancer targeting and noninvasive imaging. Quantitative Imaging in Medicine and Surgery 2(3): 219-226

Esquibies, A.E.; Karihaloo, A.; Quaggin, S.E.; Bazzy-Asaad, A.; Cantley, L.G. 2014: Heparin binding VEGF isoforms attenuate hyperoxic embryonic lung growth retardation via a FLK1-neuropilin-1-PKC dependent pathway. Respiratory Research 15: 32

Dapino, D.; Teijeiro, J.; Cane, F.; Marini, P.E. 2014: Heparin binding analysis of boar sperm and its relation with farrowing capacity. Acta Veterinaria Hungarica 62(1): 96-105

Vieira, T.C.R.G.; Reynaldo, D.P.; Gomes, M.P.B.; Almeida, M.S.; Cordeiro, Y.; Silva, J.L. 2011: Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species. Journal of the American Chemical Society 133(2): 334-344

Kumar, S.; Tomar, A.K.; Singh, S.; Gill, K.; Dey, S.; Singh, S.; Yadav, S. 2014: Heparin binding carboxypeptidase e protein exhibits antibacterial activity in human semen. International Journal of Biological Macromolecules 64: 319-327

Vieira, T.C.R.G.; Cordeiro, Y.; Caughey, B.; Silva, J.L. 2014: Heparin binding confers prion stability and impairs its aggregation. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 28(6): 2667-2676

Chillakuri, C.R.; Jones, C.él.; Mardon, H.J. 2010: Heparin binding domain in vitronectin is required for oligomerization and thus enhances integrin mediated cell adhesion and spreading. Febs Letters 584(15): 3287-3291

Mulder, G.M.; Nijboer, W.N.; Seelen, M.A.; Sandovici, M.; Bos, E.M.; Melenhorst, W.B.W.H.; Trzpis, M.; Kloosterhuis, N.J.; Visser, L.; Henning, R.H.; Leuvenink, H.G.D.; Ploeg, R.J.; Sunnarborg, S.W.; van Goor, H. 2010: Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury. Journal of Pathology 221(2): 183-192

Nash, R.J.; Heimburg-Molinaro, J.; Nash, R.J. 2009: Heparin binding epidermal growth factor-like growth factor reduces ethanol-induced apoptosis and differentiation in human embryonic stem cells. Growth Factors 27(6): 362-369

Kaukonen, K-Maija.; Herwald, H.; Lindbom, L.; Pettila, V. 2013: Heparin binding protein in patients with acute respiratory failure treated with granulocyte colony-stimulating factor (filgrastim)--a prospective, placebo-controlled, double-blind study. Bmc Infectious Diseases 13: 51

Solomon, J.P.; Bourgault, S.; Powers, E.T.; Kelly, J.W. 2011: Heparin binds 8 kDa gelsolin cross-β-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension. Biochemistry 50(13): 2486-2498

Nakayama, Y.; Okahashi, R.; Iwai, R.; Uchida, K. 2007: Heparin bioconjugate with a thermoresponsive cationic branched polymer: a novel aqueous antithrombogenic coating material. Langmuir 23(15): 8206-8211

Carlsson, P.; Kjellén, L. 2012: Heparin biosynthesis. Handbook of Experimental Pharmacology 2012(207): 23-41

Gu, L.; Wang, H.; Guo, Y-Lan.; Zen, K. 2008: Heparin blocks the adhesion of E. coli O157:H7 to human colonic epithelial cells. Biochemical and Biophysical Research Communications 369(4): 1061-1064

Atai, N.A.; Balaj, L.; van Veen, H.; Breakefield, X.O.; Jarzyna, P.A.; Van Noorden, C.J.F.; Skog, J.; Maguire, C.A. 2013: Heparin blocks transfer of extracellular vesicles between donor and recipient cells. Journal of Neuro-Oncology 115(3): 343-351

Davidson, I.; Hackerman, C.; Kapadia, A.; Minhajuddib, A. 2009: Heparin bonded hemodialysis e-PTFE grafts result in 20% clot free survival benefit. Journal of Vascular Access 10(3): 153-156

Allemang, M.T.; Schmotzer, B.; Wong, V.L.; Chang, A.; Lakin, R.O.; Woodside, K.J.; Wang, J.; Kashyap, V.S. 2014: Heparin bonding does not improve patency of polytetrafluoroethylene arteriovenous grafts. Annals of Vascular Surgery 28(1): 28-34

Vanassche, T.; Lauw, M.N.; Connolly, S.J.; Eikelboom, J.W. 2014: Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far?. European Heart Journal 35(28): 1831-1833

Bonnet-Zamponi, D.; Aumont, M-Claude.; Comets, E.; Bruhat, C.; Chauveheid, M-Paule.; Duval, X.; Huisse, M-Genviève.; Diquet, B.; Berrut, G.; Mentre, F.; Delpierre, S.; Legrain, S. 2011: Heparin bridging therapy and bleeding events in octogenarian inpatients with atrial fibrillation starting anticoagulation: results of an ancillary study. Journal of the American Geriatrics Society 59(11): 2174-2178

Lahtela, H.; Rubboli, A.; Schlitt, A.; Karjalainen, P.P.; Niemelä, M.; Vikman, S.; Puurunen, M.; Weber, M.; Valencia, J.è; Biancari, F.; Lip, G.Y.H.; Airaksinen, K.E.J.; Lahtela, H.; Porela, P.; Airaksinen, K.E.J.; Niemelä, M.; Kervinen, K.; Biancari, F.; Karjalainen, P.; Mikkelsson, J.; Ylitalo, A.; Puurunen, M.; Laine, M.; Vikman, S.; Annala, A.-P.; Tuomainen, P.; Nyman, K.; Sia, J.; Schlitt, A.; Kirchhof, P.; Weber, M.; Ehret, J.; Thiele, H.; Woinke, M.; Kreuzer, J.; Rubboli, A.; Vecchia, L.; Lip, G.Y.H.; Valencia, J. 2012: Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry. Circulation Journal: Official Journal of the Japanese Circulation Society 76(6): 1363-1368

Truss, N.J.; Armstrong, P.C.J.; Liverani, E.; Vojnovic, I.; Warner, T.D. 2009: Heparin but not citrate anticoagulation of blood preserves platelet function for prolonged periods. Journal of Thrombosis and Haemostasis: Jth 7(11): 1897-1905

Barna, G.áb.; Sebestyén, A.; Dunai, Z.A.; Csernus, B.áz.; Mihalik, R. 2012: Heparin can liberate high molecular weight DNA from secondary necrotic cells. Cell Biology International 36(12): 1281-1286

Ling, Y.; Yang, Z.-Y.; Yin, T.; Li, L.; Yuan, W.-W.; Wu, H.-S.; Wang, C.-Y. 2011: Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro. International Immunopharmacology 11(2): 187-193

Jones, C.J.; Beni, S.; Limtiaco, J.F.K.; Langeslay, D.J.; Larive, C.K. 2011: Heparin characterization: challenges and solutions. Annual Review of Analytical Chemistry 4: 439-465

Liao, W.-Y.; Ho, C.-C.; Hou, H.-H.; Hsu, T.-H.; Tsai, M.-F.; Chen, K.-Y.; Chen, H.-Y.; Lee, Y.-C.; Yu, C.-J.; Lee, C.-H.; Yang, P.-C. 2015: Heparin co-factor Ii enhances cell motility and promotes metastasis in non-small cell lung cancer. Journal of Pathology 235(1): 50-64

Cai, W.-W.; Gu, Y.J.; Wang, X.-N.; Chen, C.-Z. 2009: Heparin coating of small-caliber decellularized xenografts reduces macrophage infiltration and intimal hyperplasia. Artificial Organs 33(6): 448-455

Church, F.C.; Hoffman, M.R. 1994: Heparin cofactor Ii and thrombin Heparin-binding proteins linking hemostasis and inflammation. Trends in Cardiovascular Medicine 4(3): 140-146

Aihara, K.-I.; Azuma, H.; Akaike, M.; Sata, M.; Matsumoto, T. 2009: Heparin cofactor Ii as a novel vascular protective factor against atherosclerosis. Journal of Atherosclerosis and Thrombosis 16(5): 523-531

Aihara, K.-i. 2010: Heparin cofactor Ii attenuates vascular remodeling in humans and mice. Circulation Journal: Official Journal of the Japanese Circulation Society 74(8): 1518-1523

Rau, J.C.; Deans, C.; Hoffman, M.R.; Thomas, D.B.; Malcom, G.T.; Zieske, A.W.; Strong, J.P.; Koch, G.G.; Church, F.C. 2009: Heparin cofactor Ii in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Experimental and Molecular Pathology 87(3): 178-183

Aihara, K.-i.; Azuma, H.; Akaike, M.; Kurobe, H.; Takamori, N.; Ikeda, Y.; Sumitomo, Y.; Yoshida, S.; Yagi, S.; Iwase, T.; Ishikawa, K.; Sata, M.; Kitagawa, T.; Matsumoto, T. 2009: Heparin cofactor Ii is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors. Journal of Atherosclerosis and Thrombosis 16(2): 127-134

Sumitomo-Ueda, Y.; Aihara, K.-I.; Ise, T.; Yoshida, S.; Ikeda, Y.; Uemoto, R.; Yagi, S.; Iwase, T.; Ishikawa, K.; Hirata, Y.; Akaike, M.; Sata, M.; Kato, S.; Matsumoto, T. 2010: Heparin cofactor Ii protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice. Hypertension 56(3): 430-436

Pandey, S.K.; Singh, A.; Dubey, A.P.; Mishra, T.K.; Kapoor, S. 2014: Heparin cofactor Ii thrombin complex as a biomarker for mucopolysaccharidosis: Indian experience. Indian Pediatrics 51(2): 128-130

Ikeda, Y.; Aihara, K.-i.; Yoshida, S.; Iwase, T.; Tajima, S.; Izawa-Ishizawa, Y.; Kihira, Y.; Ishizawa, K.; Tomita, S.; Tsuchiya, K.; Sata, M.; Akaike, M.; Kato, S.; Matsumoto, T.; Tamaki, T. 2012: Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway. Journal of Biological Chemistry 287(41): 34256-34263

Langford-Smith, K.J.; Mercer, J.; Petty, J.; Tylee, K.; Church, H.; Roberts, J.; Moss, G.; Jones, S.; Wynn, R.; Wraith, J.E.; Bigger, B.W. 2011: Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases. Journal of Inherited Metabolic Disease 34(2): 499-508

Randall, D.R.; Colobong, K.E.; Hemmelgarn, H.; Sinclair, G.B.; Hetty, E.; Thomas, A.; Bodamer, O.A.; Volkmar, B.; Fernhoff, P.M.; Casey, R.; Chan, A.K.; Mitchell, G.; Stockler, S.; Melancon, S.; Rupar, T.; Clarke, L.A. 2008: Heparin cofactor II-thrombin complex: a biomarker of MPS disease. Molecular Genetics and Metabolism 94(4): 456-461

Schwartz, L.B. 2008: Heparin comes clean. New England Journal of Medicine 358(23): 2505-2509

Beigi, A.A.; HadiZadeh, M.S.; Salimi, F.; Ghaheri, H. 2014: Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: a randomized controlled trial. Advanced Biomedical Research 3: 121

Hemeda, H.; Kalz, J.; Walenda, G.; Lohmann, M.; Wagner, W. 2013: Heparin concentration is critical for cell culture with human platelet lysate. CytoTherapy 15(9): 1174-1181

Garvin, S.; FitzGerald, D.C.; Despotis, G.; Shekar, P.; Body, S.C. 2010: Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements. Anesthesia and Analgesia 111(4): 849-855

Davidson, S.J.; Tillyer, M.L.; Keogh, J.; Hall, J.; Kelleher, A.A. 2012: Heparin concentrations in neonates during cardiopulmonary bypass. Journal of Thrombosis and Haemostasis: Jth 10(4): 730-732

Keogh, J.; Davidson, S.J.; Machin, M.; Hall, J.; Kelleher, A.A. 2009: Heparin concentrations in neonates during cardiopulmonary bypass as measured by the activated clotting time and anti-Xa assay. Anaesthesia 64(12): 1388-1389

Ignjatovic, V.; Newall, F.; Monagle, P. 2012: Heparin concentrations in neonates during cardiopulmonary bypass: a rebuttal. Journal of thrombosis and haemostasis: JTH 10(9): 1972

Mullin, M. 2010: Heparin confusion. Radiologic Technology 82(1): 11

Maguire, C.M.; Mahfoud, O.K.; Rakovich, T.; Gerard, V.A.; Prina-Mello, A.; Gun'ko, Y.; Volkov, Y. 2014: Heparin conjugated quantum dots for in vitro imaging applications. Nanomedicine: Nanotechnology Biology and Medicine 10(8): 1853-1861

Rosania, L. 2010: Heparin crisis 2008: a tipping point for increased FDA enforcement in the pharma sector?. Food and Drug Law Journal 65(3): 489-501 Ii

Skop, N.B.; Calderon, F.; Levison, S.W.; Gandhi, C.D.; Cho, C.H. 2013: Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair. Acta Biomaterialia 9(6): 6834-6843

Minsky, B.B.; Nguyen, T.V.; Peyton, S.R.; Kaltashov, I.A.; Dubin, P.L. 2013: Heparin decamer bridges a growth factor and an oligolysine by different charge-driven interactions. Biomacromolecules 14(11): 4091-4098

Kos, M.Kerec.; Bogataj, M.; Mrhar, A. 2008: Heparin decreases permeability of pig urinary bladder wall preliminarily enhanced by chitosan. Drug Development and Industrial Pharmacy 34(2): 215-220

Nitz, M.; Rullo, A.; Ding, M.X.Y. 2008: Heparin dependent coiled-coil formation. Chembiochem: a European Journal of Chemical Biology 9(10): 1545-1548

Seeger, F.H.; Rasper, T.; Fischer, A.; Muhly-Reinholz, M.; Hergenreider, E.; Leistner, D.M.; Sommer, K.; Manavski, Y.; Henschler, R.; Chavakis, E.; Assmus, B.; Zeiher, A.M.; Dimmeler, S. 2012: Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair. Circulation Research 111(7): 854-862

Viskov, C.; Elli, S.; Urso, E.; Gaudesi, D.; Mourier, P.; Herman, F.; Boudier, C.; Casu, B.; Torri, G.; Guerrini, M. 2013: Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties. Journal of Biological Chemistry 288(36): 25895-25907

Lindstedt, S.; Pierre, L.; Hlebowicz, J.; Ingemansson, R. 2013: Heparin does not seem to improve the function of pulmonary grafts for lung transplantation. Scandinavian Cardiovascular Journal: Scj 47(5): 307-313

Meng, S.; Rouabhia, M.; Shi, G.; Zhang, Z. 2008: Heparin dopant increases the electrical stability, cell adhesion, and growth of conducting polypyrrole/poly(L,L-lactide) composites. Journal of Biomedical Materials Research. Part a 87(2): 332-344

Aronow, H.D. 2012: Heparin dose and harm: absence of evidence or evidence of absence?. Journal of Invasive Cardiology 24(4): 157-158

Rosin, M.W.; Holt, D. 2013: Heparin dose and postoperative bleeding in patients undergoing cardiopulmonary bypass. Journal of Extra-Corporeal Technology 45(4): 228-234

Garvin, S.; Fitzgerald, D.; Muehlschlegel, J.D.; Perry, T.ör.E.; Fox, A.A.; Shernan, S.K.; Collard, C.D.; Aranki, S.; Body, S.C. 2010: Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations. Anesthesia and Analgesia 111(4): 856-861

Wahby, K.A.; Jhajhria, S.; Dalal, B.D.; Soubani, A.O. 2014: Heparin dosing in critically ill patients undergoing therapeutic hypothermia following cardiac arrest. Resuscitation 85(4): 533-537

Lim Fat, M.J.; Al-Hazzaa, M.; Bussière, M.; dos Santos, M.P.; Lesiuk, H.; Lum, C. 2013: Heparin dosing is associated with diffusion weighted imaging lesion load following aneurysm coiling. Journal of Neurointerventional Surgery 5(4): 366-370

Kincaid, K. 2007: Heparin during neonatal bypass. Perfusion 22(2): 143

Thalheimer, U.; Triantos, C.; Samonakis, D.; Patch, D.; Burroughs, A.K. 2009: Heparin effect on thromboelastography after transjugular intrahepatic portosystemic shunt procedure. Scandinavian Journal of Gastroenterology 44(12): 1463-1470

Julianelli, V.; Farrando, B.; Alvarez Sedó, C.; Calvo, L.; Romanato, M.; Calvo, J.C. 2012: Heparin enhances protamine disulfide bond reduction during in vitro decondensation of human spermatozoa. Human Reproduction 27(7): 1930-1938

Higgins, W.J.; Fox, D.M.; Kowalski, P.S.; Nielsen, J.E.; Worrall, D.M. 2010: Heparin enhances serpin inhibition of the cysteine protease cathepsin L. Journal of Biological Chemistry 285(6): 3722-3729

Hedberg, A.; Fismen, S.; Fenton, K.A.; Fenton, C.; Osterud, B.; Mortensen, E.S.; Rekvig, O.Petter. 2011: Heparin exerts a dual effect on murine lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin binding in glomerular membranes. Arthritis and Rheumatism 63(4): 1065-1075

Arimateia, D.S.; da Silva Brito, A.; de Azevedo, F.M.; de Andrade, G.P.V.; Chavante, S.F. 2015: Heparin fails to inhibit the leukocyte recruitment for an extended time following inflammatory stimulus. Pharmaceutical Biology 53(1): 72-77

Mitchell, M.D.; Anderson, B.J.; Williams, K.; Umscheid, C.A. 2009: Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. Journal of Advanced Nursing 65(10): 2007-2021

Berge, E. 2007: Heparin for acute ischaemic stroke: a never-ending story?. Lancet. Neurology 6(5): 381-382

Kement, M.; Censur, Z.; Oncel, M.; Buyukokuroglu, M.E.; Gezen, F.C. 2011: Heparin for adhesion prevention: comparison of three different dosages with Seprafilm in a murine model. International Journal of Surgery 9(3): 225-228

Akhtar, M.A.; Sur, S.; Raine-Fenning, N.; Jayaprakasan, K.; Thornton, J.G.; Quenby, S. 2013: Heparin for assisted reproduction. Cochrane Database of Systematic Reviews 8: Cd009452

Akhtar, M.Ahsan.; Sur, S.; Raine-Fenning, N.; Jayaprakasan, K.; Thornton, J.; Quenby, S.; Marjoribanks, J. 2015: Heparin for assisted reproduction: summary of a Cochrane review. Fertility and Sterility 103(1): 33-34

Wilshaw, R.H.; Hannon, J.H.; Stoker, S.B. 1947: Heparin for coronary thrombosis. British Medical Journal 2(4533): 838

Yu, Y.-H.; Shen, L.-Y.; Zou, H.; Wang, Z.-J.; Gong, S.-P. 2010: Heparin for patients with growth restricted fetus: a prospective randomized controlled trial. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 23(9): 980-987

Alikhan, R.; Bedenis, R.; Cohen, A.T. 2014: Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction). Cochrane Database of Systematic Reviews 2014(5): Cd003747

Alikhan, R.; Cohen, A.T. 2009: Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database of Systematic Reviews 2009(3): Cd003747

Liu, Z.; Zhu, H.; Ma, X. 2014: Heparin for treatment of sepsis: a systemic review. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26(3): 135-141

Tovar, A.M.F.; Capillé, N.V.M.; Santos, G.R.C.; Vairo, B.C.; Oliveira, S.-N.M.C.G.; Fonseca, R.J.C.; Mourão, P.A.S. 2012: Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects. Thrombosis and Haemostasis 107(5): 903-915

Pitarresi, G.; Fiorica, C.; Palumbo, F.S.; Rigogliuso, S.; Ghersi, G.; Giammona, G. 2014: Heparin functionalized polyaspartamide/polyester scaffold for potential blood vessel regeneration. Journal of Biomedical Materials Research. Part a 102(5): 1334-1341

Hashii, N.; Kawasaki, N.; Itoh, S.; Qin, Y.; Fujita, N.; Hattori, T.; Miyata, K.; Bando, A.; Sekimoto, Y.; Hama, T.; Kashimura, M.; Tatsumi, M.; Mabuchi, K.; Namekawa, H.; Sakai, T.; Hirose, M.; Dobashi, S.; Shimahashi, H.; Koyama, S.; Herr, S.O.; Kawai, K.; Yoden, H.; Yamaguchi, T. 2010: Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography. Biologicals: Journal of the International Association of Biological Standardization 38(5): 539-543

Lee, K.; Lee, H.; Bae, K.Hyun.; Park, T.Gwan. 2010: Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells. Biomaterials 31(25): 6530-6536

Benítez, M.; González Gómez, I.; González Carmelo, I.; Palma, A.; Cruz, S.; Rodríguez, E.; Amián, A.; Fernández M, F.; Merino, M.J.; Fernández G, F.; Suárez, C.; Onaindía, J.M.; González, J. 2007: Heparin immune thrombocytopenia in a hemodialysis patient. A case report. Literature review. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(6): 756-760

Shen, X.; Fang, J.; Lv, X.; Pei, Z.; Wang, Y.; Jiang, S.; Ding, K. 2011: Heparin impairs angiogenesis through inhibition of microRNA-10b. Journal of Biological Chemistry 286(30): 26616-26627

Dockeray, G.C.; Kawerau, E. 1940: Heparin in Subacute Bacterial Endocarditis. British Medical Journal 2(4168): 703

Chamorro, A. 2008: Heparin in acute ischemic stroke revisited. Revue Neurologique (Paris) 164(10): 815-818

Levene, D.L. 1973: Heparin in clinical medicine. Canadian Family Physician Medecin de Famille Canadien 19(2): 75-76

Macmillan, A.E. 1947: Heparin in empyema; report of a case. Diseases of the Chest 13(6): 686-688

Chacko, M.K.; Mathew, T.; Sugathan, P.; Nair, L.V. 1998: Heparin in psoriasis. Indian Journal of Dermatology Venereology and Leprology 64(6): 273-274

Pechlaner, C.; Joannidis, M. 2007: Heparin in sepsis treatment. Lancet 370(9589): 738; Author Reply 738

Massie, F.M. 1945: Heparin in the Abdomen : A Clinical Report. Annals of Surgery 121(4): 508-516

Hiremath, M.; Elder, J.; Newall, F.; Mitchell, S.; Dyas, R.; Monagle, P. 2011: Heparin in the long-term management of ligneous conjunctivitis: a case report and review of literature. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 22(7): 606-609

Gresele, P.; Busti, C.; Paganelli, G. 2012: Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. Handbook of Experimental Pharmacology 207: 179-209

Dernaika, T.A.; Kinasewitz, G.T. 2008: Heparin in the treatment of severe sepsis: a new look at an old therapy. Critical Care Medicine 36(11): 3098-3099

Loewe, L.; Hirsch, E. 1947: Heparin in the treatment of thromboembolic disease. Journal of the American Medical Association 133(17): 1263-1268

Maeck, J.V.S.; Zilliacus, H. 1948: Heparin in the treatment of toxemia of pregnancy; a preliminary report. American Journal of Obstetrics and Gynecology 55(2): 326-331

Yaoita, E.; Yoshida, Y.; Nameta, M.; Zhang, Y.; Fujinaka, H.; Magdeldin, S.; Xu, B.; Yamamoto, T. 2014: Heparin increasing podocyte-specific gene expressions. Nephrology 19(4): 195-201

Hoefgen, S.; Coburger, I.; Roeser, D.; Schaub, Y.; Dahms, S.O.; Than, M.E. 2014: Heparin induced dimerization of APP is primarily mediated by E1 and regulated by its acidic domain. Journal of Structural Biology 187(1): 30-37

Shen, Y-Xiang.; Zhu, Z-Yu.; Wu, H. 2012: Heparin induced fulminant thrombocytopenia:one case report. Zhonghua Xin Xue Guan Bing Za Zhi 40(2): 98

Zaman, S.R.; Rawlins, J.M. 2014: Heparin induced thrombocytopaenia (HIT) as a cause of free flap failure in lower limb trauma. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 67(6): 884-886

Maurer, S.H.; Wilimas, J.A.; Wang, W.C.; Reiss, U.M. 2009: Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child. Pediatric Blood and Cancer 53(3): 468-471

Ban-Hoefen, M.; Francis, C. 2009: Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital. Thrombosis Research 124(2): 189-192

Kouerinis, I.A.; Kourtesis, A.; El-Ali, M.; Sergentanis, T.; Plagou, A.; Argiriou, M.; Theakos, N.; Giannakopoulou, A. 2008: Heparin induced thrombocytopenia diagnosis in cardiac surgery: is there a role for thromboelastography?. Interactive Cardiovascular and Thoracic Surgery 7(4): 560-563

Chaubey, S.; Davidson, S.J.; Desouza, A.C. 2009: Heparin induced thrombocytopenia in a patient with factor V Leiden following cardiac surgery. Interactive Cardiovascular and Thoracic Surgery 9(6): 1023-1025

Nocera, P.; Thiranos, J.C.; Steib, A.; Morelli, U. 2008: Heparin induced thrombocytopenia in patients with ventricular assistance device bridge-to-transplantation. a case series. Minerva Cardioangiologica 56(6): 697-701

Meera, R.; Rachel, D.; Ramakrishnapillai, V.; Vijayaraghavan, G. 2007: Heparin induced thrombocytopenia management with bivalirudin. Indian Heart Journal 59(4): 354-355

Dandekar, U.; Young, J.; Kalkat, M.; Satur, C.M.R. 2004: Heparin induced thrombocytopenia type Ii complicating coronary artery bypass surgery: a tale of caution. Interactive Cardiovascular and Thoracic Surgery 3(1): 121-123

Thachil, J. 2008: Heparin induced thrombocytopenia with thrombosis: a two step process?. Hematology 13(3): 181-182

Majeed, T.A. 2010: Heparin induced thrombocytopenia-type 2. Asian Journal of Transfusion Science 4(2): 137

Cohen, R.A.; Castellano, M.; Garcia, C.A. 2012: Heparin induced thrombocytopenia: case presentation and review. Journal of Clinical Medicine Research 4(1): 68-72

Alaraj, A.; Wallace, A.; Tesoro, E.; Ruland, S.; Amin-Hanjani, S.; Charbel, F.T.; Aletich, V. 2010: Heparin induced thrombocytopenia: diagnosis and management. Journal of Neurointerventional Surgery 2(4): 371-378

Ahmed, I.; Majeed, A.; Powell, R. 2007: Heparin induced thrombocytopenia: diagnosis and management update. Postgraduate Medical Journal 83(983): 575-582

Castelli, R.; Cassinerio, E.; Cappellini, M.D.; Porro, F.; Graziadei, G.; Fabris, F. 2007: Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects. Cardiovascular and Hematological Disorders Drug Targets 7(3): 153-162

Dasararaju, R.; Singh, N.; Mehta, A. 2013: Heparin induced thrombocytopenia: review. Expert Review of Hematology 6(4): 419-428

Royston, D. 2007: Heparin induced thrombotic thrombocytopaenia +/- thrombosis. Acta Anaesthesiologica Belgica 58(4): 243

Ueda, K.; Inoue, S.; Zhang, Y.; Kutsuna, T.; Inoue, S.; Noto, K.; Arai, N.; Noguchi, M. 2009: Heparin induces apoptosis through suppression of AKt in oral squamous cell carcinoma cells. Anticancer Research 29(4): 1079-1088

Vilasi, S.; Sarcina, R.; Maritato, R.; De Simone, A.; Irace, G.; Sirangelo, I. 2011: Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro. Plos one 6(7): E22076

Paredes-Gamero, E.J.; Medeiros, V.ír.P.; Farias, E.H.C.; Justo, G.Z.; Trindade, E.S.; Andrade-Lopes, A.L.; Godinho, R.O.; de Miranda, A.; Ferreira, A.T.; Tersariol, I.L.S.; Nader, H.B. 2010: Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors. Hypertension 56(4): 713-721

Zibaeenezhad, M.J.; Mazloum, Y. 2009: Heparin infusion after successful percutaneous coronary intervention: a prospective, randomized trial. Acta Cardiologica 64(1): 65-70

Bernabucci, G.; Marchetti, S.; Quarti, A.; Oggianu, A.; Pozzi, M. 2012: Heparin infusion and haemorrhagic complications in patients treated with modified Blalock-Taussig shunt: significance of a nurse and medical audit. European Journal of Cardiovascular Nursing 11(4): 419-422

Khouzam, R.N.; Soufi, M.K.; Weatherly, M. 2013: Heparin infusion through a central line misplaced in the carotid artery leading to hemorrhagic stroke. Journal of Emergency Medicine 45(3): E87-E89

Kanzaki, S.; Takahashi, T.; Kanno, T.; Ariyoshi, W.; Shinmyouzu, K.; Tujisawa, T.; Nishihara, T. 2008: Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. Journal of Cellular Physiology 216(3): 844-850

Ozen, E.; Gozukizil, A.; Erdal, E.; Uren, A.; Bottaro, D.P.; Atabey, N. 2012: Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1. Plos one 7(8): E42717

Wei, W.; Zuo, Y.; Hu, Y.; Wang, L.; Jia, L.; Zhang, J. 2009: Heparin inhibits P388D1 cells adherence and metastasis to peripheral lymph nodes in vitro and in vivo. Lymphology 42(1): 10-18

Spratte, J.; Meyer zu Schwabedissen, H.; Endlich, N.; Zygmunt, M.; Fluhr, H. 2013: Heparin inhibits TNF-α signaling in human endometrial stromal cells by interaction with NF-κB. Molecular Human Reproduction 19(4): 227-236

Lee, M.J. 2013: Heparin inhibits activation of latent transforming growth factor-β1. Pharmacology 92(5-6): 238-244

Xie-Zukauskas, H.; Das, J.; Short, B.L.; Gutkind, J.S.; Ray, P.E. 2013: Heparin inhibits angiotensin II-induced vasoconstriction on isolated mouse mesenteric resistance arteries through Rho-A- and PKA-dependent pathways. Vascular Pharmacology 58(4): 313-318

Zhao, S.; Zhang, X.; Zhang, X.; Shi, X.; Yu, Z.; Kan, Q. 2014: Heparin inhibits burn-induced spleen cell apoptosis by suppressing interleukin-1 expression. Chinese Medical Journal 127(13): 2463-2469

Lobov, G.I.; Pan'kova, M.N. 2010: Heparin inhibits contraction of smooth muscle cells in lymphatic vessels. Bulletin of Experimental Biology and Medicine 149(1): 4-6

Fluhr, H.; Spratte, J.; Heidrich, S.; Ehrhardt, J.; Steinmüller, F.; Zygmunt, M. 2011: Heparin inhibits interferon-γ signaling in human endometrial stromal cells by interference with the cellular binding of interferon-γ. Fertility and Sterility 95(4): 1272-1277

Makino-Okamura, C.; Niki, Y.; Takeuchi, S.; Nishigori, C.; Declercq, L.; Yaroch, D.B.; Saito, N. 2014: Heparin inhibits melanosome uptake and inflammatory response coupled with phagocytosis through blocking PI3k/Akt and MEK/ERK signaling pathways in human epidermal keratinocytes. Pigment Cell and Melanoma Research 27(6): 1063-1074

Bazar, E.; Sheynis, T.; Dorosz, J.; Jelinek, R. 2011: Heparin inhibits membrane interactions and lipid-induced fibrillation of a prion amyloidogenic determinant. Chembiochem: a European Journal of Chemical Biology 12(5): 761-767

Ogawa, T.; Shimizu, S.; Tojima, I.; Kouzaki, H.; Shimizu, T. 2011: Heparin inhibits mucus hypersecretion in airway epithelial cells. American Journal of Rhinology and Allergy 25(2): 69-74

Warzecha, Z.; Dembinski, A.; Ceranowicz, P.; Dembinski, M.; Sendur, R.; Cieszkowski, J.; Sendur, P.; Tomaszewska, R. 2012: Heparin inhibits protective effect of ischemic preconditioning in ischemia/reperfusion-induced acute pancreatitis. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 63(4): 355-365

Yu, L.; Quinn, D.A.; Garg, H.G.; Hales, C.A. 2011: Heparin inhibits pulmonary artery smooth muscle cell proliferation through guanine nucleotide exchange factor-H1/RhoA/Rho kinase/p27. American Journal of Respiratory Cell and Molecular Biology 44(4): 524-530

Guo, H.; Xu, F.; Sun, A.; Liu, L.; Shi, Y. 2010: Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice. Coronary Artery Disease 21(1): 39-45

Tan, H.; Zhou, Q.; Qi, H.; Zhu, D.; Ma, X.; Xiong, D. 2012: Heparin interacting protein mediated assembly of nano-fibrous hydrogel scaffolds for guided stem cell differentiation. Macromolecular Bioscience 12(5): 621-627

Yang, J.-Y.; Chien, T.-I.; Lu, J.-Y.; Kao, J.-T. 2009: Heparin interference in the cerebrospinal fluid protein assay measured with a pyrogallol red-molybdate complex. Clinica Chimica Acta; International Journal of Clinical Chemistry 408(1-2): 75-78

Huang, X.; Rezaie, A.R.; Broze, G.J.; Olson, S.T. 2011: Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor. Journal of Biological Chemistry 286(11): 8740-8751

Nasu, K.; Tsuno, A.; Hirao, M.; Kobayashi, H.; Yuge, A.; Narahara, H. 2010: Heparin is a promising agent for the treatment of endometriosis-associated fibrosis. Fertility and Sterility 94(1): 46-51

Brown, K.; Tay-Uyboco, J.S.; McMillan, D.D. 1999: Heparin is not required for peripheral intravenous locks in neonates. Paediatrics and Child Health 4(1): 39-42

Smith, S.A.; Morrissey, J.H. 2008: Heparin is procoagulant in the absence of antithrombin. Thrombosis and Haemostasis 100(1): 160-162

Dreyer, G.; Lawton, P.; Jose, M. 2008: Heparin leak from a hemodialysis catheter causing major bleeding, ultimately leading to transplant rejection and death. Hemodialysis International. International Symposium on Home Hemodialysis 12(4): 431-433

Huang, C.; Wang, S.; Qiu, L.; Ke, Q.; Zhai, W.; Mo, X. 2013: Heparin loading and pre-endothelialization in enhancing the patency rate of electrospun small-diameter vascular grafts in a canine model. Acs Applied Materials and Interfaces 5(6): 2220-2226

Kaakinen, T.; Laurila, J.; Ala-Kokko, T. 2013: Heparin lock--preventing clots but causing bleeding?. Duodecim; Laaketieteellinen Aikakauskirja 129(18): 1928-1931

Wang, Y.; Zheng, Q.-C.; Kong, C.-P.; Tian, Y.; Zhan, J.; Zhang, J.-L.; Zhang, H.-X. 2015: Heparin makes differences: a molecular dynamics simulation study on the human βII-tryptase monomer. Molecular Biosystems 11(1): 252-261

Belchikov, Y.G.; Marotta, S.E. 2010: Heparin management in a patient with thyroid storm. PharmacoTherapy 30(4): 134e-138e

Xiao, Z.; Tappen, B.R.; Ly, M.; Zhao, W.; Canova, L.P.; Guan, H.; Linhardt, R.J. 2011: Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin. Journal of Medicinal Chemistry 54(2): 603-610

Hettiaratchi, M.H.; Miller, T.; Temenoff, J.S.; Guldberg, R.E.; McDevitt, T.C. 2014: Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2. Biomaterials 35(25): 7228-7238

Mammadov, R.; Mammadov, B.; Toksoz, S.; Aydin, B.; Yagci, R.; Tekinay, A.B.; Guler, M.O. 2011: Heparin mimetic peptide nanofibers promote angiogenesis. Biomacromolecules 12(10): 3508-3519

Coombe, D.R.; Kett, W.C. 2012: Heparin mimetics. Handbook of Experimental Pharmacology 2012(207): 361-383

Sangaj, N.; Kyriakakis, P.; Yang, D.; Chang, C.-W.; Arya, G.; Varghese, S. 2010: Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells. Biomacromolecules 11(12): 3294-3300

Knaack, S.; Lode, A.; Hoyer, B.; Rösen-Wolff, A.; Gabrielyan, A.; Roeder, I.; Gelinsky, M. 2014: Heparin modification of a biomimetic bone matrix for controlled release of VEGF. Journal of Biomedical Materials Research. Part a 102(10): 3500-3511

Lode, A.; Reinstorf, A.; Bernhardt, A.; Wolf-Brandstetter, C.; König, U.; Gelinsky, M. 2008: Heparin modification of calcium phosphate bone cements for VEGF functionalization. Journal of Biomedical Materials Research. Part a 86(3): 749-759

Chudasama, S.L.; Espinasse, B.; Hwang, F.; Qi, R.; Joglekar, M.; Afonina, G.; Wiesner, M.R.; Welsby, I.J.; Ortel, T.L.; Arepally, G.M. 2010: Heparin modifies the immunogenicity of positively charged proteins. Blood 116(26): 6046-6053

Judice, W.A.S.; Manfredi, M.A.; Souza, G.P.; Sansevero, T.M.; Almeida, P.C.; Shida, C.áu.S.; Gesteira, T.F.; Juliano, L.; Westrop, G.D.; Sanderson, S.J.; Coombs, G.H.; Tersariol, I.L.S. 2013: Heparin modulates the endopeptidase activity of Leishmania mexicana cysteine protease cathepsin L-Like rCPB2.8. Plos one 8(11): E80153

Taha, M.O.; Ferreira, R.M.; Taha, N.S.A.ão.; Monteiro, H.P.; Caricati-Neto, A.; Fagundes, D.J.é 2014: Heparin modulates the expression of genes encoding pro and anti-apoptotic proteins in endothelial cells exposed to intestinal ischemia and reperfusion in rats. Acta Cirurgica Brasileira 29(7): 445-449

Hassanin, A.; Malek, H.A.; Saleh, D. 2014: Heparin modulation on hepatic nitric oxide synthase in experimental steatohepatitis. Experimental and Therapeutic Medicine 8(5): 1551-1558

Hellstern, P.; Bach, J.; Simon, M.; Saggau, W. 2007: Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi. Journal of Extra-Corporeal Technology 39(2): 81-86

Lincoff, A.M. 2014: Heparin monotherapy for percutaneous coronary intervention?. Lancet 384(9943): 564-566

Bangalore, S.; Pencina, M.J.; Kleiman, N.S.; Cohen, D.J. 2014: Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Circulation. Cardiovascular Interventions 7(3): 365-373

Tao, Y.; Hu, T.; Wu, Z.; Tang, H.; Hu, Y.; Tan, Q.; Wu, C. 2012: Heparin nanomodification improves biocompatibility and biomechanical stability of decellularized vascular scaffolds. International Journal of Nanomedicine 7: 5847-5858

Ziarek, J.J.; Veldkamp, C.T.; Zhang, F.; Murray, N.J.; Kartz, G.A.; Liang, X.; Su, J.; Baker, J.E.; Linhardt, R.J.; Volkman, B.F. 2013: Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. Journal of Biological Chemistry 288(1): 737-746

Schallom, M.E.; Prentice, D.; Sona, C.; Micek, S.T.; Skrupky, L.P. 2012: Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Critical Care Medicine 40(6): 1820-1826

Hoppe, B.; Burmester, G.-R.üd.; Dörner, T. 2011: Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). Current Opinion in Rheumatology 23(3): 299-304

Brieger, D.; Collet, J.-P.; Silvain, J.; Landivier, A.; Barthélémy, O.; Beygui, F.; Bellemain-Appaix, A.; Mercadier, A.; Choussat, R.; Vignolles, N.; Costagliola, D.; Montalescot, G. 2011: Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 77(2): 182-190

Anand, S.; Siddhartha, W.; Karnad, D.R.; Shrivastava, M.; Ghatge, S.; Limaye, U.S. 2006: Heparin or local thrombolysis in the management of cerebral venous sinus thrombosis?. Interventional Neuroradiology: Journal of Peritherapeutic Neuroradiology Surgical Procedures and Related Neurosciences 12(2): 131-140

Anonymous 2008: Heparin overdose scare in 14 babies at Texas hospital. Healthcare Benchmarks and Quality Improvement 15(9): 89-90

Junqueira, D.R.G.; Viana, T.ér.G.; Peixoto, E.R.d.M.; Barros, F.C.R.d.; Carvalho, M.d.G.ça.; Perini, E. 2011: Heparin pharmacovigilance in Brazil. Revista da Associacao Medica Brasileira 57(3): 322-326

Chalkiadaki, G.; Nikitovic, D.; Berdiaki, A.; Katonis, P.; Karamanos, N.K.; Tzanakakis, G.N. 2011: Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration. Iubmb Life 63(2): 109-119

Wang, A.; Ren, J.; Wang, C.P.; Hascall, V.C. 2014: Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division. Journal of Biological Chemistry 289(13): 9418-9429

Gao, C.; Boylan, B.; Fang, J.; Wilcox, D.A.; Newman, D.K.; Newman, P.J. 2011: Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. Blood 117(18): 4946-4952

Gris, J-C.; Marès, P. 2012: Heparin promotes soluble vascular enothelial growth factor receptor expression in human placental villi: a rebuttal. Journal of thrombosis and haemostasis: JTH 10(3): 499-500

Li, L.; Qin, J.; Feng, Q.; Tang, H.; Liu, R.; Xu, L.; Chen, Z. 2011: Heparin promotes suspension adaptation process of CHO-TS28 cells by eliminating cell aggregation. Molecular Biotechnology 47(1): 9-17

Furue, M.K.; Na, J.; Jackson, J.P.; Okamoto, T.; Jones, M.; Baker, D.; Hata, R.-I.; Moore, H.D.; Sato, J.D.; Andrews, P.W. 2008: Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proceedings of the National Academy of Sciences of the United States of America 105(36): 13409-13414

Madine, J.; Davies, H.A.; Hughes, E.; Middleton, D.A. 2013: Heparin promotes the rapid fibrillization of a peptide with low intrinsic amyloidogenicity. Biochemistry 52(50): 8984-8992

Patel, T.; Kirby, W.; Hruby, G.; Benson, M.C.; McKiernan, J.M.; Badani, K. 2011: Heparin prophylaxis and the risk of venous thromboembolism after robotic-assisted laparoscopic prostatectomy. Bju International 108(5): 729-732

Cook, D. 2008: Heparin prophylaxis did not increase mortality and was beneficial in adults with sepsis receiving drotrecogin alfa. Acp Journal Club 148(2): 32

Snee, M. 2012: Heparin prophylaxis has no benefit in medical patients. Bmj 345: E4940

Nuridsany, J.; Somos, P. 1955: Heparin protamine sulfate. A Gyogyszeresz 10(7): 128-129

Fu, L.S.; Tsai, J.J.; Chen, Y.J.; Lin, H.K.; Tsai, M.C.; Chang, M.D.T. 2013: Heparin protects BALB/c mice from mite-induced airway allergic inflammation. International Journal of Immunopathology and Pharmacology 26(2): 349-359

Melo, E.I.; Pereira, M.S.; Cunha, R.S.; Sá, M.P.L.d.; Mourão, P.A.S. 2008: Heparin quality control in the Brazilian market: implications in the cardiovascular surgery. Revista Brasileira de Cirurgia Cardiovascular: Orgao Oficial da Sociedade Brasileira de Cirurgia Cardiovascular 23(2): 169-174

Sharma, V.; Sharma, A.; Aggarwal, S. 2008: Heparin recall and India. Journal of Postgraduate Medicine 54(4): 335-336

Zayas, G.J.; Bonilla, A.M.; Saliba, M.J. 2007: Heparin reduced mortality and sepsis in severely burned children. Annals of Burns and Fire Disasters 20(1): 29-34

Chatzinikolaou, G.; Nikitovic, D.; Berdiaki, A.; Zafiropoulos, A.; Katonis, P.; Karamanos, N.K.; Tzanakakis, G.N. 2010: Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling. Cell Proliferation 43(1): 9-18

Gruber, M.; Spaeth, R.; Bechmann, V. 2008: Heparin release is insufficient in syringes with platelets as heparin source. Clinica Chimica Acta; International Journal of Clinical Chemistry 395(1-2): 187

Ma, X.; Mohammad, S.F.; Kim, S.W. 1992: Heparin removal from blood using poly(L-lysine) immobilized hollow fiber. Biotechnology and Bioengineering 40(4): 530-536

Baydemir, G.öz.; Denizli, A. 2015: Heparin removal from human plasma using molecular imprinted cryogels. Artificial Cells Nanomedicine and Biotechnology 43(6): 403-412

Zhao, D.; Ding, R.; Mao, Y.; Wang, L.; Zhang, Z.; Ma, X. 2012: Heparin rescues sepsis-associated acute lung injury and lethality through the suppression of inflammatory responses. Inflammation 35(6): 1825-1832

Maurin, N. 2009: Heparin resistance and antithrombin deficiency. Medizinische Klinik 104(6): 441-449

Koster, A.; Zittermann, A.; Schirmer, U. 2013: Heparin resistance and excessive thrombocytosis. Anesthesia and Analgesia 117(5): 1262

Kumano, N.; Ikeda, S.; Arimori, Y.; Ono, T.; Saeki, S. 2008: Heparin resistance associated with elevated factor VIIi. MASUI. Japanese Journal of Anesthesiology 57(4): 471-473

Dejardin, L.; Mascart, P. 1950: Heparin resistance test in surgical patients. Journal International de Chirurgie 10(5): 384-398

Gilotti, A.C.; Nimlamool, W.; Pugh, R.; Slee, J.B.; Barthol, T.C.; Miller, E.A.; Lowe-Krentz, L.J. 2014: Heparin responses in vascular smooth muscle cells involve cGMP-dependent protein kinase (PKG). Journal of Cellular Physiology 229(12): 2142-2152

Alexander, W. 2009: Heparin revisions: a call for heightened vigilance and monitoring. P and T: a Peer-Reviewed Journal for Formulary Management 34(11): 634-638

Boeckel, J.-N.; Thomé, C.E.; Leistner, D.; Zeiher, A.M.; Fichtlscherer, S.; Dimmeler, S. 2013: Heparin selectively affects the quantification of micro RNAs in human blood samples. Clinical Chemistry 59(7): 1125-1127

Bromfield, S.M.; Wilde, E.; Smith, D.K. 2013: Heparin sensing and binding - taking supramolecular chemistry towards clinical applications. Chemical Society Reviews 42(23): 9184-9195

Ohmori, S.; Hino, R.; Nakamura, M.; Tokura, Y. 2012: Heparin serves as a natural stimulant of the inflammasome and exacerbates the symptoms of tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Journal of Dermatological Science 66(1): 82-84

Mourier, P.A.J.; Guichard, O.Y.; Herman, Féderic.; Viskov, C. 2012: Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signal. Journal of pharmaceutical and biomedical analysis 67-68: 169-174

Mourier, P.A.J.; Guichard, O.Y.; Herman, Féderic.; Viskov, C. 2011: Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signal. Journal of pharmaceutical and biomedical analysis 54(2): 337-344

Bisogni, S.; Giusti, F.; Ciofi, D.; Festini, F. 2014: Heparin solution for maintaining peripheral venous catheter patency in children: a survey of current practice in Italian pediatric units. Issues in Comprehensive Pediatric Nursing 37(2): 122-135

Fu, L.; Li, L.; Cai, C.; Li, G.; Zhang, F.; Linhardt, R.J. 2014: Heparin stability by determining unsubstituted amino groups using hydrophilic interaction chromatography mass spectrometry. Analytical Biochemistry 461: 46-48

Relini, A.; De Stefano, S.; Torrassa, S.; Cavalleri, O.; Rolandi, R.; Gliozzi, A.; Giorgetti, S.; Raimondi, S.; Marchese, L.; Verga, L.; Rossi, A.; Stoppini, M.; Bellotti, V. 2008: Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type i collagen. Journal of Biological Chemistry 283(8): 4912-4920

Chu, H.-N.ü 2008: Heparin successfully improved an early onset intrauterine growth restriction accompanied by severe oligohydramnios. International Journal of General Medicine 1: 1-2

Zhang, Z.; Liu, X.; Chen, J.; Su, H.; Luo, Q.; Ye, J.; Tang, N.; Zhang, W.; Chen, W.; Ko, B.C.B.; Huang, A. 2010: Heparin sulphate D-glucosaminyl 3-O-sulfotransferase 3B1 plays a role in HBV replication. Virology 406(2): 280-285

Stavrou, P.; Murray, P.I. 1994: Heparin surface modified intraocular lenses in uveitis. Ocular Immunology and Inflammation 2(3): 161-168

Tsolaki, E.; Elpiniki, T.; Salviato, E.; Rocca, T.; Braccini, L.; Galeotti, R.; Mascoli, F. 2010: Heparin surface stent-graft for the treatment of a carotid pseudoaneurysm. Annals of Vascular Surgery 24(7): 952.E9-952.E12

Gore, S.; Andersson, J.; Biran, R.; Underwood, C.; Riesenfeld, J. 2014: Heparin surfaces: Impact of immobilization chemistry on hemocompatibility and protein adsorption. Journal of Biomedical Materials Research. Part B Applied Biomaterials 102(8): 1817-1824

Fritsma, G.A. 2013: Heparin therapeutic range. Clinical Laboratory Science: Journal of the American Society for Medical Technology 26(2): 66

Palmer, K.; Ridgway, T.; Al-Rawi, O.; Poullis, M. 2012: Heparin therapy during extracorporeal circulation: deriving an optimal activated clotting time during cardiopulmonary bypass for isolated coronary artery bypass grafting. Journal of Extra-Corporeal Technology 44(3): 145-150

Dodd, J.M.; Sahi, K.; McLeod, A.; Windrim, R.C.; Kingdom, J.P.C. 2008: Heparin therapy for complications of placental dysfunction: a systematic review of the literature. Acta Obstetricia et Gynecologica Scandinavica 87(8): 804-811

Bauer, G. 1946: Heparin therapy in acute deep venous thrombosis. Journal of the American Medical Association 131: 196-203

Wang, C.; Chi, C.; Guo, L.; Wang, X.; Guo, L.; Sun, J.; Sun, B.; Liu, S.; Chang, X.; Li, E. 2014: Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis. Critical Care 18(5): 563

Labarere, J.; Bosson, J-Luc. 2007: Heparin thromboprophylaxis for medical inpatients. American Journal of Medicine 120(5): E13; Author Reply E17-8

Gurjar, M. 2014: Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?. Indian Journal of Critical Care Medicine: Peer-Reviewed Official Publication of Indian Society of Critical Care Medicine 18(6): 345-347

Alhazzani, W.; Lim, W.; Jaeschke, R.Z.; Murad, M.H.; Cade, J.; Cook, D.J. 2013: Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Critical Care Medicine 41(9): 2088-2098

Abrahams, D.G.; Glynn, L.E.; Loewi, G. 1951: Heparin tolerance in rheumatic fever. Ii. Clinical Science 10(1): 1-11

Gurbuz, H.Alper.; Durukan, A.Baris.; Sevim, H.; Ergin, E.; Gurpinar, A.; Yorgancioglu, C. 2013: Heparin toxicity in cell culture: a critical link in translation of basic science to clinical practice. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 24(7): 742-745

Kocatürk, T.; Kocatürk, O.; Kaplan, A.; Meteoğlu, I.; Cakmak, H.; Dayanir, V. 2013: Heparin treatment for allergic conjunctivitis in the experimental BALB/c model. Ophthalmic Research 50(1): 65-71

Cole, R.P. 2009: Heparin treatment for severe hypertriglyceridemia in diabetic ketoacidosis. Archives of Internal Medicine 169(15): 1439-1441

Clark, C.A.; Spitzer, K.A.; Laskin, C.A.; Crowther, M.R.; Ginsberg, J.S. 2010: Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss. Obstetrics and Gynecology 116(4): 997-998

Ziakas, P.D.; Pavlou, M.; Voulgarelis, M. 2010: Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstetrics and Gynecology 115(6): 1256-1262

Stuckey, W.; Vainio, K. 1949: Heparin treatment of frostbite. Duodecim; Laaketieteellinen Aikakauskirja 65(3): 212-217

Blaukovitch, C.I.; Pugh, R.; Gilotti, A.C.; Kanyi, D.; Lowe-Krentz, L.J. 2010: Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1. Journal of Cellular Biochemistry 110(2): 382-391

Lavainne, Fédéric.; Meffray, E.; Pepper, R.J.; Néel, Mélanie.; Delcroix, C.; Salama, A.D.; Fakhouri, F. 2014: Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 29(6): 1225-1231

Qin, Y.; Prescott, L.M.; Deitch, E.A.; Kaiser, V.L. 2011: Heparin use in a rat hemorrhagic shock model induces biologic activity in mesenteric lymph separate from shock. Shock 35(4): 411-421

Shen, J.I.; Mitani, A.A.; Winkelmayer, W.C. 2014: Heparin use in hemodialysis patients following gastrointestinal bleeding. American Journal of Nephrology 40(4): 300-307

López-Briz, E.; Ruiz Garcia, V.; Cabello, J.B.; Bort-Marti, S.; Carbonell Sanchis, R.; Burls, A. 2014: Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews 2014(10): Cd008462

Stabile, E.; Sorropago, G.; Tesorio, T.; Popusoi, G.; Ambrosini, V.; Mottola, M.T.; Biamino, G.; Rubino, P. 2010: Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for neuroprotection: results from a prospective randomized study. Journal of Vascular Surgery 52(6): 1505-1510

Tillman, J. 2009: Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy. Nursing in Critical Care 14(4): 191-199

Vertolli, U. 2007: Heparin versus citrate in the extracorporeal circuitry. Giornale italiano di nefrologia: organo ufficiale della Societa italiana di nefrologia 24(4): 353; author reply 353-4

Nakase, J.; Toribatake, Y.; Mouri, Y.; Seki, H.; Kitaoka, K.; Tomita, K. 2009: Heparin versus danaproid for prevention of venous thromboembolism after hip surgery. Journal of Orthopaedic Surgery 17(1): 6-9

Robertson-Malt, S.; Malt, G.N.; Farquhar, V.; Greer, W. 2014: Heparin versus normal saline for patency of arterial lines. Cochrane Database of Systematic Reviews 5: Cd007364

Magee, K.D.; Campbell, S.G.; Moher, D.; Rowe, B.H. 2008: Heparin versus placebo for acute coronary syndromes. Cochrane Database of Systematic Reviews 2: Cd003462

Andrade-Castellanos, C.A.; Colunga-Lozano, L.E.; Delgado-Figueroa, N.; Magee, K. 2014: Heparin versus placebo for non-ST elevation acute coronary syndromes. Cochrane Database of Systematic Reviews 6: Cd003462

Arcangeli, A.; Rocca, B.; Salvatori, G.; Ciancia, M.; De Cristofaro, R.; Antonelli, M. 2010: Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter. Thrombosis Research 126(1): 24-31

Singh, P.; Fu Zhu, L.; Dziegielewski, P.; Harris, J.; Seikaly, H. 2011: Heparin versus tirofiban in microvascular anastomosis: randomized controlled trial in a rat model. Journal of Otolaryngology - Head and Neck Surgery 40(Suppl 1): S59-S64

Ricci, G.; Giolo, E.; Simeone, R. 2010: Heparin's 'potential to improve pregnancy rates and outcomes' is not evidence-based. Human reproduction update 16(2): 225-7; author reply 227-8

Hughes, G.R.V. 2012: Heparin, antiphospholipid antibodies and the brain. Lupus 21(10): 1039-1040

Li, J.-P.; Vlodavsky, I. 2009: Heparin, heparan sulfate and heparanase in inflammatory reactions. Thrombosis and Haemostasis 102(5): 823-828

Borawski, J.; Naumnik, B.; Mysliwiec, M. 2007: Heparin, myeloperoxidase, and atherosclerosis: a new focus on an old drug. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 13(2): 219-220

Crotty, R.; Nazarian, R.M.; Song, P.I.; Van Cott, E.M. 2014: Heparin, warfarin, or calciphylaxis?. American Journal of Hematology 89(7): 785-786

Zhang, G.Wei.; Liu, X.C.; Mphil, Y.Luan.; Zhao, J.; Shi, R.Fang.; Zhao, X.Bin.; Liu, T.J.; Lü, F.; Yang, Q.; He, G.W. 2011: Heparin- and basic fibroblast growth factor-incorporated degradable stent: comparison with traditional transmyocardial revascularization. Journal of Cardiovascular Surgery 52(2): 261-270

Liu, X-Cheng.; Zhao, J.; Wang, Y.; Liu, T-Jun.; Lü, F.; He, G-Wei. 2010: Heparin- and basic fibroblast growth factor-incorporated stent: a new promising method for myocardial revascularization. Journal of Surgical Research 164(2): 204-213

Chatzinikolaou, G.; Nikitovic, D.; Asimakopoulou, A.; Tsatsakis, A.; Karamanos, N.K.; Tzanakakis, G.N. 2008: Heparin--a unique stimulator of human colon cancer cells' growth. Iubmb Life 60(5): 333-340

Drewlo, S. 2013: Heparin--not only thinning the blood. Blood 121(11): 1932-1933

Pomin, V.H. 2014: Heparin-Binding Proteins (Chemokines and Defensins) and their complexes with glycosaminoglycans from the solution NMR perspective. Current Protein and Peptide Science 15(7): 738-744

Ye, L.; Wu, X.; Mu, Q.; Chen, B.; Duan, Y.; Geng, X.; Gu, Y.; Zhang, A.; Zhang, J.; Feng, Z-guo. 2011: Heparin-Conjugated PCL Scaffolds Fabricated by Electrospinning and Loaded with Fibroblast Growth Factor 2. Journal of Biomaterials Science. Polymer Edition 22(1-3): 389-406

Newkirk, C.E. 2010: Heparin-Induced thrombocytopenia (HIT): a case study. Clinical Laboratory Science: Journal of the American Society for Medical Technology 23(1): 5-11

Brandan, E.; Llona, I.; Inestrosa, N.C. 1986: Heparin-acetylcholinesterase interaction: Specific detachment of class I-A forms and binding of class i and II-A forms to heparin-agarose. Neurochemistry International 9(1): 75-84

Durdureanu-Angheluta, A.; Uritu, C.M.; Coroaba, A.; Minea, B.; Doroftei, F.; Calin, M.; Maier, S.Sergiu.; Pinteala, M.; Simionescu, M.; Simionescu, B.C. 2014: Heparin-anthranoid conjugates associated with nanomagnetite particles and their cytotoxic effect on cancer cells. Journal of Biomedical Nanotechnology 10(1): 131-142

Becker, R.C.; Mahaffey, K.W.; Yang, H.; Marian, A.J.; Furman, M.I.; Michael Lincoff, A.; Hazen, S.L.; Petersen, J.L.; Reist, C.J.; Kleiman, N.S. 2011: Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome. Journal of Thrombosis and Thrombolysis 31(2): 146-153

Falvo, N.; Bonithon-Kopp, C.; Rivron Guillot, K.; Todoli, J.A.; Jiménez-Gil, M.; Di Micco, P.; Monreal, M.; Monreal, M.; Decousus, H.; Prandoni, P.; Brenner, B.; Barba, R.; Di Micco, P.; Rivron-Guillot, K.; Bosevski, M. 2011: Heparin-associated thrombocytopenia in 24,401 patients with venous thromboembolism: findings from the RIETE Registry. Journal of Thrombosis and Haemostasis: Jth 9(9): 1761-1768

Kim, M.; Lee, J.Y.; Jones, C.N.; Revzin, A.; Tae, G. 2010: Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytes. Biomaterials 31(13): 3596-3603

Kemp, M.M.; Linhardt, R.J. 2010: Heparin-based nanoparticles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology 2(1): 77-87

Spencer, A.; Cawood, T.; Frampton, C.; Jardine, D. 2014: Heparin-based treatment to prevent symptomatic deep venous thrombosis, pulmonary embolism or death in general medical inpatients is not supported by best evidence. Internal Medicine Journal 44(11): 1054-1065

Al-Akeel, R.A.; El-Kersh, T.A.; Al-Sheikh, Y.A.; Al-Ahmadey, Z.Z. 2013: Heparin-benzyl alcohol enhancement of biofilms formation and antifungal susceptibility of vaginal Candida species isolated from pregnant and nonpregnant Saudi women. Bioinformation 9(7): 357-362

Rahman, F.B.; Ishihara, S.; Aziz, M.M.; Mishima, Y.; Oshima, N.; Li, Y.-Y.; Sanchez-Siles, A.A.; Otani, A.; Oka, A.; Kusunoki, R.; Tada, Y.; Moriyama, I.; Ishimura, N.; Yuki, T.; Kazumori, H.; Amano, Y.; Sato, S.; Ansary, M.U.; Kinoshita, Y. 2010: Heparin-binding EGF-like factor augments esophageal epithelial cell proliferation, migration and inhibits TRAIL-mediated apoptosis via EGFR/MAPK signaling. Scandinavian Journal of Gastroenterology 45(11): 1350-1359

Su, Y.; Besner, G.E. 2014: Heparin-binding EGF-like growth factor (HB-EGF) promotes cell migration and adhesion via focal adhesion kinase. Journal of Surgical Research 189(2): 222-231

Yang, J.; Su, Y.; Zhou, Y.; Besner, G.E. 2014: Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects. Pathophysiology: the Official Journal of the International Society for Pathophysiology 21(1): 95-104

Ota, I.; Higashiyama, S.; Masui, T.; Yane, K.; Hosoi, H.; Matsuura, N. 2013: Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells. Oncology Reports 30(4): 1593-1600

Sánchez-Vizcaíno, E.; Vehí, C.; Campreciós, Gís.; Morcillo, César.; Soley, M.; Ramírez, I. 2010: Heparin-binding EGF-like growth factor in human serum. Association with high blood cholesterol and heart hypertrophy. Growth Factors 28(2): 98-103

Yu, X.; Radulescu, A.; Zorko, N.; Besner, G.E. 2009: Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis. Gastroenterology 137(1): 221-230

Lian, H.; Ma, Y.; Feng, J.; Dong, W.; Yang, Q.; Lu, D.; Zhang, L. 2012: Heparin-binding EGF-like growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway. Plos one 7(9): E44946

El-Assal, O.N.; Radulescu, A.; Besner, G.E. 2007: Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation. Surgery 142(2): 234-242

Radulescu, A.; Zhang, H.-Y.; Chen, C.-L.; Chen, Y.; Zhou, Y.; Yu, X.; Otabor, I.; Olson, J.K.; Besner, G.E. 2011: Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing. Journal of Surgical Research 171(2): 540-550

Yu, X.; Radulescu, A.; Chen, C.-L.; James, I.O.; Besner, G.E. 2012: Heparin-binding EGF-like growth factor protects pericytes from injury. Journal of Surgical Research 172(1): 165-176

Piltonen, M.; Bespalov, M.M.; Ervasti, D.; Matilainen, T.; Sidorova, Y.A.; Rauvala, H.; Saarma, M.; Männistö, P.T. 2009: Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons. Experimental Neurology 219(2): 499-506

Martino, Mël.M.; Briquez, P.S.; Ranga, A.; Lutolf, M.P.; Hubbell, J.A. 2013: Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proceedings of the National Academy of Sciences of the United States of America 110(12): 4563-4568

Scuderi, R.; Failla, A. 2008: Heparin-binding epidermal growth factor (HB-EGF): myth or reality?. La Clinica Terapeutica 159(2): 111-116

Hofbauer, R.; Pasching, E.; Moser, D.; Frass, M. 2010: Heparin-binding epidermal growth factor expression in KATO-IIi cells after Helicobacter pylori stimulation under the influence of strychnos Nux vomica and Calendula officinalis. Homeopathy: the Journal of the Faculty of Homeopathy 99(3): 177-182

Taylor, S.R.; Markesbery, M.G.; Harding, P.A. 2014: Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): a regulator of several pathways. Seminars in Cell and Developmental Biology 28: 22-30

Zhang, X.-H.; Liang, X.; Wang, T.-S.; Liang, X.-H.; Zuo, R.-J.; Deng, W.-B.; Zhang, Z.-R.; Qin, F.-N.; Zhao, Z.-A.; Yang, Z.-M. 2013: Heparin-binding epidermal growth factor-like growth factor (HB-EGF) induction on Snail expression during mouse decidualization. Molecular and Cellular Endocrinology 381(1-2): 272-279

Miyamoto, S.; Yagi, H.; Yotsumoto, F.; Kawarabayashi, T.; Mekada, E. 2008: Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy. Advances in Experimental Medicine and Biology 622: 281-295

Lutmer, J.; Watkins, D.; Chen, C.-L.; Velten, M.; Besner, G. 2013: Heparin-binding epidermal growth factor-like growth factor attenuates acute lung injury and multiorgan dysfunction after scald burn. Journal of Surgical Research 185(1): 329-337

Luo, C.-C.; Ming, Y.-C.; Chao, H.-C.; Chu, S.-M.; Pang, S.-T. 2011: Heparin-binding epidermal growth factor-like growth factor downregulates expression of activator protein-1 transcription factor after intestinal ischemia-reperfusion injury. Neonatology 99(4): 241-246

Kim, J.; Keay, S.K.; Freeman, M.R. 2009: Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation. Bju International 103(4): 541-546

El-Assal, O.N.; Paddock, H.; Marquez, A.; Besner, G.E. 2008: Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice. Journal of Pediatric Surgery 43(6): 1182-1190

Zhou, Y.; Besner, G.E. 2010: Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells. Neuro-Signals 18(3): 141-151

Ohnishi, Y.; Inoue, H.; Furukawa, M.; Kakudo, K.; Nozaki, M. 2012: Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma. Oncology Reports 27(4): 954-958

Zhang, H-Yi.; Radulescu, A.; Besner, G.E. 2009: Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice. Surgery 146(2): 334-339

Radulescu, A.; Zhang, H.-Y.; Yu, X.; Olson, J.K.; Darbyshire, A.K.; Chen, Y.; Besner, G.E. 2010: Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis. Journal of Pediatric Surgery 45(10): 1933-1939

Yagi, H.; Yotsumoto, F.; Miyamoto, S. 2008: Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition. Molecular Cancer Therapeutics 7(10): 3441-3451

Liao, X.; Chen, L.; Fu, W.; Zhou, J. 2013: Heparin-binding epidermal growth factor-like growth factor protects rat intestine after portal triad clamping. Growth Factors 31(2): 74-80

Chen, C.-L.; Yang, J.; James, I.O.A.; Zhang, H.-Y.; Besner, G.E. 2014: Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury. Surgery 155(6): 1069-1080

Zhang, D.; Zhang, J.; Jiang, X.; Li, X.; Wang, Y.; Ma, J.; Jiang, H. 2014: Heparin-binding epidermal growth factor-like growth factor: a hepatic stellate cell proliferation inducer via ErbB receptors. Journal of Gastroenterology and Hepatology 29(3): 623-632

Olwin, B.B. 1989: Heparin-binding growth factors and their receptors. Cytotechnology 2(4): 351-365

Dessein, R.; Corbière, V.ér.; Nortier, J.ël.; Dratwa, M.; Gastaldello, K.; Pozdzik, A.; Lecher, S.; Grandbastien, B.; Locht, C.; Mascart, F.ço. 2013: Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patients. Plos one 8(8): E71088

Esposito, C.; Marasco, D.; Delogu, G.; Pedone, E.; Berisio, R. 2011: Heparin-binding hemagglutinin HBHA from Mycobacterium tuberculosis affects actin polymerisation. Biochemical and Biophysical Research Communications 410(2): 339-344

Zheng, Q.; Yang, L.; Yang, J.; Zhou, S.; Zhou, L.; Han, R.; Hao, X.; Ma, Y. 2014: Heparin-binding hemagglutinin enhances Mycobacterium smegmatis infection by inhibiting autophagy in A549 cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 30(7): 696-699; 703

Loxton, A.é G.; Black, G.F.; Stanley, K.; Walzl, G. 2012: Heparin-binding hemagglutinin induces IFN-γ(+) IL-2(+) IL-17(+) multifunctional CD4(+) T cells during latent but not active tuberculosis disease. Clinical and Vaccine Immunology: Cvi 19(5): 746-751

Lund, J.; Søndergaard, M.T.; Conover, C.A.; Overgaard, M.T. 2014: Heparin-binding mechanism of the IGF2/IGF-binding protein 2 complex. Journal of Molecular Endocrinology 52(3): 345-355

Green, J.V.; Orsborn, K.I.; Zhang, M.; Tan, Q.K.G.; Greis, K.D.; Porollo, A.; Andes, D.R.; Long Lu, J.; Hostetter, M.K. 2013: Heparin-binding motifs and biofilm formation by Candida albicans. Journal of Infectious Diseases 208(10): 1695-1704

Kaukonen, K.-M.; Linko, R.; Herwald, H.; Lindbom, L.; Ruokonen, E.; Ala-Kokko, T.; Pettilä, V. 2013: Heparin-binding protein (HBP) in critically ill patients with influenza A(H1N1) infection. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 19(12): 1122-1128

Persson, B.P.; Halldorsdottir, H.; Lindbom, L.; Rossi, P.; Herwald, H.; Weitzberg, E.; Oldner, A. 2014: Heparin-binding protein (HBP/CAP37) - a link to endothelin-1 in endotoxemia-induced pulmonary oedema?. Acta Anaesthesiologica Scandinavica 58(5): 549-559

Beran, O.; Herwald, H.; Dzupová, O.; Chalupa, P.; Holub, M. 2010: Heparin-binding protein as a biomarker of circulatory failure during severe infections: a report of three cases. Scandinavian Journal of Infectious Diseases 42(8): 634-636

Linder, A.; Akesson, P.; Brink, M.; Studahl, M.; Björck, L.; Christensson, B. 2011: Heparin-binding protein: a diagnostic marker of acute bacterial meningitis. Critical Care Medicine 39(4): 812-817

Huttunen, R.; Syrjänen, J. 2010: Heparin-binding protein: a potential biomarker in sepsis?. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 50(2): 283-4; author reply 284-5

Dankiewicz, J.; Linder, A.; Annborn, M.; Rundgren, M.; Friberg, H. 2013: Heparin-binding protein: an early indicator of critical illness and predictor of outcome in cardiac arrest. Resuscitation 84(7): 935-939

Linder, A.; Christensson, B.; Herwald, H.; Björck, L.; Akesson, P. 2009: Heparin-binding protein: an early marker of circulatory failure in sepsis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 49(7): 1044-1050

Mariscalco, M.M. 2011: Heparin-binding protein: another neutrophil granule protein ... another new biomarker?. Critical Care Medicine 39(4): 910-911

Place, S.; Verscheure, V.; de San, N.; Hougardy, J.-M.; Schepers, K.; Dirix, V.; Dediste, A.; Michel, O.; Drowart, A.; Allard, S.D.; Doherty, T.M.; Lecher, S.; Locht, C.; Mascart, F.ço. 2010: Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans. American Journal of Respiratory and Critical Care Medicine 182(6): 848-854

Wood, M.D.; Hunter, D.; Mackinnon, S.E.; Sakiyama-Elbert, S.E. 2010: Heparin-binding-affinity-based delivery systems releasing nerve growth factor enhance sciatic nerve regeneration. Journal of Biomaterials Science. Polymer Edition 21(6-7): 771-787

Hougardy, J.-M.; Schepers, K.; Place, S.; Drowart, A.; Lechevin, V.ér.; Verscheure, V.; Debrie, A.-S.; Doherty, T.M.; Van Vooren, J.-P.; Locht, C.; Mascart, F.ço. 2007: Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. Plos one 2(10): E926

Shah, P.S.; Shah, N. 2014: Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews 2: Cd005983

Anton, N.; Cox, P.N.; Massicotte, M.P.; Chait, P.; Yasui, Y.; Dinyari, P.M.; Marzinotto, V.; Mitchell, L.G. 2009: Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 123(3): E453-E458

Lammer, J.; Zeller, T.; Hausegger, K.A.; Schaefer, P.J.; Gschwendtner, M.; Mueller-Huelsbeck, S.; Rand, T.; Funovics, M.; Wolf, F.; Rastan, A.; Gschwandtner, M.; Puchner, S.; Ristl, R.; Schoder, M. 2013: Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). Journal of the American College of Cardiology 62(15): 1320-1327

Daenens, K.; Schepers, S.; Fourneau, I.; Houthoofd, S.; Nevelsteen, A.é 2009: Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. Journal of Vascular Surgery 49(5): 1210-1216

Lösel-Sadée, H.; Alefelder, C. 2009: Heparin-bonded expanded polytetrafluoroethylene graft for infragenicular bypass: five-year results. Journal of Cardiovascular Surgery 50(3): 339-343

Dorrucci, V.; Griselli, F.; Petralia, G.; Spinamano, L.; Adornetto, R. 2008: Heparin-bonded expanded polytetrafluoroethylene grafts for infragenicular bypass in patients with critical limb ischemia: 2-year results. Journal of Cardiovascular Surgery 49(2): 145-149

Saxon, R.R.; Chervu, A.; Jones, P.A.; Bajwa, T.K.; Gable, D.R.; Soukas, P.A.; Begg, R.J.; Adams, J.G.; Ansel, G.M.; Schneider, D.B.; Eichler, C.M.; Rush, M.J. 2013: Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. Journal of Vascular and Interventional Radiology: Jvir 24(2): 165-173; Quiz 174

Park, T.-J.; Lee, S.-H.; Simmons, T.J.; Martin, J.G.; Mousa, S.A.; Snezhkova, E.A.; Sarnatskaya, V.V.; Nikolaev, V.G.; Linhardt, R.J. 2008: Heparin-cellulose-charcoal composites for drug detoxification prepared using room temperature ionic liquids. Chemical Communications 40: 5022-5024

Thomas, A.M.; Gomez, A.J.; Palma, J.L.; Yap, W.Teck.; Shea, L.D. 2014: Heparin-chitosan nanoparticle functionalization of porous poly(ethylene glycol) hydrogels for localized lentivirus delivery of angiogenic factors. Biomaterials 35(30): 8687-8693

Sun, X.-j.; Peng, W.; Yang, Z.-l.; Ren, M.-l.; Zhang, S.-c.; Zhang, W.-g.; Zhang, L.-y.; Xiao, K.; Wang, Z.-g.; Zhang, B.; Wang, J. 2011: Heparin-chitosan-coated acellular bone matrix enhances perfusion of blood and vascularization in bone tissue engineering scaffolds. Tissue Engineering. Part a 17(19-20): 2369-2378

Hein, E.; Munthe-Fog, L.; Thiara, A.S.; Fiane, A.E.; Mollnes, T.E.; Garred, P. 2015: Heparin-coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin-2 of the lectin complement pathway in vivo. Clinical and Experimental Immunology 179(2): 294-299

Argyo, C.; Cauda, V.; Engelke, H.; Rädler, J.; Bein, G.; Bein, T. 2012: Heparin-coated colloidal mesoporous silica nanoparticles efficiently bind to antithrombin as an anticoagulant drug-delivery system. Chemistry 18(2): 428-432

Mirow, N.; Zittermann, A.; Koertke, H.; Maleszka, A.; Knobl, H.; Coskun, T.; Kleesiek, K.; Koerfer, R. 2008: Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery. Journal of Cardiovascular Surgery 49(2): 277-284

Tagarakis, G.I.; Tsilimingas, N.B. 2009: Heparin-coated extracorporeal circulation systems in heart surgery. Recent Patents on Cardiovascular Drug Discovery 4(3): 177-179

Sun, I-Cheol.; Eun, D-Kyung.; Na, J.Hee.; Lee, S.; Kim, I-Jin.; Youn, I-Chan.; Ko, C-Yong.; Kim, H-Sung.; Lim, D.; Choi, K.; Messersmith, P.B.; Park, T.Gwan.; Kim, S.Yoon.; Kwon, I.Chan.; Kim, K.; Ahn, C-Hee. 2009: Heparin-coated gold nanoparticles for liver-specific CT imaging. Chemistry 15(48): 13341-13347

Evenepoel, P.; Dejagere, T.; Verhamme, P.; Claes, K.; Kuypers, D.; Bammens, B.; Vanrenterghem, Y. 2007: Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 49(5): 642-649

Sherman, K.L.; Obi, S.H.; Aranha, G.V.; Yao, K.A.; Shoup, M.C. 2009: Heparin-coated stents do not protect cancer patients from cardiac complications after noncardiac surgery. American Surgeon 75(1): 61-65

Lee, J.-h.; Jung, M.J.; Hwang, Y.H.; Lee, Y.J.; Lee, S.; Lee, D.Y.; Shin, H. 2012: Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs. Biomaterials 33(19): 4861-4871

Jung, M.Jin.; Ha, Y.Eun.; Lee, D.Yun. 2011: Heparin-coated superparamagnetic iron oxide nanoparticles as highly effective MRI contrast agent for cell labeling. Journal of Controlled Release: Official Journal of the Controlled Release Society 152 Suppl. 1: E214-E215

Yang, H.S.; La, W.-G.; Bhang, S.H.; Jeon, J.-Y.; Lee, J.H.; Kim, B.-S. 2010: Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2. Tissue Engineering. Part a 16(4): 1225-1233

Joung, Y.K.; Jang, J.Y.; Choi, J.H.; Han, D.K.; Park, K.D. 2013: Heparin-conjugated pluronic nanogels as multi-drug nanocarriers for combination chemotherapy. Molecular Pharmaceutics 10(2): 685-693

La, W.-G.; Yang, H.S. 2015: Heparin-conjugated poly(lactic-co-glycolic acid) nanospheres enhance large-wound healing by delivering growth factors in platelet-rich plasma. Artificial Organs 39(4): 388-394

Jeon, O.; Yang, H.S.; Lee, T.-J.; Kim, B.-S. 2008: Heparin-conjugated polyethylenimine for gene delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society 132(3): 236-242

Kuo, Y.-C.; Tsai, Y.-T. 2011: Heparin-conjugated scaffolds with pore structure of inverted colloidal crystals for cartilage regeneration. Colloids and Surfaces. B Biointerfaces 82(2): 616-623

Go, D.H.; Joung, Y.K.; Park, S.Y.; Park, Y.D.; Park, K.D. 2008: Heparin-conjugated star-shaped PLA for improved biocompatibility. Journal of Biomedical Materials Research. Part a 86(3): 842-848

Xu, X.; Jha, A.K.; Duncan, R.L.; Jia, X. 2011: Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2. Acta Biomaterialia 7(8): 3050-3059

Lai, J.-P.; Thompson, J.R.; Sandhu, D.S.; Roberts, L.R. 2008: Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets. Future Oncology 4(6): 803-814

Bream-Rouwenhorst, H.R.; Hobbs, R.A. 2008: Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia. PharmacoTherapy 28(11): 1401-1407

Parker, R.I. 2007: Heparin-dependent platelet antibodies in children: problem or merely problematic?. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 8(4): 404-405

Perry, S.L.; Whitlatch, N.L.; Ortel, T.L. 2009: Heparin-dependent platelet factor 4 antibodies and the impact of renal function on clinical outcomes: a retrospective study in hospitalized patients. Journal of Thrombosis and Thrombolysis 28(2): 146-150

Hubbard, B.; Buczek-Thomas, J.A.; Nugent, M.A.; Smith, M.L. 2014: Heparin-dependent regulation of fibronectin matrix conformation. Matrix Biology: Journal of the International Society for Matrix Biology 34: 124-131

Casu, B.; Naggi, A.; Torri, G. 2010: Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. Matrix Biology: Journal of the International Society for Matrix Biology 29(6): 442-452

Hughes, E.; Edwards, R.; Middleton, D.A. 2010: Heparin-derived oligosaccharides interact with the phospholamban cytoplasmic domain and stimulate SERCA function. Biochemical and Biophysical Research Communications 401(3): 370-375

Ahmed, T.; Smith, G.; Abraham, W.M. 2014: Heparin-derived supersulfated disaccharide inhibits allergic airway responses in sheep. Pulmonary Pharmacology and Therapeutics 28(1): 77-86

Golembiewski, J. 2008: Heparin-focus on safety. Journal of Perianesthesia Nursing: Official Journal of the American Society of Perianesthesia Nurses 23(4): 276-278

Tran, T.H.; Bae, B.-c.; Lee, Y.-k.; Na, K.; Huh, K.M. 2013: Heparin-folate-retinoic acid bioconjugates for targeted delivery of hydrophobic photosensitizers. Carbohydrate Polymers 92(2): 1615-1624

Gümüşderelioğlu, M.şe.; Aday, S. 2011: Heparin-functionalized chitosan scaffolds for bone tissue engineering. Carbohydrate Research 346(5): 606-613

Ho, Y.-C.; Mi, F.-L.; Sung, H.-W.; Kuo, P.-L. 2009: Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor. International Journal of Pharmaceutics 376(1-2): 69-75

Wu, J.M.; Xu, Y.Y.; Li, Z.H.; Yuan, X.Y.; Wang, P.F.; Zhang, X.Z.; Liu, Y.Q.; Guan, J.; Guo, Y.; Li, R.X.; Zhang, H. 2011: Heparin-functionalized collagen matrices with controlled release of basic fibroblast growth factor. Journal of Materials Science. Materials in Medicine 22(1): 107-114

Fernàndez-Busquets, X. 2013: Heparin-functionalized nanocapsules: enabling targeted delivery of antimalarial drugs. Future Medicinal Chemistry 5(7): 737-739

Liang, Y.; Kiick, K.L. 2014: Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications. Acta Biomaterialia 10(4): 1588-1600

Arisaka, Y.; Kobayashi, J.; Yamato, M.; Akiyama, Y.; Okano, T. 2013: Heparin-functionalized thermoresponsive surface: a versatile cell culture substrate for regulating multivalent affinity binding with heparin-binding proteins by temperature changes. Organogenesis 9(3): 125-127

Duo, J.; Stenken, J.A. 2011: Heparin-immobilized microspheres for the capture of cytokines. Analytical and Bioanalytical Chemistry 399(2): 773-782

Gong, F.; Cheng, X.; Wang, S.; Zhao, Y.; Gao, Y.; Cai, H. 2010: Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents. Acta Biomaterialia 6(2): 534-546

Socher, I.; Kroll, H.; Jorks, S.; Santoso, S.; Sachs, U.J.H. 2008: Heparin-independent activation of platelets by heparin-induced thrombocytopenia antibodies: a common occurrence. Journal of Thrombosis and Haemostasis: Jth 6(1): 197-200

Padmanabhan, A.; Jones, C.G.; Bougie, D.W.; Curtis, B.R.; McFarland, J.G.; Wang, D.; Aster, R.H. 2015: Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis. Blood 125(1): 155-161

Leone, S.; Zuccoli, M.L.; Fucile, C.; Storace, S.; Martelli, A.; Mattioli, F. 2012: Heparin-induced acute adverse reaction--case report of a patient with acute trauma and a genetic predisposition to thrombotic events: a concurrence of events. Journal of Clinical Pharmacy and Therapeutics 37(6): 733-735

Warkentin, T.E.; Greinacher, A. 2009: Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Expert Opinion on Drug Safety 8(2): 129-144

Foreman, J.S.; Daniels, L.M.; Stettner, E.A. 2014: Heparin-induced anaphylactoid reaction associated with heparin-induced thrombocytopenia in the ED. American Journal of Emergency Medicine 32(12): 1559.E5-6

Asmis, L.M.; Segal, J.B.; Plantinga, L.C.; Fink, N.E.; Kerman, J.S.; Kickler, T.S.; Coresh, J.; Gardner, L.B. 2008: Heparin-induced antibodies and cardiovascular risk in patients on dialysis. Thrombosis and Haemostasis 100(3): 498-504

Choudhry, S.; Fishman, P.M.; Hernandez, C. 2013: Heparin-induced bullous hemorrhagic dermatosis. Cutis 91(2): 93-98

Stanley, F.E.; Warner, A.M.; McWilliams, K.M.; Stalcup, A.M. 2011: Heparin-induced circular dichroism of an achiral, bicyclic species. Chirality 23(1): 84-92

Stanley, F.E.; Warner, A.M.; Gutierrez, S.M.; Stalcup, A.M. 2009: Heparin-induced circular dichroism of chloroquine. Biochemical and Biophysical Research Communications 388(1): 28-30

Roux, J.; Duong, T.A.; Ingen-Housz-Oro, S.; Valeyrie-Allanore, L.; Ortonne, N.; Chosidow, O.; Wolkenstein, P. 2013: Heparin-induced hemorrhagic blisters. European Journal of Dermatology: Ejd 23(1): 105-107

Thomas, C.M.; Thomas, J.; Smeeton, F.; Leatherdale, B.A. 2008: Heparin-induced hyperkalemia. Diabetes Research and Clinical Practice 80(2): E7-E8

Cho, R.; Leclaire, M.; Kempainen, R. 2013: Heparin-induced hyperkalemia in a patient diagnosed with thyroid storm. Annals of PharmacoTherapy 47(9): 1213-1217

Shimokaze, T.; Akaba, K.; Saito, E. 2014: Heparin-induced hyperkalemia in an extremely-low-birth-weight infant: a case report. Journal of Clinical Research in Pediatric Endocrinology 6(2): 125-128

Zhang, S.; Condac, E.; Qiu, H.; Jiang, J.; Gutierrez-Sanchez, G.; Bergmann, C.; Handel, T.; Wang, L. 2012: Heparin-induced leukocytosis requires 6-O-sulfation and is caused by blockade of selectin- and CXCL12 protein-mediated leukocyte trafficking in mice. Journal of Biological Chemistry 287(8): 5542-5553

Galea, V.; Khaterchi, A.; Robert, F.; Gerotziafas, G.; Hatmi, M.; Elalamy, I. 2013: Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study. Platelets 24(6): 441-447

Elalamy, I.; Galea, V.; Hatmi, M.; Gerotziafas, G.T. 2009: Heparin-induced multiple electrode aggregometry: a potential tool for improvement of heparin-induced thrombocytopenia diagnosis. Journal of Thrombosis and Haemostasis: Jth 7(11): 1932-1934

Schindewolf, M.; Kroll, H.; Ackermann, H.; Garbaraviciene, J.; Kaufmann, R.; Boehncke, W.-H.; Ludwig, R.J.; Lindhoff-Last, E. 2010: Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis: Jth 8(7): 1486-1491

Le Templier, G.; Rodger, M.A. 2008: Heparin-induced osteoporosis and pregnancy. Current Opinion in Pulmonary Medicine 14(5): 403-407

Sator, P.; Kiprov, A.; Feldmann, R.; Breier, F.; Steiner, A. 2016: Heparin-induced skin necrosis. Journal of the European Academy of Dermatology and Venereology: Jeadv 30(1): 161-163

Bertrand, P.-M.; Perbet, S.éb.; Sapin, A.-F.ço.; Salavert, M.; Constantin, J.-M.; Elalamy, I.; Bazin, J.-E. 2011: Heparin-induced skin necrosis: HIT-2 without thrombocytopenia. Intensive Care Medicine 37(1): 172-173

Nowicka, A.; Kandziora, M.; Szymanowska, K.; Michalski, M.; Piatkowska, A.; Biegalski, W.; Dankowski, Rł.; Poprawski, K.; Wierzchowiecki, Mł. 2008: Heparin-induced thrombocythopenia in a patient with massive pulmonary embolism and dilated cardiomyopathy, successfuly treated with fondaparinux - a case report. Kardiologia Polska 66(12): 1306-1308

Gounden, R.; Blockman, M. 2008: Heparin-induced thrombocytopaenia. Cardiovascular Journal of Africa 19(6): 325-327

Dave, P.A. 2009: Heparin-induced thrombocytopaenia/thrombosis: a clinicopathologic review. East African Medical Journal 86(12 Suppl): S62-S70

Warkentin, T.E. 2007: Heparin-induced thrombocytopenia. Hematology/Oncology Clinics of North America 21(4): 589-607 V

Unkle, D.W. 2007: Heparin-induced thrombocytopenia. Orthopedic Nursing 26(6): 383-385; Quiz: 386-387

Greinacher, A. 2009: Heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis: Jth 7(Suppl 1): 9-12

Arepally, G.M.; Ortel, T.L. 2010: Heparin-induced thrombocytopenia. Annual Review of Medicine 61: 77-90

Szokol, J.W. 2010: Heparin-induced thrombocytopenia. Seminars in Cardiothoracic and Vascular Anesthesia 14(1): 73-74

Shaikh, N. 2011: Heparin-induced thrombocytopenia. Journal of Emergencies Trauma and Shock 4(1): 97-102

Greinacher, A.; Fürll, B.; Selleng, S. 2013: Heparin-induced thrombocytopenia. Methods in Molecular Biology 992: 301-318

Lovecchio, F. 2014: Heparin-induced thrombocytopenia. Clinical Toxicology 52(6): 579-583

Nowak, G.öt. 2009: Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease. Thrombosis and Haemostasis 102(5): 887-891

Al-Lamee, R.K.; Gerber, R.T.; Kooner, J.S. 2010: Heparin-induced thrombocytopenia (HIT) as an unusual cause of acute stent thrombosis. European Heart Journal 31(5): 613

Lammering, J.C.; Wang, D.S.; Shin, L.K. 2012: Heparin-induced thrombocytopenia (HIT) causing portosplenic, superior mesenteric, and splenic vein thrombosis resulting in splenic rupture and pulmonary emboli formation. Clinical Imaging 36(6): 865-868

Jiji, R.S.; Michaels, A.D. 2008: Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli during coronary intervention. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 72(6): 819-822

Wang, J.-Y.; Jin, X.; Zhang, X.; Li, X.-F. 2018: CC-223 inhibits human head and neck squamous cell carcinoma cell growth. Biochemical and Biophysical Research Communications 496(4): 1191-1196

Cuker, A. 2011: Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis. Thrombosis and Haemostasis 106(6): 993-994

Szromba, C. 2010: Heparin-induced thrombocytopenia (HIT) in patients on hemodialysis: an update. Nephrology Nursing Journal: Journal of the American Nephrology Nurses' Association 37(2): 185-187

Baroletti, S.; Piovella, C.; Fanikos, J.; Labreche, M.; Lin, J.; Goldhaber, S.Z. 2008: Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes. Thrombosis and Haemostasis 100(6): 1130-1135

Beyer, J.; Halbritter, K.; Weise, M.; Leonhard, J.; Schellong, S. 2007: Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatroban. Thrombosis and Haemostasis 98(2): 470-472

de Bree, L.Charlotte.J.; Alings, A.Marco.W.; van Wijngaarden, P. 2014: Heparin-induced thrombocytopenia after ICD-lead flushing. Acta Cardiologica 69(2): 197-199

Thakur, S.; Pigott, J.P.; Comerota, A.J. 2009: Heparin-induced thrombocytopenia after implantation of a heparin-bonded polytetrafluoroethylene lower extremity bypass graft: A case report and plan for management. Journal of Vascular Surgery 49(4): 1037-1040

Kigawa, I.; Okamura, Y.; Fukuda, S.; Miyairi, T. 2010: Heparin-induced thrombocytopenia after on-pump coronary artery bypass grafting. Kyobu Geka. Japanese Journal of Thoracic Surgery 63(6): 442-445

Ma, Y.-t.; Ma, X.; Yang, Y.-n. 2008: Heparin-induced thrombocytopenia after percutaneous balloon mitral valvuloplasty. Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 617

Levy, J.H.; Winkler, A.M. 2010: Heparin-induced thrombocytopenia and cardiac surgery. Current Opinion in Anaesthesiology 23(1): 74-79

Durand, M.; Lecompte, T.; Hacquard, M.; Carteaux, J.-P. 2008: Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 34(3): 687-689

Fesler, M.J.; Creer, M.H.; Richart, J.M.; Edgell, R.; Havlioglu, N.; Norfleet, G.; Cruz-Flores, S. 2011: Heparin-induced thrombocytopenia and cerebral venous sinus thrombosis: case report and literature review. Neurocritical Care 15(1): 161-165

Shah, S.D.; Shah, C.; Vora, R. 2010: Heparin-induced thrombocytopenia and cerebral venous thrombosis after low-molecular weight heparin. Neurology India 58(4): 669-670

Wang, J.-h.; Wang, C.-y.; Chen, X. 2012: Heparin-induced thrombocytopenia and crossreactivity study between anti-heparin/platelet factor 4 -antibody and low molecular weight heparin. Zhonghua Xue Ye Xue Za Zhi 33(7): 584-586

Okamura, K.; Kitajima, K.; Maeyama, T.; Fukuyama, S.; Inoue, H.; Nakanishi, Y. 2010: Heparin-induced thrombocytopenia and disseminated intravascular coagulation in a patient with drug-induced pneumonia. Nihon Kokyuki Gakkai Zasshi 48(2): 157-161

Pollak, U.; Yacobobich, J.; Tamary, H.; Dagan, O.; Manor-Shulman, O. 2011: Heparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literature. Journal of Extra-Corporeal Technology 43(1): 5-12

Liodakis, E.; Hildebrand, F.; Frink, M.; Mommsen, P.; Krettek, C.; Probst, C. 2009: Heparin-induced thrombocytopenia and liver hemorrhage following polytrauma. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 80(9): 872-874

Filis, K.; Lagoudianakis, E.E.; Pappas, A.; Kotzadimitriou, K.; Genetzakis, M.; Sigala, F.; Theodorou, D.; Manouras, A. 2008: Heparin-induced thrombocytopenia and phlegmasia cerulea dolens of the upper limb successfully treated with fondaparinux. Acta Haematologica 120(3): 190-191

Coventry, D.A.; Webster, N.R. 2014: Heparin-induced thrombocytopenia and the health economic analysis of argatroban. British Journal of Anaesthesia 112(6): 964-967

Khan, M.M.; Noble, D.W.; Watson, H.G. 2011: Heparin-induced thrombocytopenia and the utility of the 4Ts score in the Intensive Care Unit. British Journal of Haematology 152(5): 672-674

Tessler, O.; Vorstenbosch, J.; Jones, D.; Lalonde, S.; Zadeh, T. 2014: Heparin-induced thrombocytopenia and thrombosis as an under-diagnosed cause of flap failure in heparin-naive patients: a case report and systematic review of the literature. Microsurgery 34(2): 157-163

Kaiber, Fávia.Larissa.; Malucelli, T.Osternack.; Baroni, Eína.do.Rocio.Valenga.; Schafranski, M.Derbly.; Akamatsu, Hélcio.Takeshi.; Schmidt, C.Cecília.Finkler. 2010: Heparin-induced thrombocytopenia and warfarin-induced skin necrosis: case report. Anais Brasileiros de Dermatologia 85(6): 915-918

Pannicke, N.; Pollok, J.-M.; Kluge, S.; Petzoldt, M. 2012: Heparin-induced thrombocytopenia associated with acute liver graft failure. BMJ Case Reports

Chong, B.H.; Chong, J.J.H. 2010: Heparin-induced thrombocytopenia associated with fondaparinux. Clinical Advances in Hematology and Oncology: H&o 8(1): 63-65

Tsai, H.C.; Yen, H.C.; Hsu, J.C.; Lin, C.L. 2009: Heparin-induced thrombocytopenia associated with intra-tumour haemorrhage in cavernous sinus after cardiac myxoma surgery. British Journal of Neurosurgery 23(1): 95-96

Ahmed, A.; Al-Mondhiry, H.; Milling, T.J.; Campbell, D. 2012: Heparin-induced thrombocytopenia associated with massive intracardiac thrombosis: a case report. Case Reports in Hematology 2012: 257023

Mumoli, N.; Cei, M. 2010: Heparin-induced thrombocytopenia associated with pulmonary embolism. Clinical Cardiology 33(2): E65-E67

Studt, J.-D.; Binet, I.; Nair, G.; Schanz, U. 2013: Heparin-induced thrombocytopenia associated with thrombotic microangiopathy. Hamostaseologie 33(2): 160-163

Altoijry, A.; MacKenzie, K.S.; Corriveau, M.-M.; Obrand, D.I.; Abraham, C.Z.; Steinmetz, O.K. 2015: Heparin-induced thrombocytopenia causing graft thrombosis and bowel ischemia postendovascular aneurysm repair. Journal of Vascular Surgery 61(1): 234-236

Howard-Thompson, A.; Usery, J.B.; Lobo, B.L.; Finch, C.K. 2008: Heparin-induced thrombocytopenia complicated by warfarin-induced skin necrosis. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(12): 1144-1147

Barginear, M.F.; Donahue, L.; Allen, S.L.; Budman, D.R.; Bradley, T.; Bhaskaran, M.; Shapira, I. 2008: Heparin-induced thrombocytopenia complicating hemodialysis. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 14(1): 105-107

Chan, K.Ming.; Cheung, C.Yuen.; Chau, K.Foon. 2014: Heparin-induced thrombocytopenia due to heparin lock in a hemodialysis patient: a case report. Hemodialysis International. International Symposium on Home Hemodialysis 18(2): 555-558

Welp, H.; Ellger, B.ör.; Scherer, M.; Lanckohr, C.; Martens, S.; Gottschalk, A. 2014: Heparin-induced thrombocytopenia during extracorporeal membrane oxygenation. Journal of Cardiothoracic and Vascular Anesthesia 28(2): 342-344

Davenport, A. 2004: Heparin-induced thrombocytopenia during renal replacement therapy. Hemodialysis International. International Symposium on Home Hemodialysis 8(3): 295-303

Davenport, A. 2008: Heparin-induced thrombocytopenia during renal replacement therapy in the intensive care unit. Critical Care 12(3): 158

Wang, J.; Dong, X.; Xin, Y.; Xu, P.; Xue, Y.; Wang, L.; Wang, Y.; Wang, C.; Chen, X.; Guan, Y.; Liu, J.; Chang, Y.; Gao, X.; Jin, Y.; Zhang, Y.; Li, X.; Dai, H. 2013: Heparin-Induced Thrombocytopenia in Chinese Patients: 240 Patients Study in One Center. Clinical Laboratory 2013(7-8): 10.7754/Clin.Lab.2012.120701

Nitta, N.; Shitara, S.; Nozaki, K. 2011: Heparin-induced thrombocytopenia in a glioblastoma multiforme patient with inferior vena cava filter placement for deep venous thrombosis. Neurologia Medico-Chirurgica 51(6): 445-448

Busche, M.N.; Peters, T.; Knobloch, K.; Vogt, P.M.; Rennekampff, H.-O. 2009: Heparin-induced thrombocytopenia in a nonthrombocytopenic patient with toxic epidermal necrolysis causing fatal outcome: is HIT still a HIT?. Journal of Burn Care and Research: Official Publication of the American Burn Association 30(4): 747-751

Ratuapli, S.K.; Bobba, B.; Zafar, H. 2010: Heparin-induced thrombocytopenia in a patient treated with fondaparinux. Clinical Advances in Hematology and Oncology: H&o 8(1): 61-65

Koul, A.N.; Ahad, R. 2013: Heparin-induced thrombocytopenia in a patient with colon cancer. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical and Paediatric Oncology 34(4): 336-337

Doboszyńska, A.; Rozek, M.; Swietlik, E.; Tomaszewska, I. 2007: Heparin-induced thrombocytopenia in a patient with lung embolism and left-sided pneumonia: a case report. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 58 Suppl. 5(Pt 1): 135-139

Matsuo, T.; Kusano, H.; Wanaka, K.; Ishihara, M.; Oyama, A. 2007: Heparin-induced thrombocytopenia in a uremic patient requiring hemodialysis: an alternative treatment and reexposure to heparin. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 13(2): 182-187

Peteja, M.; Chmelo, J.; Zuchnická, J.; Zonča, P.; Mazur, M. 2013: Heparin-induced thrombocytopenia in a patient with acute thrombosis, acute aortic dissection and acute lower limb ischaemia. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 92(11): 650-653

Miriovsky, B.J.; Ortel, T.L. 2011: Heparin-induced thrombocytopenia in cancer. Journal of the National Comprehensive Cancer Network: Jnccn 9(7): 781-787

Yoon, J.H.; Jang, I.-K. 2011: Heparin-induced thrombocytopenia in cardiovascular patients: pathophysiology, diagnosis, and treatment. Cardiology in Review 19(3): 143-153

Murawaki, A.; Nakayasu, H.; Doi, M.; Suzuki-Kinoshita, K.; Asai, Y.; Omura, H.; Nakashima, K. 2012: Heparin-induced thrombocytopenia in essential thrombocytosis. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 21(8): 916.E1

Quiñones-Ortiz, L.; Suárez-Laurés, A.; Pablos-de Pablo, M.; Robles, V.ón.; Calzón-Blanco, C.; Quiñones-Pérez, S.; Ayausty-Ruiz, A. 2014: Heparin-induced thrombocytopenia in haemodialysis treated with argatroban. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 34(5): 670-674

Schroder, J.N.; Daneshmand, M.A.; Villamizar, N.R.; Petersen, R.P.; Blue, L.J.; Welsby, I.J.; Lodge, A.J.; Ortel, T.L.; Rogers, J.G.; Milano, C.A. 2007: Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients. Annals of Thoracic Surgery 84(3): 841

Warkentin, T.E.; Sheppard, J.-A.I.; Heels-Ansdell, D.; Marshall, J.C.; McIntyre, L.; Rocha, M.G.; Mehta, S.; Davies, A.R.; Bersten, A.D.; Crozier, T.M.; Ernest, D.; Vlahakis, N.E.; Hall, R.I.; Wood, G.G.; Poirier, G.; Crowther, M.A.; Cook, D.J. 2013: Heparin-induced thrombocytopenia in medical surgical critical illness. Chest 144(3): 848-858

Limaye, K.; Ravilla, R.; Boye, B.; Sahaya, K.; Motwani, P. 2014: Heparin-induced thrombocytopenia in patients receiving plasma exchange. American Journal of Medicine 127(12): E3-E4

Selleng, S.; Selleng, K.; Wollert, H.-G.; Muellejans, B.; Lietz, T.; Warkentin, T.E.; Greinacher, A. 2008: Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass. Journal of Thrombosis and Haemostasis: Jth 6(3): 428-435

Randi, M.L.; Tezza, F.; Scapin, M.; Duner, E.; Scarparo, P.; Scandellari, R.; Fabris, F. 2010: Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis. Acta Haematologica 123(3): 140-145

Warkentin, T.E.; Greinacher, A.; Koster, A. 2009: Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?. Annals of Thoracic Surgery 87(5): 1633-1640

Knobloch, K.; Gohritz, A.; Redeker, J.; Vogt, P.M. 2008: Heparin-induced thrombocytopenia in plastic surgery: do we take care enough?. Plastic and Reconstructive Surgery 122(5): 1592-1593

Battistelli, S.; Genovese, A.; Gori, T. 2010: Heparin-induced thrombocytopenia in surgical patients. American Journal of Surgery 199(1): 43-51

Warkentin, T.E. 2012: Heparin-induced thrombocytopenia in the ICU: a transatlantic perspective. Chest 142(4): 815-816

Sakr, Y. 2011: Heparin-induced thrombocytopenia in the ICU: an overview. Critical Care 15(2): 211

Rice, L. 2011: Heparin-induced thrombocytopenia in the cardiac patient: 10 points to help the physician. Methodist Debakey Cardiovascular Journal 7(4): 6-9

Crowther, M.; Cook, D.; Guyatt, G.; Zytaruk, N.; McDonald, E.; Williamson, D.; Albert, M.; Dodek, P.; Finfer, S.; Vallance, S.; Heels-Ansdell, D.; McIntyre, L.; Mehta, S.; Lamontagne, F.; Muscedere, J.; Jacka, M.; Lesur, O.; Kutsiogiannis, J.; Friedrich, J.; Klinger, J.R.; Qushmaq, I.; Burry, L.; Khwaja, K.; Sheppard, J.-A.; Warkentin, T.E.; Cook, D.; McDonald, E.; Tkaczyk, A.; Clarke, F.; Wallace, C.; Hall, R.; Rocker, G.; Julien, L.; Wright, D.; Roy, C.; Theriault, J.; Pleasance, S.; Snow, D.; Herbert, S.; Meade, M.; Hand, L.; Biljan, M.; Freitag, A.; Wynne, C.; Duffett, M.; Kho, M.; Zytaruk, N.; Currie, K.; Granton, J.; Matte, A.; Farias, P.; Chu, L.; Brockest, N.; Go, S.; McGrath-Chong, M.; Dennis, M.; Lipkus, M.; Stern, E.; Albert, R.; 2014: Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial. Journal of Critical Care 29(3): 470.E7

Argudín, M.A.; Deplano, A.; Vandendriessche, S.; Dodémont, M.; Nonhoff, C.; Denis, O.; Roisin, S. 2018: CC398 Staphylococcus aureus subpopulations in Belgian patients. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 37(5): 911-916

Wheatcroft, M.D.; Greco, E.; Tse, L.; Roche-Nagle, G. 2011: Heparin-induced thrombocytopenia in the presence of a heparin-bonded bypass graft. Vascular 19(6): 338-341

Frykberg, R.G.; Gordon, S.; Tierney, E.; Tallis, A. 2013: Heparin-induced thrombocytopenia in the setting of perioperative bridging for podiatric surgery: a case report. Journal of the American Podiatric Medical Association 103(1): 67-72

Sugimoto, T.; Matsuo, T.; Wanaka, K. 2010: Heparin-induced thrombocytopenia in two patients undergoing abdominal aortic aneurysm surgery. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 16(1): 110-114

Medina, N.D.; Mehan, V.; Schmidt, S.T. 2010: Heparin-induced thrombocytopenia leading to flap failure: Hirudo medicinalis and implications. Plastic and Reconstructive Surgery 125(5): 217e-219e

Nazliel, B.; Batur Caglayan, H.Z.; Yildirim Capraz, I.; Irkec, C.; Yagci, M.; Gesoglu, T. 2014: Heparin-induced thrombocytopenia leading to stroke, lower extremity arterial occlusive disease, and skin necrosis: a case report. Platelets 25(2): 129-131

Djunić, I.; Tomin, D.; Antonijević, N.; Gradinac, S.; Kovac, M.; Vidović, A.; Djurasinović, V.; Elezović, I. 2009: Heparin-induced thrombocytopenia occurring after surgical treatment of atrial myxoma--a case report. Srpski Arhiv Za Celokupno Lekarstvo 137(9-10): 540-544

Marinella, M.A. 2007: Heparin-induced thrombocytopenia presenting as otalgia. Southern Medical Journal 100(10): 1057

Takemoto, C.M.; Streiff, M.B. 2011: Heparin-induced thrombocytopenia screening and management in pediatric patients. HEMATOLOGY. American Society of Hematology. Education Program 2011: 162-169

Seldrum, S.; Lambert, M.; Hainaut, P. 2009: Heparin-induced thrombocytopenia successfully treated with fondaparinux. Acta Clinica Belgica 64(2): 144-146

Lasocki, S.; Ajzenberg, N.; Quintard, H.é; Plantefève, G.; Desmonts, J.-M.; Montravers, P. 2007: Heparin-induced thrombocytopenia suspected because of repeated hemofiltration filter clotting. Intensive Care Medicine 33(7): 1305-1307

Tremblay, D.M.; Harris, P.G.; Gagnon, A.R.; Cordoba, C.; Brutus, J.Paul.; Nikolis, A. 2008: Heparin-induced thrombocytopenia syndrome as a cause of flap failure: a report of two cases. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 61(1): 78-83

Martin, K.; Kia, L.; Parikh, N.D.; Kulik, L.; McMahon, B. 2014: Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis and correlates with poor clinical outcomes. Annals of Hepatology 13(5): 548-554

Heil, S. 2009: Heparin-induced thrombocytopenia type Ii with thrombosis in an intensive care patient: therapy management using the direct thrombin inhibitor argatroban. Der Anaesthesist 58(11): 1119-1122

Dracopoulos, S.; Vougas, V.; Kassimatis, T.I.; Theodoridis, T.; Ali, M.E.; Apostolou, T. 2007: Heparin-induced thrombocytopenia type II: a serious hazard in preemptive renal transplantation: a case report. Transplantation Proceedings 39(10): 3481-3484

Vucelić, D.; Antonijević, N.; Galun, D.; Bulajić, P.; Basarić, D.; Milićević, M. 2011: Heparin-induced thrombocytopenia with iliacofemoropopliteal thrombosis in a patient operated for colorectal carcinoma liver metastases. Acta Chirurgica Iugoslavica 58(4): 93-96

Ichinoe, M.; Mikami, T.; Ujiie, S.; Suzuki, K.; Okayasu, I. 2009: Heparin-induced thrombocytopenia with multiple organized thrombi accompanied by unusual cholesterin deposition: autopsy case after long-term follow up. Pathology International 59(10): 757-761

Kolluri, R.; Rocha-Singh, K.; Sarac, T.; Bartholomew, J.R. 2009: Heparin-induced thrombocytopenia with thrombosis after endovascular aneurysm repair. Vascular and Endovascular Surgery 43(1): 89-92

Kramer, R.; Oberg-Higgins, P.; Russo, L.; Braxton, J.H. 2009: Heparin-induced thrombocytopenia with thrombosis syndrome managed with plasmapheresis. Interactive Cardiovascular and Thoracic Surgery 8(4): 439-441

Benyounes, N.; Engrand, N.; Bartolini, B.; Taylor, G.; Devys, J.-M. 2013: Heparin-induced thrombocytopenia without thrombocytopenia in an intensive care unit. Presse Medicale 42(7-8): 1140-1142

Krauel, K.; Fürll, B.; Warkentin, T.E.; Weitschies, W.; Kohlmann, T.; Sheppard, J.I.; Greinacher, A. 2008: Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes. Journal of Thrombosis and Haemostasis: Jth 6(12): 2160-2167

Shantsila, E.; Lip, G.Y.H.; Chong, B.H. 2009: Heparin-induced thrombocytopenia. a contemporary clinical approach to diagnosis and management. Chest 135(6): 1651-1664

Bartholomew, J.R. 2008: Heparin-induced thrombocytopenia: 2008 update. Current Treatment Options in Cardiovascular Medicine 10(2): 117-127

Miyata, S. 2012: Heparin-induced thrombocytopenia: HIT. Japanese Journal of Clinical Hematology 53(10): 1709-1719

Prisco, D. 2007: Heparin-induced thrombocytopenia: a brief update in an Italian perspective. Recenti Progressi in Medicina 98(9): 452-456

Jourdain, M.; Ennezat, P.-V.; Darchis, J.; Aubert, J.-M.; Bauchart, J.-J.; Auffray, J.-L.; Asseman, P. 2007: Heparin-induced thrombocytopenia: a case of persistent thrombocytopenia. Archives des Maladies du Coeur et des Vaisseaux 100(11): 959-962

Pouplard, C.; Regina, S.; May, M.-A.; Gruel, Y. 2007: Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery. Archives des Maladies du Coeur et des Vaisseaux 100(6-7): 563-568

Swanson, J.M. 2007: Heparin-induced thrombocytopenia: a general review. Journal of Infusion Nursing: the Official Publication of the Infusion Nurses Society 30(4): 232-240

Kelton, J.G.; Warkentin, T.E. 2008: Heparin-induced thrombocytopenia: a historical perspective. Blood 112(7): 2607-2616

Hong, M.S.; Amanullah, A.M. 2010: Heparin-induced thrombocytopenia: a practical review. Reviews in Cardiovascular Medicine 11(1): 13-25

Greinacher, A.; Juhl, D.; Strobel, U.; Wessel, A.; Lubenow, N.; Selleng, K.; Eichler, P.; Warkentin, T.E. 2007: Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes. Journal of Thrombosis and Haemostasis: Jth 5(8): 1666-1673

Junqueira, D.R.G.; Carvalho, M.d.G.ça.; Perini, E. 2013: Heparin-induced thrombocytopenia: a review of concepts regarding a dangerous adverse drug reaction. Revista da Associacao Medica Brasileira 59(2): 161-166

Talati, R.; Colemen, C.I.; White, C.M. 2008: Heparin-induced thrombocytopenia: a review of current pharmacologic treatment. Connecticut Medicine 72(5): 275-279

Kawano, H.; Toyoda, K.; Miyata, S.; Yamamoto, H.; Okamoto, A.; Kakutani, I.; Walenga, J.M.; Naritomi, H.; Minematsu, K. 2008: Heparin-induced thrombocytopenia: a serious complication of heparin therapy for acute stroke. Cerebrovascular Diseases 26(6): 641-649

Greinacher, A.; Alban, S.; Omer-Adam, M.A.; Weitschies, W.; Warkentin, T.E. 2008: Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings. Thrombosis Research 122(2): 211-220

Elalamy, I.; Le Gal, G.; Nachit-Ouinekh, F.; Lafuma, A.; Emery, C.; Le-Fur, C.; Chapuis, F.ço. 2009: Heparin-induced thrombocytopenia: an estimate of the average cost in the hospital setting in France. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 15(4): 428-434

Rosenberger, L.H.; Smith, P.W.; Sawyer, R.G. 2011: Heparin-induced thrombocytopenia: an increasingly common cause of bilateral adrenal hemorrhage. Journal of the American Geriatrics Society 59(6): 1157-8; author reply 1158

Kato, S.; Takahashi, K.; Ayabe, K.; Samad, R.; Fukaya, E.; Friedmann, P.; Varma, M.; Bergmann, S.R. 2011: Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients. British Journal of Haematology 154(3): 373-377

Al-Rossaies, A.; Alkharfy, K.M.; Al-Ayoubi, F.; Al-Momen, A. 2011: Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin. International Journal of Clinical Pharmacy 33(6): 997-1001

Otis, S.A.; Zehnder, J.L. 2010: Heparin-induced thrombocytopenia: current status and diagnostic challenges. American Journal of Hematology 85(9): 700-706

Liebman, H.A. 2008: Heparin-induced thrombocytopenia: diagnosis and management. Vascular 16(Suppl 1): S71-S76

Morel-Kopp, M.-C.; Aboud, M.; Tan, C.W.; Kulathilake, C.; Ward, C. 2011: Heparin-induced thrombocytopenia: evaluation of IgG and IgGAM ELISA assays. International Journal of Laboratory Hematology 33(3): 245-250

Pötschke, C.; Selleng, S.; Bröker, B.M.; Greinacher, A. 2012: Heparin-induced thrombocytopenia: further evidence for a unique immune response. Blood 120(20): 4238-4245

Koposova, N.; Eriksen, H.M.; Widström, E.; Handegård, B.ør.H.; Pastbin, M.; Koposov, R. 2013: Caries prevalence and determinants among 12-year-olds in North-West Russia and Northern Norway. Stomatologija 15(1): 3-11

Zinkovsky, D.A.; Antonopoulos, M.S. 2008: Heparin-induced thrombocytopenia: overview and treatment. P and T: a Peer-Reviewed Journal for Formulary Management 33(11): 642-651

Cuker, A. 2011: Heparin-induced thrombocytopenia: present and future. Journal of Thrombosis and Thrombolysis 31(3): 353-366

Gruel, Y.; Rollin, J.; Leroux, D.; Pouplard, C. 2014: Heparin-induced thrombocytopenia: recent data. La Revue de Medecine Interne 35(3): 174-182

Lubenow, N.; Greinacher, A. 2000: Heparin-induced thrombocytopenia: recommendations for optimal use of recombinant hirudin. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 14(2): 109-125

Alberio, L. 2008: Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment. Current Opinion in Hematology 15(5): 456-464

Desconclois, C.él.; Ract, C.; Boutekedjiret, T.; Alhenc-Gelas, M.; Duranteau, J.; Dreyfus, M.; Proulle, V. 2011: Heparin-induced thrombocytopenia: successful biological and clinical management with lepirudin despite severe renal impairment. Thrombosis and Haemostasis 105(3): 568-569

Pamela, S.; Anna Maria, L.; Elena, D.; Giovanni, M.; Emanuele, A.; Silvia, V.; Carmen, B.; Andreas, G.; Fabrizio, F. 2013: Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms. Platelets 24(5): 362-368

Gur'ianov, V.A.; Tolmachev, G.N. 2013: Heparin-induced thrombocytopenia: theory and practice. Anesteziologiia i Reanimatologiia 6: 60-62

Greinacher, A.; Ittermann, T.; Bagemühl, J.; Althaus, K.; Fürll, B.; Selleng, S.; Lubenow, N.; Schellong, S.; Sheppard, J.I.; Warkentin, T.E. 2010: Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests. Journal of Thrombosis and Haemostasis: Jth 8(9): 2025-2031

Dalainas, I.; Avgerinos, E.D.; Liapis, C.D. 2011: Heparin-induced thrombocytopenia: what a vascular surgeon needs to know. Journal of Cardiovascular Surgery 52(1): 81-88

Chong, B.H.; Isaacs, A. 2009: Heparin-induced thrombocytopenia: what clinicians need to know. Thrombosis and Haemostasis 101(2): 279-283

Ortel, T.L. 2009: Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. HEMATOLOGY. American Society of Hematology. Education Program 2009: 225-232

Glass, M.; Spitrey, J. 2009: Heparin-induced thrombocytopenia: your questions answered. AACN Advanced Critical Care 20(1): 5-9; Quiz 10-1

Tibayan, F.A.; Leung, L.L.; Burdon, T.A.; Fann, J.I. 2010: Heparin-induced thrombosis without thrombocytopenia. Journal of Thoracic and Cardiovascular Surgery 139(2): E6-E7

Bigdeli, A.K.; Schmitz, C.; Bruegger, D.; Weis, F.; Weis, M.; Michel, S.; Schmauss, D.; Reichart, D.; Reichart, B.; Sodian, R. 2009: Heparin-induced thrombosis without thrombocytopenia causing fulminant pulmonary embolism after off-pump coronary artery bypass grafting. Heart Surgery Forum 12(6): E368-E370

Esposito, P.; Libetta, C.; Borettaz, I.; Barone, M.; Canevari, M.; Martinelli, C.; Montagna, F.; Romeo, S.; Margiotta, E.; Calatroni, M.; La Porta, E.; Dal Canton, A. 2014: Heparin-induced trombocytopenia: pathogenesis, clinical manifestations and management in hemodialysis. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 31(3)

Madhugiri, V.S.; Mahadevan, A.; Gundamaneni, S.K.; Singh, M. 2012: Heparin-induced tumour bleed. BMJ Case Reports

Medeiros, V.ír.P.; Paredes-Gamero, E.J.; Monteiro, H.P.; Rocha, H.A.O.; Trindade, E.S.; Nader, H.B. 2012: Heparin-integrin interaction in endothelial cells: downstream signaling and heparan sulfate expression. Journal of Cellular Physiology 227(6): 2740-2749

Tao, Y.; Hu, T.; Wu, Z.; Tang, H.; Hu, Y.; Tan, Q. 2012: Heparin-iron complex multilayer nanomodification improves hemocompatibility of decellular xenograft. Zhong Nan da Xue Xue Bao. Yi Xue Ban 37(3): 260-266

Senzolo, M.; Agarwal, S.; Zappoli, P.; Vibhakorn, S.; Mallett, S.; Burroughs, A.K. 2009: Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation. Liver International: Official Journal of the International Association for the Study of the Liver 29(5): 754-759

Senzolo, M.; Cholongitas, E.; Thalheimer, U.; Riddell, A.; Agarwal, S.; Mallett, S.; Ferronato, C.; Burroughs, A.K. 2009: Heparin-like effect in liver disease and liver transplantation. Clinics in Liver Disease 13(1): 43-53

Ranucci, M.; Baryshnikova, E.; Isgrò, G.; Carlucci, C.; Cotza, M.; Carboni, G.; Ballotta, A. 2014: Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients. Critical Care 18(5): 504

Colliec-Jouault, S.; Bavington, C.; Delbarre-Ladrat, C. 2012: Heparin-like entities from marine organisms. Handbook of Experimental Pharmacology 207: 423-449

Ran, F.; Nie, S.; Li, J.; Su, B.; Sun, S.; Zhao, C. 2012: Heparin-like macromolecules for the modification of anticoagulant biomaterials. Macromolecular Bioscience 12(1): 116-125

Pollari, S.; Käkönen, R.S.; Mohammad, K.S.; Rissanen, J.P.; Halleen, J.M.; Wärri, A.; Nissinen, L.; Pihlavisto, M.; Marjamäki, A.; Perälä, M.; Guise, T.A.; Kallioniemi, O.; Käkönen, S.-M. 2012: Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis. Molecular Cancer Research: Mcr 10(5): 597-604

Arlov, Øy.; Aachmann, F.L.; Sundan, A.; Espevik, T.; Skjåk-Bræk, G. 2014: Heparin-like properties of sulfated alginates with defined sequences and sulfation degrees. Biomacromolecules 15(7): 2744-2750

Tang, M.; Xue, J.; Yan, K.; Xiang, T.; Sun, S.; Zhao, C. 2012: Heparin-like surface modification of polyethersulfone membrane and its biocompatibility. Journal of Colloid and Interface Science 386(1): 428-440

Shao, M.; Wang, H.-F. 2013: Heparin-mediated fluorescence anisotropy assay of antithrombin based on polyethyleneimine capped Mn-doped ZnS quantum dots. Analyst 138(16): 4618-4623

Satoh, Y.; Masuda, A.; Jona, M.; Nannya, Y.; Yokota, H.; Kurokawa, M.; Yatomi, Y. 2014: Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia. European Journal of Haematology 92(5): 456-457

Deng, J.; Liu, X.; Ma, L.; Cheng, C.; Shi, W.; Nie, C.; Zhao, C. 2014: Heparin-mimicking multilayer coating on polymeric membrane via LbL assembly of cyclodextrin-based supramolecules. Acs Applied Materials and Interfaces 6(23): 21603-21614

Princz, M.A.; Sheardown, H. 2008: Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2). Journal of Biomaterials Science. Polymer Edition 19(9): 1201-1218

Princz, M.A.; Sheardown, H. 2012: Heparin-modified dendrimer crosslinked collagen matrices for the delivery of heparin-binding epidermal growth factor. Journal of Biomedical Materials Research. Part a 100(8): 1929-1937

Niu, G.; Choi, J.-S.; Wang, Z.; Skardal, A.; Giegengack, M.; Soker, S. 2014: Heparin-modified gelatin scaffolds for human corneal endothelial cell transplantation. Biomaterials 35(13): 4005-4014

Janairo, R.R.R.; Henry, J.J.D.; Lee, B.L.-P.; Hashi, C.K.; Derugin, N.; Lee, R.; Li, S. 2012: Heparin-modified small-diameter nanofibrous vascular grafts. IEEE Transactions on Nanobioscience 11(1): 22-27

Wang, Y.; Xin, D.; Liu, K.; Zhu, M.; Xiang, J. 2009: Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity. Bioconjugate Chemistry 20(12): 2214-2221

Wang, Y.; Xin, D.; Liu, K.; Xiang, J. 2009: Heparin-paclitaxel conjugates using mixed anhydride as intermediate: synthesis, influence of polymer structure on drug release, anticoagulant activity and in vitro efficiency. Pharmaceutical Research 26(4): 785-793

Levine, R.L.; Hergenroeder, G.W.; Francis, J.L.; Miller, C.C.; Hursting, M.J. 2010: Heparin-platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study. Journal of Thrombosis and Thrombolysis 30(2): 142-148

Kleschyov, A.L.; Sen', V.D. 2013: Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease?. Future Medicinal Chemistry 5(4): 385-388

Kleschyov, A.L.; Sen', V.; Golubev, V.; Münnemann, K.; Hinderberger, D.; Lackner, K.J.; Weber, S.; Terekhov, M.; Schreiber, L.M.; Münzel, T. 2012: Heparin-polynitroxides: synthesis and preliminary evaluation as cardiovascular EPR/MR imaging probes and extracellular space-targeted antioxidants. European Journal of Medicinal Chemistry 58: 265-271

Peysselon, F.; Ricard-Blum, S. 2014: Heparin-protein interactions: from affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis. Matrix Biology: Journal of the International Society for Matrix Biology 35: 73-81

McGonigle, J.S.; Tae, G.; Stayton, P.S.; Hoffman, A.S.; Scatena, M. 2008: Heparin-regulated delivery of osteoprotegerin promotes vascularization of implanted hydrogels. Journal of Biomaterials Science. Polymer Edition 19(8): 1021-1034

Spadaccio, C.; Rainer, A.; Centola, M.; Trombetta, M.; Chello, M.; Lusini, M.; Covino, E.; Toyoda, Y.; Genovese, J.A. 2010: Heparin-releasing scaffold for stem cells: a differentiating device for vascular aims. Regenerative Medicine 5(4): 645-657

Absar, S.; Choi, S.; Yang, V.C.; Kwon, Y.M. 2012: Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis. Journal of Controlled Release: Official Journal of the Controlled Release Society 157(1): 46-54

Elsharnouby, N.M.; Eid, H.E.A.; Abou Elezz, N.F.; Aboelatta, Y.A. 2014: Heparin/N-acetylcysteine: an adjuvant in the management of burn inhalation injury: a study of different doses. Journal of Critical Care 29(1): 182.E1-4

Selleng, S.; Greinacher, A.; Ittermann, T.; Wollert, H.-G. 2009: Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up. American Heart Journal 158(1): E15

Lin, Q.; Yan, J.; Qiu, F.; Song, X.; Fu, G.; Ji, J. 2011: Heparin/collagen multilayer as a thromboresistant and endothelial favorable coating for intravascular stent. Journal of Biomedical Materials Research. Part a 96(1): 132-141

Myette, J.R.; Soundararajan, V.; Shriver, Z.; Raman, R.; Sasisekharan, R. 2009: Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity. Journal of Biological Chemistry 284(50): 35177-35188

Myette, J.R.; Soundararajan, V.; Behr, J.; Shriver, Z.; Raman, R.; Sasisekharan, R. 2009: Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage. Journal of Biological Chemistry 284(50): 35189-35200

Carlsson, P.; Presto, J.; Spillmann, D.; Lindahl, U.; Kjellén, L. 2008: Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains. Journal of Biological Chemistry 283(29): 20008-20014

Sabatier, L.; Djokic, J.; Hubmacher, D.; Dzafik, D.; Nelea, V.; Reinhardt, D.P. 2014: Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. Febs Letters 588(17): 2890-2897

Gandhi, N.S.; Mancera, R.L. 2010: Heparin/heparan sulphate-based drugs. Drug Discovery Today 15(23-24): 1058-1069

Poli, M.; Girelli, D.; Campostrini, N.; Maccarinelli, F.; Finazzi, D.; Luscieti, S.; Nai, A.; Arosio, P. 2011: Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. Blood 117(3): 997-1004

Xu, X.; Dai, Y. 2010: Heparin: an intervenor in cell communication. Journal of Cellular and Molecular Medicine 14(1-2): 175-180

Middeldorp, S. 2008: Heparin: from animal organ extract to designer drug. Thrombosis Research 122(6): 753-762

Kotwal, J.; Chaudhary, S.; Manoj, M.G.; Hasnain, S.; Nair, V.; Luthra, M. 2014: Heparin: induced thrombocytopenia: incidence and laboratory approach to diagnosis in Indians. Indian Journal of Pathology and Microbiology 57(1): 31-38

Xiao, Z.; Zhao, W.; Yang, B.; Zhang, Z.; Guan, H.; Linhardt, R.J. 2011: Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages. Glycobiology 21(1): 13-22

Levin, A.I.; Heine, A.M.; Coetzee, J.F.; Coetzee, A.é 2014: Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 28(2): 224-229

Cvirn, G.; Tafeit, E.; Hoerl, G.; Janschitz, M.; Wagner, T.; Juergens, G.; Koestenberger, M. 2010: Heparinase-Modified Thrombelastometry: Inactivation of Heparin in Plasma Samples. Clinical Laboratory 56(11-12): 585-589

Durila, M.; Kalincik, T.; Cvachovec, K.; Filho, R. 2010: Heparinase-modified thromboelastography can result in a fibrinolytic pattern. Anaesthesia 65(8): 864-865

Trethewie, E.R.; Melvin, P.A. 1945: Heparine evaluation. Australian journal of experimental biology and medical science 23: 241

Tocantins, L.M. 1948: Heparinemia. Blood 3(11): 1304-1306

Emile, C. 2007: Heparinemia (anti-factor Xa activity. Revue de l'Infirmiere 135: 49-50

Kannan, A. 2008: Heparinised saline or normal saline?. Journal of Perioperative Practice 18(10): 440-441

König, U.; Lode, A.; Welzel, P.B.; Ueda, Y.; Knaack, S.; Henß, A.; Hauswald, A.; Gelinsky, M. 2014: Heparinization of a biomimetic bone matrix: integration of heparin during matrix synthesis versus adsorptive post surface modification. Journal of Materials Science. Materials in Medicine 25(3): 607-621

Wang, W.; Hu, J.; He, C.; Nie, W.; Feng, W.; Qiu, K.; Zhou, X.; Gao, Y.; Wang, G. 2015: Heparinized PLLA/PLCL nanofibrous scaffold for potential engineering of small-diameter blood vessel: tunable elasticity and anticoagulation property. Journal of Biomedical Materials Research. Part a 103(5): 1784-1797

Wilbring, M.; Ebner, A.; Schoenemann, K.; Knaut, M.; Tugtekin, S.M.; Zatschler, B.; Waldow, T.; Alexiou, K.; Matschke, K.; Deussen, A. 2013: Heparinized blood better preserves cellular energy charge and vascular functions of intraoperatively stored saphenous vein grafts in comparison to isotonic sodium-chloride-solution. Clinical Hemorheology and Microcirculation 55(4): 445-455

Øvrum, E.; Tangen, G.; Tølløfsrud, S.; Skeie, B.ør.; Ringdal, M.A.L.; Istad, R.; Øystese, R. 2011: Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery 141(5): 1145-1149

Tang, D-Wei.; Yu, S-Huei.; Ho, Y-Cheng.; Mi, F-Long.; Kuo, P-Li.; Sung, H-Wen. 2010: Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin. Biomaterials 31(35): 9320-9332

Brouwer, K.M.; Wijnen, R.é M.; Reijnen, D.; Hafmans, T.G.; Daamen, W.F.; van Kuppevelt, T.H. 2013: Heparinized collagen scaffolds with and without growth factors for the repair of diaphragmatic hernia: construction and in vivo evaluation. Organogenesis 9(3): 161-167

Teixeira, S.; Yang, L.; Dijkstra, P.J.; Ferraz, M.P.; Monteiro, F.J. 2010: Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering. Journal of Materials Science. Materials in Medicine 21(8): 2385-2392

Wu, Q.; Liu, C.; Fan, L.; Shi, J.; Liu, Z.; Li, R.; Sun, L. 2012: Heparinized magnetic mesoporous silica nanoparticles as multifunctional growth factor delivery carriers. Nanotechnology 23(48): 485703

Jiang, T.; Wang, G.; Qiu, J.; Luo, L.; Zhang, G. 2009: Heparinized poly(vinyl alcohol)--small intestinal submucosa composite membrane for coronary covered stents. Biomedical Materials 4(2): 025012

Ma, K.-w.; Dai, X.-z.; Feng, S.-y.; Jing, A.-h.; Yang, J.-y. 2011: Heparinized polyvinyl alcohol to specifically adsorb low-density lipoprotein from plasma. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 44(1): 3-9

Cook, L.; Bellini, S.; Cusson, R.M. 2011: Heparinized saline vs normal saline for maintenance of intravenous access in neonates: an evidence-based practice change. Advances in Neonatal Care: Official Journal of the National Association of Neonatal Nurses 11(3): 208-215

Del Cotillo, M.; Grané, N.úr.; Llavoré, M.; Quintana, S. 2008: Heparinized solution vs. saline solution in the maintenance of arterial catheters: a double blind randomized clinical trial. Intensive Care Medicine 34(2): 339-343

Fulcher, Y.G.; Sanganna Gari, R.Reddy.; Frey, N.C.; Zhang, F.; Linhardt, R.J.; King, G.M.; Van Doren, S.R. 2014: Heparinoids activate a protease, secreted by mucosa and tumors, via tethering supplemented by allostery. Acs Chemical Biology 9(4): 957-966

De Azevedo, T.C.G.; Bezerra, M.E.íl.B.; Santos, M.d.G.ór.d.L.; Souza, L.A.; Marques, C.T.; Benevides, N.M.B.; Leite, E.L. 2009: Heparinoids algal and their anticoagulant, hemorrhagic activities and platelet aggregation. Biomedicine and PharmacoTherapy 63(7): 477-483

Cavalheiro Filho, C.; Chamone, D.d.A.F.; Rached, R.A.; Maffei, F.H. 2008: Heparins - current status. Revista da Associacao Medica Brasileira 54(6): 471-472

Stiefelhagen, P. 2013: Heparins after thrombosis and during bridging. MMW Fortschritte der Medizin 155(11): 22

Noble, S. 2014: Heparins and cancer survival: where do we stand?. Thrombosis Research 133(Suppl 2): S133-S138

Barouti, N.; Masouyé, I.; Boehncke, W.-H.; Prins, C. 2013: Heparins and skin reactions: from diagnostic to management. Revue Medicale Suisse 9(380): 705

Laubli, H.; Borsig, L. 2009: Heparins attenuate cancer metastasis: are selectins the link?. Cancer Investigation 27(5): 474-481

Sciahbasi, A.; Rigattieri, S.; Calcagno, S.; Mancone, M.; Pendenza, G.; Cera, M.; Danza, A.I.; Di Russo, C.; Bruno, P.; Fedele, S.; Pugliese, F.R.; Sardella, G. 2015: Heparins crossover in percutaneous coronary interventions: a real issue with increasing rate of transradial procedures?. Journal of Cardiovascular Medicine 16(7): 507-511

Gallus, A.S. 2014: Heparins for preventing venous thromboembolism in general medical wards: evidence and guidelines. Internal Medicine Journal 44(11): 1051-1054

Hitzeman, N.; Rafii, F. 2009: Heparins for unstable angina and non-ST segment elevation myocardial infarction. American Family Physician 79(7): 560-562

Aquino, R.S.; Pereira, M.S.; Vairo, B.C.; Cinelli, L.P.; Santos, G.R.C.; Fonseca, R.J.C.; Mourão, P.A.S. 2010: Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?. Thrombosis and Haemostasis 103(5): 1005-1015

Dinwoodey, D.L.; Ansell, J.E. 2008: Heparins, low-molecular-weight heparins, and pentasaccharides: use in the older patient. Cardiology Clinics 26(2): 145-155 V

Liverani, L.; Mascellani, G.; Spelta, F. 2009: Heparins: process-related physico-chemical and compositional characteristics, fingerprints and impurities. Thrombosis and Haemostasis 102(5): 846-853

Chen, J.-X.; Liu, W.; Zhang, M.; Chen, J.-H. 2014: Heparosan based negatively charged nanocarrier for rapid intracellular drug delivery. International Journal of Pharmaceutics 473(1-2): 493-500

DeAngelis, P.L. 2015: Heparosan, a promising 'naturally good' polymeric conjugating vehicle for delivery of injectable therapeutics. Expert Opinion on Drug Delivery 12(3): 349-352

Gao, M.; Zhan, Y.-Q.; Yu, M.; Ge, C.-H.; Li, C.-Y.; Zhang, J.-H.; Wang, X.-H.; Ge, Z.-Q.; Yang, X.-M. 2014: Hepassocin activates the EGFR/ERK cascade and induces proliferation of L02 cells through the Src-dependent pathway. Cellular Signalling 26(10): 2161-2166

Calvaruso, V. 2010: Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human?. Gut 59(6): 709-710

Cao, M.-M.; Xu, W.-X.; Li, C.-Y.; Cao, C.-Z.; Wang, Z.-D.; Yao, J.-W.; Yu, M.; Zhan, Y.-Q.; Wang, X.-H.; Tang, L.-J.; Chen, H.; Li, W.; Ge, C.-H.; Yang, X.-M. 2011: Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms. Journal of Cellular Biochemistry 112(10): 2882-2890

Aller, M.-A.; Lorente, L.; Prieto, I.; Moquillaza, L.M.; Arias, J. 2009: Hepatectomies in the rat: a look at the caudate process through microsurgery. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 41(10): 695-699

Xing, Q.; Luo, Y.; Gao, Y.; Zhang, S.; Zhu, Z.; Wang, Y.; Yuan, Q.; Shu, G.; Lou, C.; Wang, J.; Wang, P.; Du, Z. 2014: Hepatectomised patient sera promote hepatocyte differentiation of human-induced pluripotent stem cells. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 46(8): 731-737

Hobsley, M. 1964: Hepatectomy [Abridged. Proceedings of the Royal Society of Medicine 57(7): 550-551

Brown, R.E.; Bower, M.R.; Metzger, T.L.; Scoggins, C.R.; McMasters, K.M.; Hahl, M.J.; Tatum, C.; Martin, R.C.G. 2011: Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 13(2): 91-95

Li, A.-J.; Zhou, W.-P.; Wu, M.-C.; Luo, X.-J. 2007: Hepatectomy after primary repair of ruptured liver cancer. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 6(3): 267-270

Petillon, S.; Vibert, E.; Gorden, D.-L.; de la Serna, S.; Salloum, C.; Azoulay, D. 2010: Hepatectomy and intrahepatic biliary enteric anastomosis: a rescue surgery for obstructed metallic biliary stents in chronic pancreatitis. Gastroenterologie Clinique et Biologique 34(4-5): 310-313

Yan, T.D.; King, J.; Ebrahimi, A.; Sjarif, A.; Glenn, D.; Steinke, K.; Morris, D.L. 2007: Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma. Journal of Surgical Oncology 96(5): 367-373

Nanashima, A.; Yamaguchi, H.; Sumida, Y.; Abo, T.; Tobinaga, S.; Tanaka, K.; Takeshita, H.; Hidaka, S.; Sawai, T.; Yasutake, T.; Nagayasu, T. 2008: Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute. Hepato-Gastroenterology 55(84): 873-878

Chua, T.C.; Saxena, A.; Liauw, W.; Chu, F.; Morris, D.L. 2012: Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases--a systematic review. European Journal of Cancer 48(12): 1757-1765

Lu, W.-q.; Yu, N.-r.; Liu, H.-y. 2012: Hepatectomy combined with cryoablation and ethanol injection for unresectable multiple liver metastases from colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi 15(4): 370-372

Shellenberger, M.J.; Smith, R.; Varma, C.; Kotru, A.; Maloo, M.; Gerst, H. 2010: Hepatectomy cures a cough: giant cavernous hemangioma in a patient with persistent cough. Journal of the American Osteopathic Association 110(11): 675-677

Prieto-Puga Arjona, T.; Sánchez Pérez, B.; Suárez Muñoz, M.Án.; Fernández Aguilar, J.é L.; Santoyo Santoyo, J. 2014: Hepatectomy due to a saphenous vein leiomyosarcoma metastasis. Cirugia Espanola 92(3): 217-218

Yang, T.; Lau, W.Y.; Lai, E.C.H.; Yang, L.-Q.; Zhang, J.; Yang, G.-S.; Lu, J.-H.; Wu, M.-C. 2010: Hepatectomy for bilateral primary hepatolithiasis: a cohort study. Annals of Surgery 251(1): 84-90

Jabłońska, B. 2013: Hepatectomy for bile duct injuries: when is it necessary?. World Journal of Gastroenterology 19(38): 6348-6352

Brouquet, A.; Benoist, S.ép. 2011: Hepatectomy for colorectal liver metastases after neoadjuvant chemotherapy. Bulletin du Cancer 98(1): 11-18

Jaeck, D.; Oussoultzoglou, E.; Rosso, E. 2007: Hepatectomy for colorectal metastases in the presence of extrahepatic disease. Surgical Oncology Clinics of North America 16(3): 507

Fan, J.; Wang, Z. 2010: Hepatectomy for hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi 48(3): 167-168

Abdi, Z.; Krasnokutsky, S.; Rapkiewicz, A.; Saxena, A.; Villanueva, G.; Sarpel, U. 2010: Hepatectomy for hepatocellular carcinoma complicated by vasculitis flare. Hpb Surgery: a World Journal of Hepatic Pancreatic and Biliary Surgery 2010: 841754

Oishi, K.; Itamoto, T.; Kobayashi, T.; Oshita, A.; Amano, H.; Ohdan, H.; Tashiro, H.; Asahara, T. 2009: Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 13(4): 695-701

Inokawa, Y.; Sugimoto, H.; Kanda, M.; Yamada, S.; Fujii, T.; Nomoto, S.; Takeda, S.; Suzuki, N.; Matsushita, T.; Kodera, Y. 2014: Hepatectomy for hepatocellular carcinoma in patients with hemophilia. Journal of Hepato-Biliary-Pancreatic Sciences 21(11): 824-828

Tanaka, S.; Ishihara, K.; Watanabe, C.; Ohno, K.; Yamamoto, T. 2011: Hepatectomy for hepatocellular carcinoma in patients with severe thrombocytopenia. Hepato-Gastroenterology 58(109): 1316-1320

Lu, W.-P.; Dong, J.-H. 2014: Hepatectomy for hepatocellular carcinoma in the era of liver transplantation. World Journal of Gastroenterology 20(28): 9237-9244

Zeng, Q.-a.; Qiu, J.; Hong, J.; Li, Y.; Li, S.; Zou, R.; Huang, P.; Li, B.; Zheng, Y.; Lao, X.; Yuan, Y. 2012: Hepatectomy for hepatocellular carcinoma patients with macronodular cirrhosis. European Journal of Gastroenterology and Hepatology 24(5): 575-582

Yang, L.; Xu, J.; Ou, D.; Wu, W.; Zeng, Z. 2013: Hepatectomy for huge hepatocellular carcinoma: single institute's experience. World Journal of Surgery 37(9): 2189-2196

Hashimoto, M.; Sasaki, K.; Matsuda, M.; Watanabe, G. 2014: Hepatectomy for liver abscess caused by stones spilled during laparoscopic cholecystectomy. Asian Journal of Endoscopic Surgery 7(1): 60-62

Nakatake, R.; Kaibori, M.; Ishizaki, M.; Matsui, K.; Tsuda, T.; Matsushima, H.; Kwon, A-Hon. 2012: Hepatectomy for liver metastasis in malignant melanoma of ocular choroid origin-a case report. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2009-2011

Xu, J.; Wei, Y.; Zhong, Y.; Fan, J.; Zhou, J.; Qin, L.; Ren, L.; Qin, X. 2009: Hepatectomy for liver metastasis of colorectal cancer. International Journal of Colorectal Disease 24(4): 419-425

Sawada, T.; Kita, J.; Nagata, H.; Shimoda, M.; Kubota, K. 2007: Hepatectomy for metastatic liver tumor in patients with liver dysfunction. Hepato-Gastroenterology 54(80): 2306-2309

Sakaguchi, T.; Suzuki, S.; Morita, Y.; Oishi, K.; Suzuki, A.; Fukumoto, K.; Inaba, K.; Takehara, Y.; Baba, S.; Nakamura, S.; Konno, H. 2011: Hepatectomy for metastatic liver tumors complicated with right umbilical portion. Hepato-Gastroenterology 58: 107-108

Groeschl, R.T.; Nachmany, I.; Steel, J.L.; Reddy, S.K.; Glazer, E.S.; de Jong, M.C.; Pawlik, T.M.; Geller, D.A.; Tsung, A.; Marsh, J.Wallis.; Clary, B.M.; Curley, S.A.; Gamblin, T.Clark. 2012: Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. Journal of the American College of Surgeons 214(5): 769-777

Strong, R.W.; Fawcett, J.; Lynch, S.V.; Wall, D.R. 2003: Hepatectomy for pyogenic liver abscess. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 5(2): 86-90

Lupinacci, R.; Penna, C.; Nordlinger, B. 2007: Hepatectomy for resectable colorectal cancer metastases--indicators of prognosis, definition of resectability, techniques and outcomes. Surgical Oncology Clinics of North America 16(3): 493-506 Vii-Viii

Torzilli, G.; Donadon, M.; Marconi, M.; Palmisano, A.; Del Fabbro, D.; Spinelli, A.; Botea, F.; Montorsi, M. 2008: Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Archives of Surgery 143(11): 1082-1090

Zhou, Y.; Zhang, X.; Zhang, Z.; Liu, X.; Wu, L.; Li, Y.; Li, B. 2013: Hepatectomy in elderly patients: does age matter?. World Journal of Surgery 37(12): 2899-2910

Schiffman, S.C.; Bower, M.; Brown, R.E.; Martin, R.C.G.; McMasters, K.M.; Scoggins, C.R. 2010: Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 14(12): 1881-1886; Discussion: 1886-1887

Soares Júnior, Aônio.Wellington.Lima.; Tajra, C.Eduardo.Feitosa.; Soares, V.Yamashiro.Rocha.; Soares, J.Lemos.; Costa, J.Alexandre. 2011: Hepatectomy of lymphangioma in situs inversus totalis--case report. Revista do Colegio Brasileiro de Cirurgioes 38(6): 450-451

Kohya, N.; Miyazaki, K. 2008: Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma. Journal of Surgical Oncology 97(6): 498-502

Paes-Barbosa, Fábio.Colagrossi.; Ferreira, F.Gonçalves.; Szutan, L.Arnaldo. 2010: Hepatectomy preoperative planning. Revista do Colegio Brasileiro de Cirurgioes 37(5): 370-375

Shimizu, A.; Kobayashi, A.; Yokoyama, T.; Nakata, T.; Motoyama, H.; Kubota, K.; Furusawa, N.; Kitahara, H.; Kitagawa, N.; Fukushima, K.; Shirota, T.; Miyagawa, S. 2012: Hepatectomy preserving drainage veins of the posterior section for liver malignancy invading the right hepatic vein: an alternative to right hepatectomy. American Journal of Surgery 204(5): 717-723

Ishizaki, Y.; Yoshimoto, J.; Sugo, H.; Miwa, K.; Kawasaki, S. 2008: Hepatectomy using traditional Péan clamp-crushing technique under intermittent Pringle maneuver. American Journal of Surgery 196(3): 353-357

Fujita, T. 2009: Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma. Journal of hepatology 50(5): 1051-2; author reply 1052-3

Fujita, T. 2011: Hepatectomy versus radiofrequency ablation for early-stage hepatocellular carcinoma. Hepatology 53(1): 374

Belghiti, J.; Durand, F.ço. 2007: Hepatectomy vs. liver transplantation: a combination rather than an opposition. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 13(5): 636-638

Manzanet, G.; Pellicer, V.; Suelves, C.; Calabuig, Jé.P.; Morón, Rón. 2009: Hepatectomy with inferior vena cava resection. Is veno-venous bypass necessary?. Cirugia Espanola 85(2): 117-118

Hashimoto, K.; Sasaki, Y.; Yokoyama, S.; Naitou, A.; Hiraki, M.; Matsumoto, S.; Matsuyama, J.; Morita, S.; Morimoto, T.; Fukushima, Y.; Nishisho, I.; Nomura, T.; Takeda, M. 2009: Hepatectomy with microwave coagulation therapy for multiple liver metastases of rectal carcinoid--a case report. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2198-2200

Han, F.; Zhou, J-xue.; Zhang, L.; Han, Y-zhi. 2007: Hepatectomy with portal vein resection and reconstruction in the treatment of hilar cholangiocarcinoma. Zhonghua Wai Ke Za Zhi 45(11): 763-765

Nagino, M.; Nimura, Y.; Nishio, H.; Ebata, T.; Igami, T.; Matsushita, M.; Nishikimi, N.; Kamei, Y. 2010: Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Annals of Surgery 252(1): 115-123

Hovaguimian, F.; Beck-Schimmer, B.; Clavien, P.-A.; Schwartz, D.E. 2014: Hepatectomy without endotracheal general anesthesia: a safe procedure?. Journal of the American College of Surgeons 218(3): 499-500

Yuan, D.; Wei, Y.G.; Chen, K.; Li, B.; Yan, L.; Wen, T.; Zhao, J.; Yang, J. 2010: Hepatectomy-related hypophosphatemia may predict donor liver dysfunction in live-donor liver transplantation. Transplantation Proceedings 42(10): 4548-4551

Nomura, K.; Tatsumi, S.; Miyagawa, A.; Shiozaki, Y.; Sasaki, S.; Kaneko, I.; Ito, M.; Kido, S.; Segawa, H.; Sano, M.; Fukuwatari, T.; Shibata, K.; Miyamoto, K.-i. 2014: Hepatectomy-related hypophosphatemia: a novel phosphaturic factor in the liver-kidney axis. Journal of the American Society of Nephrology: Jasn 25(4): 761-772

Lopes-Junior, A.ên.G.; Belebecha, V.; Jacob, C.E. 2014: Hepatectomy: a critical analysis on expansion of the indications. Arquivos Brasileiros de Cirurgia Digestiva: Abcd 27(1): 47-52

Altuna, M.E.; Mazzetti, M.B.; Rago, L.F.; San Martín de Viale, L.C.; Damasco, M.C. 2009: Hepatic 11 beta-hydroxysteroid dehydrogenase 1 involvement in alterations of glucose metabolism produced by acidotic stress in rat. Journal of Physiology and Biochemistry 65(4): 329-337

Konopelska, S.; Kienitz, T.; Hughes, B.; Pirlich, M.; Bauditz, J.ür.; Lochs, H.; Strasburger, C.J.; Stewart, P.M.; Quinkler, M. 2009: Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis. Clinical Endocrinology 70(4): 554-560

Dube, S.; Norby, B.; Pattan, V.; Lingineni, R.K.; Singh, R.J.; Carter, R.E.; Basu, A.; Basu, R. 2014: Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique. Diabetologia 57(7): 1446-1455

Leatherland, J.F.; Reddy, P.K.; Yong, A.N.; Leatherland, A.; Lam, T.J. 1990: Hepatic 5'-monodeiodinase activity in teleosts in vitro: a survey of thirty-three species. Fish Physiology and Biochemistry 8(1): 1-10

Parks, J.S.; Chung, S.; Shelness, G.S. 2012: Hepatic ABC transporters and triglyceride metabolism. Current Opinion in Lipidology 23(3): 196-200

Liu, M.; Chung, S.; Shelness, G.S.; Parks, J.S. 2012: Hepatic ABCA1 and VLDL triglyceride production. Biochimica et Biophysica Acta 1821(5): 770-777

De Haan, W.; Karasinska, J.M.; Ruddle, P.; Hayden, M.R. 2014: Hepatic ABCA1 expression improves β-cell function and glucose tolerance. Diabetes 63(12): 4076-4082

Pedrelli, M.; Davoodpour, P.; Degirolamo, C.; Gomaraschi, M.; Graham, M.; Ossoli, A.; Larsson, L.; Calabresi, L.; Gustafsson, J.-Åk.; Steffensen, K.R.; Eriksson, M.; Parini, P. 2014: Hepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in mice. Plos one 9(4): E93552

Mo, Y.H.; Jaw, F.S.; Ho, M.C.; Wang, Y.C.; Peng, S.S.F. 2011: Hepatic ADC value correlates with cirrhotic severity of patients with biliary atresia. European Journal of Radiology 80(3): E253-E257

Damlaj, M.; Amre, R.; Wong, P.; How, J. 2014: Hepatic ALECT-2 amyloidosis causing portal hypertension and recurrent variceal bleeding: a case report and review of the literature. American Journal of Clinical Pathology 141(2): 288-291

Ong, K.Teong.; Mashek, M.T.; Bu, S.Young.; Mashek, D.G. 2013: Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(1): 313-321

Ong, K.Teong.; Mashek, M.T.; Davidson, N.O.; Mashek, D.G. 2014: Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism. Journal of lipid research 55(5): 808-815

Bidwell, L.A. 1910: Hepatic Abscess following Acute Appendicitis. British Medical Journal 2(2591): 507-508

Macleod, N. 1880: Hepatic Abscess Opened Antiseptically: Death. British Medical Journal 2(1039): 843-844

Wear, A.T. 1881: Hepatic Abscess Opened Antiseptically: Recovery. British Medical Journal 1(1046): 86

Boyce, F.F. 1939: Hepatic and Biliary Tract Disease: a Review of Recent Significant Advances. Annals of Surgery 109(3): 351-372

Banshodani, M.; Ishiyama, K.; Amano, H.; Tashiro, H.; Arihiro, K.; Itamoto, T.; Ohdan, H. 2009: Hepatic Angiomyolipoma with Minimal Intratumoral Fat Content. Case Reports in Gastroenterology 3(3): 324-331

Sergeant, G.; Schadde, E.; Maleux, G.; Aerts, R. 2013: Hepatic Artery Embolization prior to En Bloc Resection of an Encased Common Hepatic Artery in Adenocarcinoma of the Head of the Pancreas. Case Reports in Medicine 2013: 205475

Tarzamni, M.Kazem.; Khoshbaten, M.; Sadrarhami, S.; Daneshpajouhnejad, P.; Jalili, J.; Gholamian, M.; Shahmoradi, Z. 2014: Hepatic Artery and Portal Vein Doppler Indexes in Non-alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs. International Journal of Preventive Medicine 5(4): 472-477

Zhang, H.; Stolz, D.B.; Chalasani, G.; Thomson, A.W. 2013: Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells. Clinical and Experimental Immunology 173(3): 473-479

Ueki, S.; Castellaneta, A.; Yoshida, O.; Ozaki, K.; Zhang, M.; Kimura, S.; Isse, K.; Ross, M.; Shao, L.; Stolz, D.B.; Thomson, A.W.; Demetris, A.J.; Geller, D.A.; Murase, N. 2011: Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation. Hepatology 54(1): 216-228

Bailly-Maitre, B.éa.; Belgardt, B.F.; Jordan, S.D.; Coornaert, B.; von Freyend, M.J.; Kleinridders, A.; Mauer, J.; Cuddy, M.; Kress, C.L.; Willmes, D.; Essig, M.; Hampel, B.; Protzer, U.; Reed, J.C.; Brüning, J.C. 2010: Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance. Journal of Biological Chemistry 285(9): 6198-6207

Osei-Hyiaman, D.; Liu, J.; Zhou, L.; Godlewski, G.; Harvey-White, J.; Jeong, W.-i.; Bátkai, S.án.; Marsicano, G.; Lutz, B.; Buettner, C.; Kunos, G. 2008: Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. Journal of Clinical Investigation 118(9): 3160-3169

Wegscheid, C.; Karimi, K.; Tiegs, G. 2014: Hepatic CD141⁺IFNλ⁺ DC subset: one against all?. Journal of Hepatology 60(1): 9-11

Nakagawa, Y.; Satoh, A.; Yabe, S.; Furusawa, M.; Tokushige, N.; Tezuka, H.; Mikami, M.; Iwata, W.; Shingyouchi, A.; Matsuzaka, T.; Kiwata, S.; Fujimoto, Y.; Shimizu, H.; Danno, H.; Yamamoto, T.; Ishii, K.; Karasawa, T.; Takeuchi, Y.; Iwasaki, H.; Shimada, M.; Kawakami, Y.; Urayama, O.; Sone, H.; Takekoshi, K.; Kobayashi, K.; Yatoh, S.; Takahashi, A.; Yahagi, N.; Suzuki, H.; Yamada, N.; Shimano, H. 2014: Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes. Endocrinology 155(12): 4706-4719

Jacobs, R.é L.; Lingrell, S.; Zhao, Y.; Francis, G.A.; Vance, D.E. 2008: Hepatic CTP:phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein. Journal of Biological Chemistry 283(4): 2147-2155

Kubota, A.; Watanabe, M.; Kunisue, T.; Kim, E.-Y.; Tanabe, S.; Iwata, H. 2010: Hepatic CYP1A induction by chlorinated dioxins and related compounds in the endangered black-footed albatross from the North Pacific. Environmental Science and Technology 44(9): 3559-3565

Morten Sandvik Tor Einar Horsberg Janneche Utne Skaare And Kristian Ingebrigtsen 1997: Hepatic CYP1A induction in rainbow trout (Oncorhynchus mykiss) after exposure to benzo[a]pyrene in water. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 2(3): 175-180

Al Koudsi, N.; Hoffmann, E.B.; Assadzadeh, A.; Tyndale, R.F. 2010: Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors. European Journal of Clinical Pharmacology 66(3): 239-251

Al Koudsi, N.; Tyndale, R.F. 2010: Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(6): 381-392

Acharya, P.; Engel, J.C.; Correia, M.Almira. 2009: Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: a consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2alpha (eIF2alpha)-kinase (PERK) and general control nonderepressible-2 eIF2alpha kinase (GCN2), and global translational shutoff. Molecular Pharmacology 76(3): 503-515

Kimura, T.; Nakajima, T.; Kamijo, Y.; Tanaka, N.; Wang, L.; Hara, A.; Sugiyama, E.; Tanaka, E.; Gonzalez, F.J.; Aoyama, T. 2012: Hepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in Mice. PPAR research 2012: 174932

Jollye, F.W. 1892: Hepatic Cirrhosis Occurring in two Children of the Same Family. British Medical Journal 1(1634): 858-859

Noble, C.A.; Perry, I.H.; Marquis, H.H. 1936: Hepatic Cirrhosis With Encapsulated Peritonitis: Report of Case. California and Western Medicine 45(2): 172-174

Tidey, S. 1892: Hepatic Cirrhosis in Children. British Medical Journal 2(1646): 125

Poynton, F.J.; Wyllie, W.G. 1926: Hepatic Cirrhosis in Children: With special reference to the Biliary Forms. Archives of Disease in Childhood 1(1): 1-20

Powell, C.M. 1897: Hepatic Cirrhosis of Childhood: Intercurrent Typhoid Fever: Death from Acute Yellow Atrophy. British Medical Journal 2(1920): 1086-1087

Dal Palù, C.; Spandri, P.; Zuin, R. 1965: Hepatic Clearance and Lm of Galactose in Normal and Cirrhotic Subjects. Postgraduate Medical Journal 41(475): 261-267

Topletz, A.R.; Le, H.N.; Lee, N.; Chapman, J.D.; Kelly, E.J.; Wang, J.; Isoherranen, N. 2013: Hepatic Cyp2d and Cyp26a1 mRNAs and activities are increased during mouse pregnancy. Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(2): 312-319

Marques, P.E.; Oliveira, A.é G.; Pereira, R.V.; David, B.A.új.; Gomides, L.F.; Saraiva, A.M.; Pires, D.A.új.; Novaes, J.úl.T.; Patricio, D.O.; Cisalpino, D.; Menezes-Garcia, Z.él.; Leevy, W.M.; Chapman, S.E.; Mahecha, G.án.; Marques, R.E.; Guabiraba, R.; Martins, V.P.; Souza, D.G.; Mansur, D.S.; Teixeira, M.M.; Leite, M.F.; Menezes, G.B. 2015: Hepatic DNA deposition drives drug-induced liver injury and inflammation in mice. Hepatology 61(1): 348-360

Ma, Y.; Xia, W.; Wang, D.Q.; Wan, Y.J.; Xu, B.; Chen, X.; Li, Y.Y.; Xu, S.Q. 2013: Hepatic DNA methylation modifications in early development of rats resulting from perinatal BPA exposure contribute to insulin resistance in adulthood. Diabetologia 56(9): 2059-2067

Umeda, K.; Shiraki, N.; Kume, S. 2016: Hepatic Differentiation from Human Ips Cells Using M15 Cells. Methods in Molecular Biology 1357: 375-381

Yamazoe, T.; Shiraki, N.; Kume, S. 2016: Hepatic Differentiation from Murine and Human iPS Cells Using Nanofiber Scaffolds. Methods in Molecular Biology 1357: 475-483

Penn, I.; Hammond, W.; Bell, P.; McGuire, R.; Hutt, M.; Starzl, T. 1969: Hepatic Disorders in Renal Homograft Recipients. Current Topics in Surgical Research 1: 67-76

Ward, G.R. 1911: Hepatic Distomiasis (Sheep Rot) in man. British Medical Journal 1(2625): 931-935

Brown, M.J. 1928: Hepatic Efficiency: the Value of the Hæmoclastic and the Lævulose Tests in Childhood. Archives of Disease in Childhood 3(14): 81-95

Chen, A.; Guo, Z.; Zhou, L.; Yang, H. 2010: Hepatic Endosome Protein Profiling in Apolipoprotein e Deficient Mice Expressing Apolipoprotein B48 but not B100. Journal of Bioanalysis and Biomedicine 2(5): 100-106

Demuynck, F.; Morvan, J.; Brochart, C.; Blanpain, S.; Brasseur, A.; Boukadoum, N.; Herlin, C.; Fuks, D.; Chatelain, D.; Yzet, T.; Deramond, A. 2009: Hepatic Epithelioid hemangioendothelioma: a rare liver tumor. Journal de Radiologie 90(7-8 Pt 1: 845-848

Pak, K.; Kim, S-Jang.; Kim, I.Joo.; Kim, K.; Kim, H.; Kim, S.Jung. 2012: Hepatic FDG Uptake is not Associated with Hepatic Steatosis but with Visceral Fat Volume in Cancer Screening. Nuclear Medicine and Molecular Imaging 46(3): 176-181

Abdolazimi, Y.; Zhao, Z.; Lee, S.; Xu, H.; Allegretti, P.; Horton, T.M.; Yeh, B.; Moeller, H.P.; Nichols, R.J.; McCutcheon, D.; Shalizi, A.; Smith, M.; Armstrong, N.A.; Annes, J.P. 2018: CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition. Endocrinology 159(9): 3143-3157

Cui, Y.; Giesy, S.L.; Hassan, M.; Davis, K.; Zhao, S.; Boisclair, Y.R. 2014: Hepatic FGF21 production is increased in late pregnancy in the mouse. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 307(3): R290-R298

You, C.Ran.; Jang, J.Won.; Choi, J.Ki.; Bae, S.Hyun.; Yoon, S.Kew.; Kay, C.Seung.; Choi, J.Young. 2010: Hepatic Failure Caused by Reactivation of YMDD Mutants Occurring during Preemptive Lamivudine Therapy. Gut and Liver 4(2): 262-265

Anonymous 1955: Hepatic Fibrosis. British Medical Journal 1(4908): 274-275

Kang, K.-H.; Qian, Z.-J.; Ryu, B.; Karadeniz, F.; Kim, D.; Kim, S.-K. 2013: Hepatic Fibrosis Inhibitory Effect of Peptides Isolated from Navicula incerta on TGF-β1 Induced Activation of LX-2 Human Hepatic Stellate Cells. Preventive Nutrition and Food Science 18(2): 124-132

Gonnert, F.A.; Kunisch, E.; Gajda, M.; Lambeck, S.; Weber, M.; Claus, R.A.; Bauer, M.; Kinne, R.W. 2012: Hepatic Fibrosis in a Long-term Murine Model of Sepsis. Shock 37(4): 399-407

Haeusler, R.A.; Han, S.; Accili, D. 2010: Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia. Journal of Biological Chemistry 285(35): 26861-26868

Zhou, X.; Zeng, X.-Y.; Wang, H.; Li, S.; Jo, E.; Xue, C.C.L.; Tan, M.; Molero, J.C.; Ye, J.-M. 2014: Hepatic FoxO1 acetylation is involved in oleanolic acid-induced memory of glycemic control: novel findings from Study 2. Plos one 9(9): E107231

Ido-Kitamura, Y.; Sasaki, T.; Kobayashi, M.; Kim, H.-J.; Lee, Y.-S.; Kikuchi, O.; Yokota-Hashimoto, H.; Iizuka, K.; Accili, D.; Kitamura, T. 2012: Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation. Plos one 7(10): E47231

Tao, R.; Wei, D.; Gao, H.; Liu, Y.; DePinho, R.A.; Dong, X.C. 2011: Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene. Journal of Biological Chemistry 286(16): 14681-14690

Wang, H.; Feng, M.; Frey, K.; Balter, J.; Haken, R.T.; Lawrence, T.; Cao, Y. 2013: Hepatic Function Model Based Upon HIDA SPECT and Dose for Physiological Adaptive RT. Practical Radiation Oncology 3(2 Suppl 1: S2

Anonymous 1897: Hepatic Glycogenesis. British Medical Journal 2(1924): 1433-1434

Kapitsinou, P.P.; Liu, Q.; Unger, T.L.; Rha, J.; Davidoff, O.; Keith, B.; Epstein, J.A.; Moores, S.L.; Erickson-Miller, C.L.; Haase, V.H. 2010: Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116(16): 3039-3048

Jabłonowska, E.żb.; Wójcik, K.; Szymańska, B.że.; Omulecka, A.; Cwiklińska, H.; Piekarska, A. 2014: Hepatic HMOX1 expression positively correlates with Bach-1 and miR-122 in patients with HCV mono and HIV/HCV coinfection. Plos one 9(4): E95564

Matz-Soja, M.; Aleithe, S.; Marbach, E.; Böttger, J.; Arnold, K.; Schmidt-Heck, W.; Kratzsch, Jürgen.; Gebhardt, R. 2014: Hepatic Hedgehog signaling contributes to the regulation of IGF1 and IGFBP1 serum levels. Cell Communication and Signaling: Ccs 12: 11

Zitelli, B.J.; Gartner, J.C.; Malatack, J.J.; Shaw, B.W.; Iwatsuki, S.; Starzl, T.E. 1983: Hepatic Homograft Survival in Pediatric Orthotopic Liver Transplantation with Cyclosporine and Steroids. Transplantation Proceedings 15(4 Suppl 1: 2592-2596

Ilmakunnas, M.; Höckerstedt, K.; Mäkisalo, H.; Siitonen, S.; Repo, H.; Pesonen, E.J. 2010: Hepatic IL-8 release during graft procurement is associated with impaired graft function after human liver transplantation. Clinical Transplantation 24(1): 29-35

Honda, M.; Sakai, A.; Yamashita, T.; Nakamoto, Y.; Mizukoshi, E.; Sakai, Y.; Yamashita, T.; Nakamura, M.; Shirasaki, T.; Horimoto, K.; Tanaka, Y.; Tokunaga, K.; Mizokami, M.; Kaneko, S.; Kagaya, T.; Arai, K.; Kakinoki, K.; Kawaguchi, K.; Takatori, H.; Sunakosaka, H.; Nakahama, T.; Kamiyamamoto, S.; Takemori, Y.; Oguri, H.; Noda, Y.; Ogino, H.; Hinoue, Y.; Minouchi, K.; Hirai, N.; Sugimoto, T.; Adachi, K.; Nakamura, Y.; Unoura, M.; Nishino, R.; Morimoto, H.; Ohta, H.; Tsuji, H.; Iwata, A.; Terasaki, S.; Wakabayashi, T.; Shirota, Y.; Urabe, T.; Kawai, H.; Mizuno, Y.; Kameda, S.; Miyamori, H.; Fuchizaki, U.; Shyugo, H.; Osaka, H.; Matsushita, E.; Katou, Y.; Tanaka, N.; Notsumata, K.; Kumagai, M.; Yoneshima, M. 2010: Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 139(2): 499-509

Carslaw, R.W. 1939: Hepatic Insufficiency in Scarlet Fever. British Medical Journal 2(4100): 278-279

Solari, P.R.; Jones, C.; Wallace, M.R. 2014: Hepatic Lesions with Secondary Syphilis in an HIV-Infected Patient. Case Reports in Medicine 2014: 604794

Beljaars, L.; Schippers, M.; Reker-Smit, C.; Martinez, F.O.; Helming, L.; Poelstra, K.; Melgert, B.N. 2014: Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans. Frontiers in Immunology 5: 430

Bashir, M.R.; Merkle, E.M.; Smith, A.D.; Boll, D.T. 2012: Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination. European Journal of Radiology 81(2): E101-E109

Guglielmo, F.F.; Mitchell, D.G.; Roth, C.G.; Deshmukh, S. 2014: Hepatic MR imaging techniques, optimization, and artifacts. Magnetic Resonance Imaging Clinics of North America 22(3): 263-282

Li, J.; Viswanadha, S.; Loor, J.J. 2012: Hepatic Metabolic, Inflammatory, and Stress-Related Gene Expression in Growing Mice Consuming a Low Dose of Trans-10, cis-12-Conjugated Linoleic Acid. Journal of Lipids 2012: 571281

Radhi, J.; Ara, S.; Ruo, L. 2012: Hepatic Metastasis of Composite Adenocarcinoma and Neuroendocrine Carcinoma. Journal of Gastrointestinal Cancer 43(Suppl 1): S25-S27

Moir, J.A.G.; Haugk, B.; French, J.J. 2010: Hepatic Metastasis via a Ventriculo-Peritoneal Shunt from an Intracranial Meningioma: Case Report and Review of the Literature. Case Reports in Gastroenterology 4(2): 267-272

Floreani, A.; Antoniazzi, S.; Mescoli, C.; Bergasa, N.V. 2012: Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C. European Journal of Gastroenterology and Hepatology 24(4): 427-430

Quist, E.M.; Filgo, A.J.; Cummings, C.A.; Kissling, G.E.; Hoenerhoff, M.J.; Fenton, S.E. 2015: Hepatic Mitochondrial Alteration in CD-1 Mice Associated with Prenatal Exposures to Low Doses of Perfluorooctanoic Acid (PFOA). Toxicologic Pathology 43(4): 546-557

Campion, S.N.; Johnson, R.; Aleksunes, L.M.; Goedken, M.J.; van Rooijen, N.; Scheffer, G.L.; Cherrington, N.J.; Manautou, J.é E. 2008: Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. American Journal of Physiology. Gastrointestinal and Liver Physiology 295(2): G294-G304

Xie, Y.; Fung, H.Y.J.; Newberry, E.P.; Kennedy, S.; Luo, J.; Crooke, R.M.; Graham, M.J.; Davidson, N.O. 2014: Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice. Journal of Lipid Research 55(3): 540-548

Suzuki, T.; Uetsuka, K.; Kusanagi, K.; Hirai, T.; Nunoya, T.; Doi, K. 2010: Hepatic Myelolipoma with systemic amyloidosis in a goose (Anser cygnoides domesticus). Journal of Veterinary Medical Science 72(5): 669-671

McCarthy, C.F.; Sheridan, M.R. 1960: Hepatic Necrosis Due to Marsilid. Gut 1(2): 169-170

Pramfalk, C.; Jiang, Z.-Y.; Parini, P. 2011: Hepatic Niemann-Pick C1-like 1. Current Opinion in Lipidology 22(3): 225-230

Temel, R.E.; Tang, W.; Ma, Y.; Rudel, L.L.; Willingham, M.C.; Ioannou, Y.A.; Davies, J.P.; Nilsson, L-Mari.; Yu, L. 2007: Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. Journal of Clinical Investigation 117(7): 1968-1978

Petruzzelli, M.; Moschetta, A. 2007: Hepatic Niemann-Pick C1-like 1: the canalicular side of the coin. Hepatology 46(6): 2040-2042

Marina, R.; González, P.; Ferreras, M.Carmen.; Costilla, Sín.; Barrio, J-Pablo. 2015: Hepatic Nrf2 expression is altered by quercetin supplementation in X-irradiated rats. Molecular Medicine Reports 11(1): 539-546

Fahrmayr, C.; Fromm, M.F.; König, J.ör. 2010: Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects. Drug Metabolism Reviews 42(3): 380-401

Meyer zu Schwabedissen, H.E.; Kim, R.B. 2009: Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms. Molecular Pharmaceutics 6(6): 1644-1661

Moore, J.N.; Newsted, J.L.; Hecker, M.; Zwiernik, M.J.; Fitzgerald, S.D.; Kay, D.P.; Zhang, X.; Higley, E.B.; Aylward, L.L.; Beckett, K.J.; Budinsky, R.A.; Bursian, S.J.; Giesy, J.P. 2009: Hepatic P450 enzyme activity, tissue morphology and histology of mink (Mustela vison) exposed to polychlorinated dibenzofurans. Archives of Environmental Contamination and Toxicology 57(2): 416-425

Khan, H.M.; Katz, S.C.; Libbey, N.P.; Somasundar, P.S. 2014: Hepatic PEComa: a potential pitfall in the evaluation of hepatic neoplasms. BMJ Case Reports

Garcia-Manero, G.; Scott, B.L.; Cogle, C.R.; Boyd, T.E.; Kambhampati, S.; Hetzer, J.; Dong, Q.; Kumar, K.; Ukrainskyj, S.M.; Beach, C.L.; Skikne, B.S. 2018: CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia. Leukemia Research 72: 79-85

Zardi, E.M.; Navarini, L.; Sambataro, G.; Piccinni, P.; Sambataro, F.M.; Spina, C.; Dobrina, A. 2013: Hepatic PPARs: their role in liver physiology, fibrosis and treatment. Current medicinal chemistry 20(27): 3370-3396

Matsusue, K.; Aibara, D.; Hayafuchi, R.; Matsuo, K.; Takiguchi, S.; Gonzalez, F.J.; Yamano, S. 2014: Hepatic PPARγ and LXRα independently regulate lipid accumulation in the livers of genetically obese mice. FEBS letters 588(14): 2277-2281

Peyrou, M.; Bourgoin, L.; Poher, A.-L.; Altirriba, J.; Maeder, C.; Caillon, A.él.; Fournier, M.; Montet, X.; Rohner-Jeanrenaud, F.ço.; Foti, M. 2015: Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice. Journal of Hepatology 62(2): 421-429

Bence, K.K. 2010: Hepatic PTP1B Deficiency: the Promise of a Treatment for Metabolic Syndrome?. Journal of Clinical Metabolism and Diabetes 1(1): 27-33

Li, M.; Chang, B.; Zhen, Z.; Qin, P.-J.; Liu, W.-K.; Tong, X.-L. 2011: Hepatic PTP1B expression involvement in the effects of Chinese medicine formula xiao-gao-jiang-zhuo using an obese rat model. American Journal of Chinese Medicine 39(2): 301-313

Hou, J.; Zhou, Y.; Zheng, Y.; Fan, J.; Zhou, W.; Ng, I.O.L.; Sun, H.; Qin, L.; Qiu, S.; Lee, J.M.F.; Lo, C.-M.; Man, K.; Yang, Y.; Yang, Y.; Yang, Y.; Zhang, Q.; Zhu, X.; Li, N.; Wang, Z.; Ding, G.; Zhuang, S.-M.; Zheng, L.; Luo, X.; Xie, Y.; Liang, A.; Wang, Z.; Zhang, M.; Xia, Q.; Liang, T.; Yu, Y.; Cao, X. 2014: Hepatic RIG-i predicts survival and interferon-α therapeutic response in hepatocellular carcinoma. Cancer Cell 25(1): 49-63

Terblanche, J.; Starzl, T.E. 1979: Hepatic Regeneration. Viewpoints on Digestive Diseases 11(4): 40182

Niu, G-Cai.; Shen, C-Ming.; Cui, W.; Li, Q. 2012: Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer. Cancer Biology and Medicine 9(3): 182-187

Miyazaki, M.; Shimizu, H.; Ohtsuka, M.; Yoshidome, H.; Kato, A.; Yoshitomi, H.; Furukawa, K.; Kimura, F. 2012: Hepatic S4a + S5 and bile duct resection for gallbladder carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 19(3): 225-229

Sheng, L.; Liu, Y.; Jiang, L.; Chen, Z.; Zhou, Y.; Cho, K.W.; Rui, L. 2013: Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice. Plos one 8(12): E83269

Xu, J.; Li, N.; Wang, J.; Zhang, C.; Ding, S.; Jiao, Y. 2012: Hepatic SIRT1 and UCP2 expressions in rats with type 2 diabetes mellitus and nonalcoholic fatty liver. Nan Fang Yi Ke da Xue Xue Bao 32(5): 726-729

Li, Y.; Wong, K.; Giles, A.; Jiang, J.; Lee, J.W.; Adams, A.C.; Kharitonenkov, A.; Yang, Q.; Gao, B.; Guarente, L.; Zang, M. 2014: Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology 146(2): 539-49.E7

De Lima, M.; Oran, B.; Champlin, R.E.; Papadopoulos, E.B.; Giralt, S.A.; Scott, B.L.; William, B.M.; Hetzer, J.; Laille, E.; Hubbell, B.; Skikne, B.S.; Craddock, C. 2018: CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 24(10): 2017-2024

Wiersma, H.; Gatti, A.; Nijstad, N.; Kuipers, F.; Tietge, U.J.F. 2009: Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice. Journal of Lipid Research 50(8): 1571-1580

Tannour-Louet, M.; York, B.; Tang, K.; Stashi, E.; Bouguerra, H.; Zhou, S.; Yu, H.; Wong, L.-J.C.; Stevens, R.D.; Xu, J.; Newgard, C.B.; O'Malley, B.W.; Louet, J.-F. 2014: Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis. Molecular Endocrinology 28(10): 1707-1718

Tao, R.; Xiong, X.; DePinho, R.A.; Deng, C.-X.; Dong, X.C. 2013: Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6. Journal of Lipid Research 54(10): 2745-2753

Kim, H.Y.; Cho, H.K.; Yoo, S.K.; Cheong, J.H. 2012: Hepatic STAMP2 decreases hepatitis B virus X protein-associated metabolic deregulation. Experimental and Molecular Medicine 44(10): 622-632

Miyamura, T.; Kanda, T.; Nakamoto, S.; Wu, S.; Fujiwara, K.; Imazeki, F.; Yokosuka, O. 2011: Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients. Plos one 6(12): E28617

Ishaqi, M.K.; Jamil, A.; Khanani, M.; Baroudi, M.; Trad, O.; El-Hayek, M.; Bouffet, E. 2010: Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma. Journal of Neuro-Oncology 97(1): 137-141

Wang, R.-H.; Kim, H.-S.; Xiao, C.; Xu, X.; Gavrilova, O.; Deng, C.-X. 2011: Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. Journal of Clinical Investigation 121(11): 4477-4490

Berzsenyi, M.D.; Roberts, S.K.; Preiss, S.; Woollard, D.J.; Beard, M.R.; Skinner, N.A.; Bowden, D.S.; Visvanathan, K. 2011: Hepatic TLR2 and TLR4 expression correlates with hepatic inflammation and TNF-α in HCV and HCV/HIV infection. Journal of Viral Hepatitis 18(12): 852-860

Chen, Z.; Sheng, L.; Shen, H.; Zhao, Y.; Wang, S.; Brink, R.; Rui, L. 2012: Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. Diabetes 61(3): 566-573

Yuki, N.; Matsumoto, S.; Kato, M.; Yamaguchi, T. 2010: Hepatic Toll-Like Receptor 3 expression in chronic hepatitis C genotype 1 correlates with treatment response to peginterferon plus ribavirin. Journal of Viral Hepatitis 17(2): 130-138

Hennenberg, M.; Trebicka, J.; Fischer, H.-P.; Heller, J.ör.; Sauerbruch, T. 2009: Hepatic VASP upregulation in rats with secondary biliary cirrhosis by expression in the peribiliary vascular plexus. Microvascular Research 78(2): 235-240

Cano, A.; Ciaffoni, F.; Safwat, G.M.; Aspichueta, P.; Ochoa, B.ña.; Bravo, E.; Botham, K.M. 2009: Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?. Journal of Applied Physiology 107(3): 707-717

Gill, J.M.R.; Sattar, N. 2011: Hepatic VLDL overproduction: is hyperinsulinemia or insulin resistance the culprit?. Journal of Clinical Endocrinology and Metabolism 96(7): 2032-2034

Inoue, Y.; Saiura, A.; Arita, J.; Takahashi, Y. 2015: Hepatic Vein-Oriented Liver Resection Using Fusion Indocyanine Green Fluorescence Imaging. Annals of Surgery 262(6): E98-E99

Maithel, S.K.; Fong, Y. 2009: Hepatic ablation for neuroendocrine tumor metastases. Journal of Surgical Oncology 100(8): 635-638

Tang, W.; Zhang, X.-M.; Zhai, Z.-H.; Zeng, N.-L. 2013: Hepatic abnormal perfusion visible by magnetic resonance imaging in acute pancreatitis. World Journal of Radiology 5(12): 491-497

Feinstein, E.G.; Marr, B.P.; Winston, C.B.; Abramson, D.H. 2010: Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma. Archives of Ophthalmology 128(3): 319-323

Deshayes, S.; Galateau-Sallé, F.; de La Blanchardière, A. 2015: Hepatic abnormality. La Revue de Medecine Interne 36(5): 363-364

Tallón-Aguilar, L.; Gutiérrez-Moreno, M.; Flores-Cortés, M.; Pareja-Ciuró, F. 2008: Hepatic abscess after scrape for natural abortion. Medicina Clinica 131(17): 679

Mascarenhas, N.B.; Mulcahy, M.F.; Lewandowski, R.J.; Salem, R.; Ryu, R.K. 2010: Hepatic abscess after yttrium-90 radioembolization for islet-cell tumor hepatic metastasis. Cardiovascular and Interventional Radiology 33(3): 650-653

Soares, J.ão.-B.; Ferreira, A.íb.; Gonçalves, R. 2011: Hepatic abscess and colonic stenosis: two complications of an unlikely cause. Gastroenterology 141(3): E9

Ballardini, P.; Gamberini, S.; Margutti, G.; Manfredini, R. 2008: Hepatic abscess and silent underlying colon cancer: an emerging association?. Tumori 94(4): 624

Fusaro, F.; Lo Piccolo, R.; Scarpa, M.G.; Orzali, A.; Trafojer, U.; Zanon, G.F. 2003: Hepatic abscess and umbilical venous catheter: one cannot be cavalier about proper position. Journal of Vascular Access 4(1): 32-34

Gilardi, L.; Eugenia Dellepiane, M.ía. 2011: Hepatic abscess as first manifestation of pneumococcal invasive disease. Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 28(4): 381

Székely, A.ár.; Péter, M.óz.; Erdos, M.; Maródi, L.ás.ó 2012: Hepatic abscess as the single manifestation of X-linked chronic granulomatous disease. Pediatric Blood and Cancer 58(5): 828-829

Tulachan, S.S.; Wilkins, C.E.; Cutrona, A.F.; Gemmel, D.; Marnejon, T.P. 2013: Hepatic abscess associated with Salmonella serotype B in a chronic alcoholic patient. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 12(4): 440-442

Cardoso, C.áu.; Freire, R.; Mangualde, J.; Oliveira, A.P. 2013: Hepatic abscess caused by an ingested chicken bone. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 105(1): 44-45

Morelli, L.; Morelli, J.N.; Rosati, C.M.; Guadagni, S.; Doria, R.; Pisano, R.; Crocetti, L.; Tagliaferri, E.; Mosca, F. 2015: Hepatic abscess caused by trans-gastric migration of a fishbone. Surgical Infections 16(2): 206-208

Price, S.; Chang, T. 1946: Hepatic abscess complicating atresia of the small intestine of a newborn infant. Archives of Pathology 41: 450-453

Chatzipetrou, M.; Avgerinos, E.; Christianakis, E.; Barmparas, G.; Pashalidis, N.; Stathoulopoulos, A.; Tsatsoulis, P.; Smailis, D.; Filippou, D. 2008: Hepatic abscess in a pre-existed simple hepatic cyst as a late complication of sigmoid colon ruptured diverticula: a case report. Journal of Medical Case Reports 2: 83

Sharma, S.; Mohta, A.; Sharma, P. 2007: Hepatic abscess in a preterm neonate. Indian Pediatrics 44(3): 226-228

Santos, S.A.; Alberto, S.C.F.; Cruz, E.; Pires, E.; Figueira, Tás.; Coimbra, E.; Estevez, Jé.; Oliveira, Mário.; Novais, Lís.; Deus, Jão.R. 2007: Hepatic abscess induced by foreign body: case report and literature review. World Journal of Gastroenterology 13(9): 1466-1470

Kim, J.W.; Shin, S.S.; Heo, S.H.; Lim, H.S.; Hur, Y.H.; Kim, J.H. 2013: Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease. Clinical and Molecular Hepatology 19(4): 431-434

Staines, E. 1952: Hepatic abscess ruptured into the bronchi. Revista Mexicana de Tuberculosis y Enfermedades del Aparato Respiratorio 13(63): 61-67

Kark, W. 1945: Hepatic abscess secondarily infected; penicillin treatment. Indian Medical Gazette 80: 451

Karamarkovic, A.-R.; Djuranovic, S.-P.; Popovic, N.-P.; Bumbasirevic, V.-D.; Sijacki, A.-D.; Blazic, I.-V. 2007: Hepatic abscess secondary to a rosemary twig migrating from the stomach into the liver. World Journal of Gastroenterology 13(41): 5530-5532

Beaver, M.G.; Davis, P.B.; Smith, R.S. 1946: Hepatic abscess secondary to perforated duodenal ulcer. Northwest Medicine 45: 94-96

Huang, R.J.; Ambrosy, A.P.; Triadafilopoulos, G. 2013: Hepatic abscess with biliary communication following transarterial chemoembolization of hepatocellular carcinoma. Digestive Diseases and Sciences 58(9): 2463-2465

McKaigney, C. 2013: Hepatic abscess: case report and review. Western Journal of Emergency Medicine 14(2): 154-157

Hegarty, R.Mark.; Sanka, S.; Bansal, S. 2013: Hepatic abscess: presentation in a previously healthy teenager. Archives of Disease in Childhood 98(2): 145

Fantuzzi S, Aés.; Albertz A, Nás.; Valenzuela V, A.; Estuardo A, N.; Castro L, A. 2009: Hepatic abscess: series of 107 cases and literature review. Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 26(1): 49-53

Kinney, T.D.; Ferrebee, J.W. 1948: Hepatic abscess; factors determining its localization. Archives of Pathology 45(1): 41-47

Nikeghbalian, S.; Salahi, R.; Salahi, H.; Bahador, A.; Kakaie, F.; Kazemi, K.; Malek-Hosseini, S.Ali.; Janghorban, P. 2009: Hepatic abscesses after liver transplant: 1997-2008. Experimental and clinical transplantation: official journal of the Middle East Society for Organ Transplantation 7(4): 256-260

Campoamor Serrano, M.ía.T.; Galiana Martín, D.; Noval Menéndez, J.; de la Fuente García, B.én. 2007: Hepatic abscesses and hepatic venous thrombosis due to Fusobacterium necrophorum septicemia: Lemierre syndrome variant. Medicina Clinica 129(5): 197-198

Raposeiras Roubín, S.; Cabarcos Ortiz De Barrón, A.; Maldonado Bakovic, A.M.; Barreiro Pardal, C. 2010: Hepatic abscesses in a sepsis context due to Gemella morbillorum: base for gastric adenocarcinoma diagnosis. Revista Clinica Espanola 210(3): 146-147

Johnson, A.L.; Ducore, R.M.; Colgin, L.M.; Lewis, A.D. 2014: Hepatic abscesses in five outdoor-housed rhesus macaques (Macaca mulatta). Journal of Medical Primatology 43(6): 503-506

Sellon, D.C.; Spaulding, K.; Breuhaus, B.A.; Katz, L.; Mealey, R. 2000: Hepatic abscesses in three horses. Journal of the American Veterinary Medical Association 216(6): 882

Koral, K.F.; Huberty, J.P.; Frame, B.; Matthay, K.K.; Maris, J.M.; Regan, D.; Normolle, D.; Yanik, G.A. 2008: Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging 35(11): 2105-2112

Minet, J.; Warembourg, H.; Niquet 1950: Hepatic accidents during streptomycin therapy and their treatment by vitamin C in massive doses. La Revue du Foie 9(2): 69-72

Kamili, A.; Wat, E.; Chung, R.Ws.; Tandy, S.; Weir, J.M.; Meikle, P.J.; Cohn, J.S. 2010: Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids. Nutrition and Metabolism 7: 90

Martínez-Vázquez, M.A.; Garza-Galindo, A.A.; Barboza-Quintana, O.; Garza-Guajardo, R.; Navar-Vizcarra, S.; Rodríguez-Leal, M.C.; Maldonado-Garza, H.J. 2010: Hepatic actinomycosis ; presentation a case in a diabetic patient. Revista de Gastroenterologia de Mexico 75(3): 344-347

Ding, N.; Liddle, C.; Evans, R.M.; Downes, M. 2013: Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?. Expert Review of Clinical Pharmacology 6(6): 597-599

Jones, R.P.; Sutton, P.; Greensmith, R.M.D.; Santoyo-Castelazo, A.; Carr, D.F.; Jenkins, R.; Rowe, C.; Hamlett, J.; Park, B.K.; Terlizzo, M.; O'Grady, E.; Ghaneh, P.; Fenwick, S.W.; Malik, H.Z.; Poston, G.J.; Kitteringham, N.R. 2013: Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study. Cancer ChemoTherapy and Pharmacology 72(2): 359-368

Bode, J.G.; Albrecht, U.; Häussinger, D.; Heinrich, P.C.; Schaper, F. 2012: Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling. European Journal of Cell Biology 91(6-7): 496-505

Sander, L.E.; Sackett, S.D.; Dierssen, U.; Beraza, N.; Linke, R.P.; Müller, M.; Blander, J.M.; Tacke, F.; Trautwein, C. 2010: Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. Journal of Experimental Medicine 207(7): 1453-1464

Monetti, M.; Levin, M.C.; Watt, M.J.; Hubbard, B.K.; Newgard, C.; Farese, R.V.; Hevener, A.L.; Farese, R.V. 2011: Hepatic acyl-CoA:diacylglcyerol acyltransferase (DGAT) overexpression, diacylglycerol, and insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America 108(34): E523; Author Reply E524

Marion, V.; Sankaranarayanan, S.; de Theije, C.; van Dijk, P.; Hakvoort, T.B.M.; Lamers, W.H.; Köhler, E.S. 2013: Hepatic adaptation compensates inactivation of intestinal arginine biosynthesis in suckling mice. Plos one 8(6): E67021

Lim, D.; Lee, S.Y.; Lim, K.H.; Chan, C.Y. 2013: Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. World Journal of Gastroenterology 19(27): 4432-4436

Allmark, E. 2007: Hepatic adenoma: an unusual cause of abdominal pain. Emergency Nurse: the Journal of the Rcn Accident and Emergency Nursing Association 15(3): 18-22

Lee, P.U.Y.; Roberts, L.R.; Kaiya, J.K.; Lee, C.U. 2010: Hepatic adenomas associated with anti-epileptic drugs: a case series and imaging review. Abdominal Imaging 35(2): 208-211

Holter, S.; Pollett, A.; Zogopoulos, G.; Kim, H.; Schwenter, F.; Asai, K.; Gallinger, S.; Clendenning, M.; Steinbach, G.; Jacobson, A.; Boycott, K.M. 2011: Hepatic adenomas caused by somatic HNF1A mutations in children with biallelic mismatch repair gene mutations. Gastroenterology 140(2): 735-736

Ronald, M.; Woodfield, J.; McCall, J.; Koea, J. 2004: Hepatic adenomas in male patients. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 6(1): 25-27

Lorenzo Garrido, H.; Rotaetxe Vacas, O.; García Barcina, M.J.; Muñoz García, G.; Martín Bejarano, E. 2008: Hepatic adenomatosis. Anales de Pediatria 68(5): 526-527

Babaoglu, K.; Binnetoglu, F.K.ök.; Aydoğan, A.şe.; Altun, G.ür.; Gürbüz, Y.şi.; Inan, N.; Corapçioğlu, F. 2010: Hepatic adenomatosis in a 7-year-old child treated earlier with a Fontan procedure. Pediatric Cardiology 31(6): 861-864

Kwon, J.E.; Park, Y.N. 2008: Hepatic adenomatosis in glycogen storage disease. Korean Journal of Hepatology 14(1): 108-112

Sanli, Y.; Bakir, B.; Kuyumcu, S.; Ozkan, Z.Gozde.; Gulluoglu, M.; Bilge, O.; Turkmen, C.; Mudun, A. 2012: Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT. Clinical Nuclear Medicine 37(7): 697-698

De Kock, I.; Mortelé, K.J.; Smet, B.; Gillardin, P.; Pauwels, W.; De Backer, A.I. 2014: Hepatic adenomatosis: MR imaging features. Jbr-Btr: Organe de la Societe Royale Belge de Radiologie 97(2): 105-108

Lucas, E.; Pareja, E.; Carvajal, N.ás.; Pacheco, A.; Moya, A. 2014: Hepatic adenomatosis: a disease with controversial treatment. Cirugia Espanola 92(4): 284-286

Raman, S.P.; Hruban, R.H.; Fishman, E.K. 2013: Hepatic adenomatosis: spectrum of imaging findings. Abdominal Imaging 38(3): 474-481

Qin, Y.; Tian, Y.-P. 2010: Hepatic adiponectin receptor R2 expression is up-regulated in normal adult male mice by chronic exogenous growth hormone levels. Molecular Medicine Reports 3(3): 525-530

Shin, Y.M. 2010: Hepatic adrenal rest tumor mimicking hepatocellular carcinoma. Korean Journal of Hepatology 16(3): 338-341

Soo, K.Ling.; Azhar, R.; Ooi, L.Lucien. 2014: Hepatic adrenal rest tumour (HART): a case report. Annals of the Academy of Medicine Singapore 43(2): 120-122

Lindh, J. 2009: Hepatic adverse effects of allopurinol. Lakartidningen 106(38): 2374-2375

Schultz, A.; Neil, D.; Aguila, M.B.; Mandarim-de-Lacerda, C.A. 2013: Hepatic adverse effects of fructose consumption independent of overweight/obesity. International Journal of Molecular Sciences 14(11): 21873-21886

Anonymous 2010: Hepatic adverse effects of pregabalin (Lyrica). Lakartidningen 107(4): 194

Sherlock, S.; Walshe, V. 1947: Hepatic alkaline phosphatase; histological and microchemical studies on liver tissue in normal subjects and in liver and in bone disease. Journal of Pathology and Bacteriology 59(4): 615-630

Cabello Muriel, A.; Marín Pozo, J.F.; Alcalá Sanz, A.; Carrillo Ortiz, D. 2011: Hepatic alteration after treatment using tolvaptan. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 35(2): 94-96

De Melo, G.C.; Donatti, L.él.; Rudniki, C.ác.A.M.; Fanta, E. 2008: Hepatic alterations in the fish Rhamdia quelen contaminated with Folidol 600®. Ecotoxicology and Environmental Safety 71(3): 821-829

Yapici, O.; Erturk, S.M.; Ulusay, M.; Ozel, A.; Halefoglu, A.; Karpat, Z.; Basak, M. 2011: Hepatic alveolar echinococcosis: a diagnostic challenge. Jbr-Btr: Organe de la Societe Royale Belge de Radiologie 94(1): 21-23

Guinet, C.; Guiot, E.; De Miscault, G.; Galloy, M.-A.; Rivier, A.; Petit, C.; Morali, A. 2012: Hepatic alveolar echinococcosis: a rare cause of recurrent, surgically curable abdominal pain in children. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 19(11): 1200-1204

Skelding, A.; Brooks, A.; Stalker, M.; Mercer, N.; de Villa, E.; Gottstein, B.; Peregrine, A.S. 2014: Hepatic alveolar hydatid disease (Echinococcus multilocularis) in a boxer dog from southern Ontario. Canadian Veterinary Journal 55(6): 551-553

Rao, S.; Solaymani-Mohammadi, S.; Petri, W.A.; Parker, S.K. 2009: Hepatic amebiasis: a reminder of the complications. Current Opinion in Pediatrics 21(1): 145-149

Alemán, G.; Ortiz, V.; Contreras, A.V.; Quiroz, G.; Ordaz-Nava, G.; Langley, E.; Torres, N.; Tovar, A.R. 2013: Hepatic amino acid-degrading enzyme expression is downregulated by natural and synthetic ligands of PPARα in rats. Journal of nutrition 143(8): 1211-1218

Shin, Y.Moon. 2011: Hepatic amyloidosis. Korean Journal of Hepatology 17(1): 80-83

Janssens, F.; Spahr, L.; Rubbia-Brandt, L.; Giostra, E.; Bihl, F. 2010: Hepatic amyloidosis increases liver stiffness measured by transient elastography. Acta Gastro-Enterologica Belgica 73(1): 52-54

Wee, J.W.; Jeong, S.W.; Jang, J.Y. 2012: Hepatic amyloidosis presenting as a large hepatic mass. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 10(9): E73-E74

Juárez Olguín, H.; Figueroa Hernández, J.L.; Sandoval Ramírez, E.; Villalobos Romero, F.; Tena Suck, M.; Calderón Guzmán, D. 2008: Hepatic anatomophatologic injuries by extrahepatic biliar tract obstruction in mice. Revista de Gastroenterologia de Mexico 73(1): 17-20

Anonymous 1940: Hepatic and Renal Lesions after Severe Burns. British Medical Journal 2(4164): 559-560

Pischke, S.E.; Tronstad, C.; Holhjem, L.; Line, P.ål.D.; Haugaa, H.åk.; Tønnessen, T.I. 2012: Hepatic and abdominal carbon dioxide measurements detect and distinguish hepatic artery occlusion and portal vein occlusion in pigs. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 18(12): 1485-1494

Andrews, M.; Arredondo, M. 2012: Hepatic and adipocyte cells respond differentially to iron overload, hypoxic and inflammatory challenge. Biometals: An International Journal on the Role of Metal Ions in Biology Biochemistry and Medicine 25(4): 749-759

Kamath, S.M.; Nagaraj, H.K.; Mysorekar, V.V. 2013: Hepatic and adrenal hemangioendothelioma-a case report. Journal of Clinical and Diagnostic Research: Jcdr 7(11): 2583-2584

Das, A.K. 2014: Hepatic and biliary ascariasis. Journal of Global Infectious Diseases 6(2): 65-72

Sun, Z.; Li, G.; Ai, X.; Luo, B.; Wen, Y.; Zhao, Z.; Dong, S.; Guan, J. 2011: Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism. Critical Reviews in Oncology/Hematology 79(2): 164-174

Gyorgy, P. 1947: Hepatic and biliary disorders. Philadelphia Medicine 43(19): 629

Godinov, V.M. 1952: Hepatic and biliary nerves in man. Arkhiv Anatomii Gistologii i Embriologii 29(3): 41-47

Burlamaqui, I.ál.M.B.; Dornelas, C.ção.A.; Valença, J.é T.; Mesquita, F.J.C.; Veras, L.B.; Rodrigues, L.V. 2011: Hepatic and biochemical repercussions of a polyunsaturated fat-rich hypercaloric and hyperlipidic diet in Wistar rats. Arquivos de Gastroenterologia 48(2): 153-158

O'Glasser, A.Y.; Scott, D.L.; Corless, C.L.; Zaman, A.; Sasaki, A.; Gopal, D.V.; Rayhill, S.C.; Orloff, S.L.; Ham, J.M.; Rabkin, J.M.; Flora, K.; Davies, C.H.; Broberg, C.S.; Schwartz, J.M. 2010: Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation. Clinical Transplantation 24(5): 643-651

Bugianesi, E.; Gastaldelli, A. 2012: Hepatic and cardiac steatosis: are they coupled?. Heart Failure Clinics 8(4): 663-670

Petrova, Z.V.; Korshunov, D.A.; Slepichev, V.A.; Zyuz'kova, Y.G.; Yanovskaya, E.A.; Stykon, G.A.; Udut, V.V. 2010: Hepatic and cerebral energy production system in rats with acute and chronic ethanol intoxication. Bulletin of Experimental Biology and Medicine 149(2): 208-212

El Ouahabi, H.; Do Cao, C.; Janicki, E.; Mulliez, E.; Ajdi, F.; Wémeau, J.-L. 2011: Hepatic and cutaneous affections induced by antithyroid drugs revealing haemochromatosis and porphyria cutanea tarda. Presse Medicale 40(3): 319-323

Faustini, A.; Colais, P.; Fabrizi, E.; Bargagli, A.M.; Davoli, M.; Di Lallo, D.; Di Napoli, A.; Pezzotti, P.; Sorge, C.; Grillo, R.; Maresca, C.; Recchia, O.; Perucci, C.A. 2010: Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups. Bmc Infectious Diseases 10: 97

Jin, Y.; Wang, W.; Sheng, G.D.; Liu, W.; Fu, Z. 2008: Hepatic and extrahepatic expression of estrogen-responsive genes in male adult zebrafish (Danio rerio) as biomarkers of short-term exposure to 17beta-estradiol. Environmental Monitoring and Assessment 146(1-3): 105-111

Saremi, B.; Mielenz, M.; Rahman, M.M.; Hosseini, A.; Kopp, C.; Dänicke, S.; Ceciliani, F.; Sauerwein, H. 2013: Hepatic and extrahepatic expression of serum amyloid A3 during lactation in dairy cows. Journal of Dairy Science 96(11): 6944-6954

Werner, M.år.; Almer, S.; Prytz, H.; Lindgren, S.; Wallerstedt, S.; Björnsson, E.; Bergquist, A.; Sandberg-Gertzén, H.; Hultcrantz, R.; Sangfelt, P.; Weiland, O.; Danielsson, A. 2009: Hepatic and extrahepatic malignancies in autoimmune hepatitis. a long-term follow-up in 473 Swedish patients. Journal of Hepatology 50(2): 388-393

Chen, Y.; Zhang, W.; Li, D.; Ai, J.; Meng, Y.; Ying, X.; Kang, T. 2013: Hepatic and gastrointestinal first-pass effects of vitexin-4″-O-glucoside in rats. Journal of Pharmacy and Pharmacology 65(10): 1500-1507

Pal, A.; Vasishta, R.k.; Prasad, R. 2013: Hepatic and hippocampus iron status is not altered in response to increased serum ceruloplasmin and serum "free" copper in Wistar rat model for non-Wilsonian brain copper toxicosis. Biological Trace Element Research 154(3): 403-411

Osselaere, A.; De Bock, L.; Eeckhaut, V.; De Backer, P.; Van Bocxlaer, J.; Boussery, K.; Croubels, S. 2013: Hepatic and intestinal CYP3A expression and activity in broilers. Journal of Veterinary Pharmacology and Therapeutics 36(6): 588-593

Yoshida, K.; Maeda, K.; Sugiyama, Y. 2013: Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms. Annual Review of Pharmacology and Toxicology 53: 581-612

Vannozzi, G.; Tozzi, A.; Chibbaro, G.; Mello, G.; Ponzalli, M. 2008: Hepatic and mesenteric sarcoidosis without thoracic involvement: a case of severe noncirrhotic portal hypertension and successful pregnancy. European Journal of Gastroenterology and Hepatology 20(10): 1032-1035

Underwood, C.; Southwood, L.L.; Walton, R.M.; Johnson, A.L. 2010: Hepatic and metabolic changes in surgical colic patients: a pilot study. Journal of Veterinary Emergency and Critical Care 20(6): 578-586

Kalisinska, E.; Gorecki, J.; Okonska, A.; Pilarczyk, B.; Tomza-Marciniak, A.; Budis, H.; Lanocha, N.; Kosik-Bogacka, D.I.; Kavetska, K.M.; Macherzynski, M.; Golas, J. 2014: Hepatic and nephric mercury and selenium concentrations in common mergansers, Mergus merganser, from Baltic Region, Europe. Environmental Toxicology and Chemistry 33(2): 421-430

Resić, J.; Cikes-Culić, V.; Zemunik, T.; Markotić, A. 2011: Hepatic and pancreatic glycosphingolipid phenotypes of the neurological different rat strains. Collegium Antropologicum 35(Suppl 1): 259-263

Barbas, A.S.; Speicher, P.J.; Clary, B.M. 2014: Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis. Hpb: the Official Journal of the International Hepato Pancreato Biliary Association 16(11): 1016-1022

Kordes, C.; Sawitza, I.; Häussinger, D. 2009: Hepatic and pancreatic stellate cells in focus. Biological Chemistry 390(10): 1003-1012

Egorov, V.I. 2007: Hepatic and pancreatic surgery at university hospitals of Germany. Khirurgiia 2007(9): 77-79

Marolf, A.J.; Stewart, J.A.; Dunphy, T.R.; Kraft, S.L. 2011: Hepatic and pancreaticobiliary MRi and mr cholangiopancreatography with and without secretin stimulation in normal cats. Veterinary Radiology and Ultrasound: the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 52(4): 415-421

Beranger-Gibert, S.; Lagadec, M.; Boulay-Coletta, I.; Petit, E.; Barrau, V.; Zins, M.; Vilgrain, V.ér.; Ronot, M. 2015: Hepatic and perihepatic involvement of female genital diseases and pregnancy: a review. Abdominal Imaging 40(5): 1331-1349

Cohn, C.; Levine, R.; Kolinsky, M. 1948: Hepatic and peripheral removal rates, in the dog, for intravenously injected bromsulphalein. American Journal of Physiology 155(2): 286-289

Marks, K.A.; Kitson, A.P.; Stark, K.D. 2013: Hepatic and plasma sex differences in saturated and monounsaturated fatty acids are associated with differences in expression of elongase 6, but not stearoyl-CoA desaturase in Sprague-Dawley rats. Genes and Nutrition 8(3): 317-327

Bozgeyik, Z.; Ozdemir, H.; Kocakoc, E.; Simsek, M. 2009: Hepatic and portal venous Doppler waveforms and flow velocities in normal pregnancy. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 15(12): Cr624-Cr627

Develoux, M.; Enache-Angoulvant, A.; Gounant, V.; Brian, E.; Khalil, A.; Bazelly, B.; Hennequin, C. 2011: Hepatic and pulmonary cystic echinococcosis in a patient from the Central African Republic. Travel Medicine and Infectious Disease 9(2): 88-90

Yim, H.E.; Choi, B.M.; Rhie, Y.J.; Yoo, K.H.; Hong, Y.S.; Lee, J.W. 2011: Hepatic and pulmonary nodular lesions in pediatric urinary tract infections. Pediatric Nephrology 26(3): 425-431

Bourdon, J.A.; Halappanavar, S.; Saber, A.T.; Jacobsen, N.R.; Williams, A.; Wallin, Håkan.; Vogel, U.; Yauk, C.L. 2012: Hepatic and pulmonary toxicogenomic profiles in mice intratracheally instilled with carbon black nanoparticles reveal pulmonary inflammation, acute phase response, and alterations in lipid homeostasis. Toxicological Sciences: An Official Journal of the Society of Toxicology 127(2): 474-484

Lossnitzer, D.; Schwenger, V.; Lehrke, S.; Giannitsis, E.; Zeier, M.; Katus, H.A.; Steen, H. 2010: Hepatic and renal failure after anterior myocardial infarction induced apical ventricular septal defect. Case Reports in Medicine 2010: 645236

Deo, S.V.; Sharma, V.; Altarabsheh, S.E.; Hasin, T.; Dillon, J.; Shah, I.K.; Durham, L.A.; Stulak, J.M.; Daly, R.C.; Joyce, L.D.; Park, S.J. 2014: Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. Heart Lung and Circulation 23(3): 229-233

Yıldız, N.; Barlas, N. 2013: Hepatic and renal functions in growing male rats after bisphenol a and octylphenol exposure. Human and Experimental Toxicology 32(7): 675-686

Qiao, H-Xiang.; Liu, Y-Ye.; Wu, L-Mao.; Li, L-Da. 2008: Hepatic and renal injury induced by Radix Aristolochiae or Guanxin Suhe Wan for a long-term in rats. Zhongguo Zhong Yao Za Zhi 33(9): 1044-1048

Van Gulick, J.J.M.; Gevers, T.J.G.; van Keimpema, L.; Drenth, J.P.H. 2011: Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum. Netherlands Journal of Medicine 69(9): 367-371

Herbut, P.A.; Watson, J.S.; Perkins, E. 1946: Hepatic and renal necrosis in alloxan diabetes of rabbits. Archives of Pathology 41: 516-525

Diaz, G.C.; Moitra, V.; Sladen, R.N. 2008: Hepatic and renal protection during cardiac surgery. Anesthesiology Clinics 26(3): 565-590

Ribeiro-Rama, A.C.; Figueiredo, I.V.ór.; Veiga, F.J.é; Castel-Branco, M.M.; Cabrita, A.ón.M.S.ér.; Caramona, M.M. 2011: Hepatic and renal toxicities of indomethacin acid, salt form and complexed forms with hydroxypropyl-β-cyclodextrin on Wistar rats after oral administration. Fundamental and Clinical Pharmacology 25(5): 599-607

Cadranel, J.-F.; Demontis, R.; Seddik, M.; Ramdani, S.; Belloula, D.; Biour, M. 2008: Hepatic and renal toxicity to fluindione (Previscan). Gastroenterologie Clinique et Biologique 32(10): 816-818

Coman, I.; Crişan, N.; Petrut, B.; Bungărdean, C.ăt.ăl.; Cristea, T.; Crişan, D. 2007: Hepatic and skin metastases after laparoscopic radical prostatectomy for prostate cancer. Journal of Gastrointestinal and Liver Diseases: Jgld 16(3): 333-335

Fisichella, P.M.; Donaldson, K.; Helton, W.S. 2008: Hepatic and splenic hydatidosis managed with percutaneous aspiration, injection, and reaspiration (PAIR) of the hepatic cyst and laparoscopic splenectomy. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 12(9): 1615-1617

Jang, H.Y.; Cha, S.-W.; Lee, B.H.; Jung, H.E.; Choo, J.W.; Cho, Y.-J.; Ju, H.Y.; Cho, Y.D. 2013: Hepatic and splenic infarction and bowel ischemia following endoscopic ultrasound-guided celiac plexus neurolysis. Clinical Endoscopy 46(3): 306-309

Zhang, W.; Chen, B.; Deng, H.; Yang, T.; Ou, X. 2013: Hepatic and splenic uptake on bone scintigraphy in patients with intravenous administration of 99mTc methylene diphosphonate prior to gadolinium-containing contrast. Clinical Nuclear Medicine 38(3): 219-220

Olteanu, D.; Nagy, A.; Dudea, M.; Filip, A.; Muresan, A.; Catoi, C.; Mircea, P.A.; Clichici, S. 2012: Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 63(5): 483-496

Garg, H.; Kumar, A.; Garg, V.; Kumar, M.; Kumar, R.; Sharma, B.Chander.; Sarin, S.Kumar. 2013: Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure. Journal of Gastroenterology and Hepatology 28(8): 1361-1367

Kotenko, O.G.; Grinenko, A.V.; Popov, A.O.; Korshak, A.A.; Gusev, A.V.; Fedorov, D.A.; Andreeshchev, S.A. 2007: Hepatic and the portal vein resection in the surgical treatment of hepatocellular carcinoma. Klinichna Khirurhiia 2007(1): 5-11

Bugiak, B.; Weber, L.P. 2009: Hepatic and vascular mRNA expression in adult zebrafish (Danio rerio) following exposure to benzo-a-pyrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Aquatic Toxicology 95(4): 299-306

Bouanane, S.; Merzouk, H.; Benkalfat, N.Batoul.; Soulimane, N.; Merzouk, S.Ahmed.; Gresti, J.; Tessier, C.; Narce, M. 2010: Hepatic and very low-density lipoprotein fatty acids in obese offspring of overfed dams. Metabolism, Clinical and Experimental 59(12): 1701-1709

Hulsberg, P.; Garza-Jordan, J.d.l.; Jordan, R.; Matusz, P.; Tubbs, R.S.; Loukas, M. 2011: Hepatic aneurysm: a review. American Surgeon 77(5): 586-591

Stabile Ianora, A.A.; Telegrafo, M.; Fucilli, F.; Scardapane, A.; Moschetta, M. 2014: Hepatic angio-sarcoma: An unusual source of intra-hepatic bleeding. International Journal of Surgery Case Reports 5(4): 203-205

Misselbeck, T.S.; Teicher, E.J.; Cipolle, M.D.; Pasquale, M.D.; Shah, K.T.; Dangleben, D.A.; Badellino, M.M. 2009: Hepatic angioembolization in trauma patients: indications and complications. Journal of Trauma 67(4): 769-773

Lamy, M.; Jammet, M.L.; Pellerin, D.; Guibert, C. 1961: Hepatic angiomatosis. Revue Medicale de France 42: 205-210

Petrolla, A.A.; Xin, W. 2008: Hepatic angiomyolipoma. Archives of Pathology and Laboratory Medicine 132(10): 1679-1682

Hassani, K.I.M.; Souiki, T. 2013: Hepatic angiomyolipoma. Pan African Medical Journal 16: 107

Marsilia, G.M.; Boscaino, A.; La Mura, A.; Ceriello, A.; De Ritis, R. 2010: Hepatic angiomyolipoma and intramural small intestinal schwannoma: a coincidence or a relationship?. International Journal of Surgical Pathology 18(6): 537-539

Levi Sandri, G.B.; Ettorre, G.M.; Vennarecci, G. 2014: Hepatic angiomyolipoma and neurofibromatosis type 2: a novel association. Liver international: official journal of the International Association for the Study of the Liver 34(9): 1445

Bilbao, I.; Castro, E.; Dopazo, C.; Castro, S.; Allende, E.; Genesca, J.; Tallada, N.; Quiroga, S.; Margarit, C. 2007: Hepatic angiomyolipoma in two patients infected with hepatitis C virus. Gastroenterologia y Hepatologia 30(4): 222-228

Chen, P.; Yuan, T.; Liu, H. 2009: Hepatic angiomyolipoma mimicking hepatic clear cell carcinoma. Journal of International Medical Research 37(1): 257-263

Tani, A.; Yoshida, H.; Mamada, Y.; Taniai, N.; Mineta, S.; Yoshioka, M.; Kawano, Y.; Ueda, J.; Naito, Z.; Uchida, E. 2011: Hepatic angiomyolipoma with a giant hemangioma. Journal of Nippon Medical School 78(5): 317-321

Lee, S.J.; Kim, S.Y.; Kim, K.W.; Shin, Y.M.; Kim, H.J.; Lee, J.S.; Kim, S.A. 2012: Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma. Clinical and Molecular Hepatology 18(3): 330-335

Hwang, I.; Yu, E.; Cho, K.-j. 2012: Hepatic angiomyolipoma with variable histologic features: 8 cases resembling hepatocellular carcinoma or inflammatory pseudotumor. Korean Journal of Gastroenterology 60(4): 242-248

Cai, P.-q.; Wu, Y.-p.; Xie, C.-m.; Zhang, W.-d.; Han, R.; Wu, P.-h. 2013: Hepatic angiomyolipoma: CT and MR imaging findings with clinical-pathologic comparison. Abdominal Imaging 38(3): 482-489

Nakashima, A.; Murakami, Y.; Uemura, K.; Hayashidani, Y.; Sudo, T.; Hashimoto, Y.; Arihiro, K.; Sueda, T. 2010: Hepatic angiomyolipoma: a case report. Hiroshima Journal of Medical Sciences 59(1): 17-19

Gupta, A.; Ramakrishna, B. 2013: Hepatic angiomyolipoma: a case report with diagnostic challenge. Indian Journal of Pathology and Microbiology 56(3): 279-281

Iribarren Díaz, M.; Lojo Sánchez, J.L.; Carracedo Iglesias, R.; de Castro Parga, G.; Díaz Cardamas, P.; Tardío Baiges, A.; Casal Nuñez, E. 2008: Hepatic angiomyolipoma: a challenging preoperative diagnosis. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 100(10): 661-663

Zeng, J.-P.; Dong, J.-H.; Zhang, W.-Z.; Wang, J.; Pang, X.-P. 2010: Hepatic angiomyolipoma: a clinical experience in diagnosis and treatment. Digestive Diseases and Sciences 55(11): 3235-3240

Li, T.; Wang, L.; Yu, H-Hua.; Sun, H-Chuan.; Qin, L-Xiu.; Ye, Q-Hai.; Fan, J.; Tang, Z-You. 2008: Hepatic angiomyolipoma: a retrospective study of 25 cases. Surgery Today 38(6): 529-535

Agaimy, A.; Vassos, N.; Croner, R.S.; Strobel, D.; Lell, M. 2012: Hepatic angiomyolipoma: a series of six cases with emphasis on pathological-radiological correlations and unusual variants diagnosed by core needle biopsy. International Journal of Clinical and Experimental Pathology 5(6): 512-521

Wei, R.-X.; Wang, W.-P.; Ding, H.; Huang, B.-J.; Li, C.-L.; Fan, P.-L.; Hou, J.; He, N.-A. 2012: Hepatic angiomyolipoma: contrast patterns with SonoVue-enhanced real-time gray-scale ultrasonography. Asian Pacific Journal of Cancer Prevention: Apjcp 13(2): 493-497

Kamimura, K.; Nomoto, M.; Aoyagi, Y. 2012: Hepatic angiomyolipoma: diagnostic findings and management. International Journal of Hepatology 2012: 410781

Yang, B.; Chen, W.-H.; Li, Q.-Y.; Xiang, J.-J.; Xu, R.-J. 2009: Hepatic angiomyolipoma: dynamic computed tomography features and clinical correlation. World Journal of Gastroenterology 15(27): 3417-3420

Xu, L.; Shao, Y.; Zhang, H.; Wang, H. 2002: Hepatic angiomyolipoma: report of 8 cases and review of literature. Asian Journal of Surgery 25(1): 82

Barbier, L.; Torrents, J.; Hardwigsen, J. 2014: Hepatic angiomyolipoma: what management?. Acta Chirurgica Belgica 114(2): 139-142

Terzi, Aşen.; Deniz, E.Ebru.; Haberal, N.; Moray, Gökhan.; Özdemir, B.Handan. 2014: Hepatic angiosarcoma and liver transplant: a report of 2 cases with diagnostic difficulties. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation 12 Suppl. 1: 126-128

Kulkarni, M.P.; Agashe, S.R.; Singh, R.V.; Sulhyan, K.R. 2010: Hepatic angiosarcoma arising in an adult mesenchymal hamartoma. Indian Journal of Pathology and Microbiology 53(2): 322-324

Cioffi-Pretti, J.L.; Kalof, A.N.; Ebert, G.; McCahill, L.E. 2009: Hepatic angiosarcoma five years following spontaneous intraperitoneal bleed of a hepatic mass. Rare Tumors 1(2): E33

Smith, P.M.; Williams, D.M.; Evans, D.M.; Path, F.R. 1976: Hepatic angiosarcoma in a vinyl chloride worker. Bulletin of the New York Academy of Medicine 52(4): 447-452

Lee, S.-W.; Song, C.-Y.; Gi, Y.-H.; Kang, S.-B.; Kim, Y.-S.; Nam, S.-W.; Lee, D.-S.; Kim, J.-O. 2008: Hepatic angiosarcoma manifested as recurrent hemoperitoneum. World Journal of Gastroenterology 14(18): 2935-2938

Geramizadeh, B.; Safari, A.; Bahador, A.; Nikeghbalian, S.; Salahi, H.; Kazemi, K.; Dehghani, S-Mohsen.; Malek-Hosseini, S-Ali. 2011: Hepatic angiosarcoma of childhood: a case report and review of literature. Journal of Pediatric Surgery 46(1): E9-11

Yasunaka, T.; Ikeda, F.; Kobashi, H.; Miyake, Y.; Takaki, A.; Iwasaki, Y.; Hada, H.; Yamamoto, K.; Nakano, M. 2012: Hepatic angiosarcoma with characteristic laparoscopic findings. Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society 24(2): 124

Huang, H.; Le, X.-H.; Zhou, B.-P.; Lu, P.-X. 2014: Hepatic angiosarcoma with multiple metastases in a young man. Quantitative Imaging in Medicine and Surgery 4(4): 291-293

Egea Valenzuela, J.; López Poveda, M.J.; Pérez Fuenzalida, F.J.; Garre Sánchez, C.; Martínez Barba, E.; Carballo Alvarez, F. 2009: Hepatic angiosarcoma. Presentation of two cases. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 101(6): 430

Matsumoto, M.; Tamura, M.; Komiya, T.; Aridome, G.; Narita, R.; Hisaoka, M.; Ohtsuki, M.; Otsuji, Y. 2009: Hepatic angiosarcoma: a rare liver tumor in a hemodialysis patient. Clinical Nephrology 71(5): 590-592

Meng, S.Long.; Chen, J.Zhang.; Xu, P.; Qu, J.Hong.; Fan, L.Min.; Song, C.; Qiu, L.Ping. 2014: Hepatic antioxidant enzymes SOD and CAT of Nile tilapia (Oreochromis niloticus) in response to pesticide methomyl and recovery pattern. Bulletin of Environmental Contamination and Toxicology 92(4): 388-392

Hegseth, M.N.øs.; Camus, L.; Helgason, L.B.; Bocchetti, R.; Gabrielsen, G.W.; Regoli, F. 2011: Hepatic antioxidant responses related to levels of PCBs and metals in chicks of three Arctic seabird species. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 154(1): 28-35

Sai-Ching, J.Y.; Chan, L. 1998: Hepatic apolipoprotein B biogenesis: an update. Trends in Cardiovascular Medicine 8(1): 8-14

Liu, M.; Seo, J.; Allegood, J.; Bi, X.; Zhu, X.; Boudyguina, E.; Gebre, A.K.; Avni, D.; Shah, D.; Sorci-Thomas, M.G.; Thomas, M.J.; Shelness, G.S.; Spiegel, S.; Parks, J.S. 2014: Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. Journal of Biological Chemistry 289(5): 2801-2814

Marshall, A.H.; Brooks, N.C.; Hiyama, Y.; Qa'aty, N.; Al-Mousawi, A.; Finnerty, C.C.; Jeschke, M.G. 2013: Hepatic apoptosis postburn is mediated by c-Jun N-terminal kinase 2. Shock 39(2): 183-188

Yu, Y.; Zhang, C.; Liu, L.; Li, X. 2013: Hepatic arterial administration of ginsenoside Rg3 and transcatheter arterial embolization for the treatment of VX2 liver carcinomas. Experimental and Therapeutic Medicine 5(3): 761-766

Lyass, S.; Lyass, O.; Gabizon, A.; Peretz, T.; Eid, A.; Muggiasullam, M.; Durst, A.; Shiloni, E. 1996: Hepatic arterial bolus chemotherapy for colorectal metastases using an implantable port. International Journal of Oncology 9(6): 1295-1299

Sanada, Y.; Mizuta, K.; Urahashi, T.; Ihara, Y.; Wakiya, T.; Okada, N.; Yamada, N.; Egami, S.; Hishikawa, S.; Ushijima, K.; Otomo, S.; Sakamoto, K.; Yasuda, Y.; Kawarasaki, H. 2011: Hepatic arterial buffer response after pediatric living donor liver transplantation: report of a case. Transplantation Proceedings 43(10): 4019-4024

Sharma, K.V.; Gould, J.E.; Harbour, J.W.; Linette, G.P.; Pilgram, T.K.; Dayani, P.N.; Brown, D.B. 2008: Hepatic arterial chemoembolization for management of metastatic melanoma. AJR. American Journal of Roentgenology 190(1): 99-104

Gaur, S.K.; Friese, J.L.; Sadow, C.A.; Ayyagari, R.; Binkert, C.A.; Schenker, M.P.; Kulke, M.; Baum, R. 2011: Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver. Cardiovascular and Interventional Radiology 34(3): 566-572

Iida, T.; Kaido, T.; Yagi, S.; Hori, T.; Uchida, Y.; Jobara, K.; Tanaka, H.; Sakamoto, S.; Kasahara, M.; Ogawa, K.; Ogura, Y.; Mori, A.; Uemoto, S. 2014: Hepatic arterial complications in adult living donor liver transplant recipients: a single-center experience of 673 cases. Clinical Transplantation 28(9): 1025-1030

Van den Hoven, A.F.; van Leeuwen, M.S.; Lam, M.G.E.H.; van den Bosch, M.A.A.J. 2015: Hepatic arterial configuration in relation to the segmental anatomy of the liver; observations on MDCT and DSA relevant to radioembolization treatment. Cardiovascular and Interventional Radiology 38(1): 100-111

Kobayashi, K.; Szklaruk, J.; Trent, J.C.; Ensor, J.; Ahrar, K.; Wallace, M.J.; Madoff, D.C.; Murthy, R.; Hicks, M.E.; Gupta, S. 2009: Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. American Journal of Clinical Oncology 32(6): 574-581

Kamat, P.P.; Gupta, S.; Ensor, J.E.; Murthy, R.; Ahrar, K.; Madoff, D.C.; Wallace, M.J.; Hicks, M.E. 2008: Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovascular and Interventional Radiology 31(2): 299-307

Ou, H.-Y.; Concejero, A.M.; Yu, C.-Y.; Huang, T.-L.; Chen, T.-Y.; Tsang, L.L.-c.; Chen, C.-L.; Wang, S.-H.; Cheng, Y.-F. 2011: Hepatic arterial embolization for massive bleeding from an intrahepatic artery pseudoaneurysm using N-butyl-2-cyanoacrylate after living donor liver transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation 24(3): E19-E22

Lee, E.; Leon Pachter, H.; Sarpel, U. 2012: Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors. International Journal of Hepatology 2012: 471203

Del Prete, M.; Fiore, F.; Modica, R.; Marotta, V.; Marciello, F.; Ramundo, V.; Di Sarno, A.; Carratù, A.; di Roseto, C.d.L.; Tafuto, S.; Tatangelo, F.; Baldelli, R.; Colao, A.; Faggiano, A. 2014: Hepatic arterial embolization in patients with neuroendocrine tumors. Journal of Experimental and Clinical Cancer Research: Cr 33: 43

Letoublon, C.; Morra, I.; Chen, Y.; Monnin, V.; Voirin, D.; Arvieux, C. 2011: Hepatic arterial embolization in the management of blunt hepatic trauma: indications and complications. Journal of Trauma 70(5): 1032-1036; Discussion: 1036-1037

Maire, F.éd.ér.; Lombard-Bohas, C.; O'Toole, D.; Vullierme, M.-P.; Rebours, V.; Couvelard, A.; Pelletier, A.L.; Zappa, M.; Pilleul, F.; Hentic, O.; Hammel, P.; Ruszniewski, P. 2012: Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study. Neuroendocrinology 96(4): 294-300

Pohlen, U.; Buhr, H.J.; Berger, G.; Ritz, J.ör.-P.; Holmer, C. 2012: Hepatic arterial infusion (HAI) with PEGylated liposomes containing 5-FU improves tumor control of liver metastases in a rat model. Investigational new Drugs 30(3): 927-935

Bolton, J.S.; O'Connell, M.J.; Mahoney, M.R.; Farr, G.H.; Fitch, T.R.; Maples, W.J.; Nagorney, D.M.; Rubin, J.; Fuloria, J.; Steen, P.D.; Alberts, S.R. 2012: Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase Ii study, 92-46-52. Clinical Colorectal Cancer 11(1): 31-37

Sperling, J.; Schäfer, T.; Benz-Weißer, A.; Ziemann, C.; Scheuer, C.; Kollmar, O.; Schilling, M.K.; Menger, M.D. 2013: Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases. International Journal of Colorectal Disease 28(4): 555-562

Matsumoto, T.; Yamagami, T.; Yoshimatsu, R.; Morishita, H.; Kitamura, N.; Sato, O.; Hasebe, T. 2014: Hepatic arterial infusion chemotherapy by the fixed-catheter-tip method: retrospective comparison of percutaneous left subclavian and femoral port-catheter system implantation. Ajr. American Journal of Roentgenology 202(1): 211-215